<?xml version="1.0" encoding="UTF-8"?><!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD with MathML3 v1.3 20210610//EN"  "JATS-archivearticle1-3-mathml3.dtd"><article xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xmlns:xlink="http://www.w3.org/1999/xlink" article-type="research-article" dtd-version="1.3"><front><journal-meta><journal-id journal-id-type="nlm-ta">elife</journal-id><journal-id journal-id-type="publisher-id">eLife</journal-id><journal-title-group><journal-title>eLife</journal-title></journal-title-group><issn publication-format="electronic" pub-type="epub">2050-084X</issn><publisher><publisher-name>eLife Sciences Publications, Ltd</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">87081</article-id><article-id pub-id-type="doi">10.7554/eLife.87081</article-id><article-id pub-id-type="doi" specific-use="version">10.7554/eLife.87081.3</article-id><article-categories><subj-group subj-group-type="display-channel"><subject>Research Article</subject></subj-group><subj-group subj-group-type="heading"><subject>Stem Cells and Regenerative Medicine</subject></subj-group></article-categories><title-group><article-title>Human skeletal muscle organoids model fetal myogenesis and sustain uncommitted PAX7 myogenic progenitors</article-title></title-group><contrib-group><contrib contrib-type="author" corresp="yes" id="author-206469"><name><surname>Mavrommatis</surname><given-names>Lampros</given-names></name><email>lampros.mavrommatis@rub.de</email><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="aff" rid="aff3">3</xref><xref ref-type="fn" rid="con1"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" corresp="yes" id="author-152113"><name><surname>Jeong</surname><given-names>Hyun-Woo</given-names></name><contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0002-6976-6739</contrib-id><email>hyun-woo.jeong@mpi-muenster.mpg.de</email><xref ref-type="aff" rid="aff4">4</xref><xref ref-type="fn" rid="con2"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-307730"><name><surname>Kindler</surname><given-names>Urs</given-names></name><contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0001-9676-6323</contrib-id><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="con3"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-206470"><name><surname>Gomez-Giro</surname><given-names>Gemma</given-names></name><xref ref-type="aff" rid="aff5">5</xref><xref ref-type="fn" rid="con4"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-206471"><name><surname>Kienitz</surname><given-names>Marie-Cecile</given-names></name><xref ref-type="aff" rid="aff6">6</xref><xref ref-type="fn" rid="con5"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-194060"><name><surname>Stehling</surname><given-names>Martin</given-names></name><xref ref-type="aff" rid="aff7">7</xref><xref ref-type="fn" rid="con6"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-280214"><name><surname>Psathaki</surname><given-names>Olympia E</given-names></name><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="aff" rid="aff8">8</xref><xref ref-type="fn" rid="con7"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-91223"><name><surname>Zeuschner</surname><given-names>Dagmar</given-names></name><contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0002-6712-0192</contrib-id><xref ref-type="aff" rid="aff9">9</xref><xref ref-type="fn" rid="con8"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-206473"><name><surname>Bixel</surname><given-names>M Gabriele</given-names></name><xref ref-type="aff" rid="aff10">10</xref><xref ref-type="fn" rid="con9"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-307731"><name><surname>Han</surname><given-names>Dong</given-names></name><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="fn" rid="con10"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-206474"><name><surname>Morosan-Puopolo</surname><given-names>Gabriela</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="con11"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-186639"><name><surname>Gerovska</surname><given-names>Daniela</given-names></name><xref ref-type="aff" rid="aff11">11</xref><xref ref-type="fn" rid="con12"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-307732"><name><surname>Yang</surname><given-names>Ji Hun</given-names></name><xref ref-type="aff" rid="aff12">12</xref><xref ref-type="aff" rid="aff13">13</xref><xref ref-type="fn" rid="con13"/><xref ref-type="fn" rid="conf2"/></contrib><contrib contrib-type="author" id="author-131358"><name><surname>Kim</surname><given-names>Jeong Beom</given-names></name><contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0001-6230-8826</contrib-id><xref ref-type="aff" rid="aff14">14</xref><xref ref-type="fn" rid="con14"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-206475"><name><surname>Arauzo-Bravo</surname><given-names>Marcos J</given-names></name><contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0002-3264-464X</contrib-id><xref ref-type="aff" rid="aff11">11</xref><xref ref-type="fn" rid="con15"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-35633"><name><surname>Schwamborn</surname><given-names>Jens C</given-names></name><contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0003-4496-0559</contrib-id><xref ref-type="aff" rid="aff5">5</xref><xref ref-type="fn" rid="con16"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-157114"><name><surname>Hahn</surname><given-names>Stephan A</given-names></name><contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0003-0855-9741</contrib-id><xref ref-type="aff" rid="aff15">15</xref><xref ref-type="fn" rid="con17"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-15679"><name><surname>Adams</surname><given-names>Ralf H</given-names></name><contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0003-3031-7677</contrib-id><xref ref-type="aff" rid="aff10">10</xref><xref ref-type="aff" rid="aff16">16</xref><xref ref-type="fn" rid="con18"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-206476"><name><surname>Schöler</surname><given-names>Hans R</given-names></name><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="fn" rid="con19"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-206477"><name><surname>Vorgerd</surname><given-names>Matthias</given-names></name><xref ref-type="aff" rid="aff3">3</xref><xref ref-type="fn" rid="con20"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-206478"><name><surname>Brand-Saberi</surname><given-names>Beate</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="other" rid="fund1"/><xref ref-type="fn" rid="con21"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" corresp="yes" id="author-204426"><name><surname>Zaehres</surname><given-names>Holm</given-names></name><contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0001-8062-8428</contrib-id><email>holm.zaehres@rub.de</email><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="other" rid="fund1"/><xref ref-type="other" rid="fund2"/><xref ref-type="fn" rid="con22"/><xref ref-type="fn" rid="conf1"/></contrib><aff id="aff1"><label>1</label><institution-wrap><institution-id institution-id-type="ror">https://ror.org/04tsk2644</institution-id><institution>Ruhr University Bochum, Medical Faculty, Institute of Anatomy, Department of Anatomy and Molecular Embryology</institution></institution-wrap><addr-line><named-content content-type="city">Bochum</named-content></addr-line><country>Germany</country></aff><aff id="aff2"><label>2</label><institution-wrap><institution-id institution-id-type="ror">https://ror.org/040djv263</institution-id><institution>Max Planck Institute for Molecular Biomedicine, Department of Cell and Developmental Biology</institution></institution-wrap><addr-line><named-content content-type="city">Münster</named-content></addr-line><country>Germany</country></aff><aff id="aff3"><label>3</label><institution-wrap><institution-id institution-id-type="ror">https://ror.org/04j9bvy88</institution-id><institution>Department of Neurology with Heimer Institute for Muscle Research, University Hospital Bergmannsheil</institution></institution-wrap><addr-line><named-content content-type="city">Bochum</named-content></addr-line><country>Germany</country></aff><aff id="aff4"><label>4</label><institution-wrap><institution-id institution-id-type="ror">https://ror.org/040djv263</institution-id><institution>Max Planck Institute for Molecular Biomedicine, Sequencing Core Facility</institution></institution-wrap><addr-line><named-content content-type="city">Münster</named-content></addr-line><country>Germany</country></aff><aff id="aff5"><label>5</label><institution-wrap><institution-id institution-id-type="ror">https://ror.org/036x5ad56</institution-id><institution>Luxembourg Centre for Systems Biomedicine, LCSB, Developmental and Cellular Biology, University of Luxembourg</institution></institution-wrap><addr-line><named-content content-type="city">Belvaux</named-content></addr-line><country>Luxembourg</country></aff><aff id="aff6"><label>6</label><institution-wrap><institution-id institution-id-type="ror">https://ror.org/04tsk2644</institution-id><institution>Ruhr University Bochum, Medical Faculty, Department of Cellular Physiology</institution></institution-wrap><addr-line><named-content content-type="city">Bochum</named-content></addr-line><country>Germany</country></aff><aff id="aff7"><label>7</label><institution-wrap><institution-id institution-id-type="ror">https://ror.org/040djv263</institution-id><institution>Max Planck Institute for Molecular Biomedicine, Flow Cytometry Unit</institution></institution-wrap><addr-line><named-content content-type="city">Münster</named-content></addr-line><country>Germany</country></aff><aff id="aff8"><label>8</label><institution-wrap><institution-id institution-id-type="ror">https://ror.org/04qmmjx98</institution-id><institution>Center for Cellular Nanoanalytics Osnabrück, CellNanOs, University of Osnabrück</institution></institution-wrap><addr-line><named-content content-type="city">Osnabrück</named-content></addr-line><country>Germany</country></aff><aff id="aff9"><label>9</label><institution-wrap><institution-id institution-id-type="ror">https://ror.org/040djv263</institution-id><institution>Max Planck Institute for Molecular Biomedicine, Electron Microscopy Unit</institution></institution-wrap><addr-line><named-content content-type="city">Münster</named-content></addr-line><country>Germany</country></aff><aff id="aff10"><label>10</label><institution-wrap><institution-id institution-id-type="ror">https://ror.org/040djv263</institution-id><institution>Max Planck Institute for Molecular Biomedicine, Department of Tissue Morphogenesis</institution></institution-wrap><addr-line><named-content content-type="city">Münster</named-content></addr-line><country>Germany</country></aff><aff id="aff11"><label>11</label><institution>Computational Biology and Systems Biomedicine, Biodonostia Health Research Institute</institution><addr-line><named-content content-type="city">San Sebastián</named-content></addr-line><country>Spain</country></aff><aff id="aff12"><label>12</label><institution-wrap><institution-id institution-id-type="ror">https://ror.org/047dqcg40</institution-id><institution>School of Mechanical Engineering, Korea University</institution></institution-wrap><addr-line><named-content content-type="city">Seoul</named-content></addr-line><country>Republic of Korea</country></aff><aff id="aff13"><label>13</label><institution>R&amp;D Research Center, Next &amp; Bio Inc</institution><addr-line><named-content content-type="city">Seoul</named-content></addr-line><country>Republic of Korea</country></aff><aff id="aff14"><label>14</label><institution-wrap><institution-id institution-id-type="ror">https://ror.org/017cjz748</institution-id><institution>School of Life Sciences, Ulsan National Institute of Science and Technology (UNIST)</institution></institution-wrap><addr-line><named-content content-type="city">Ulsan</named-content></addr-line><country>Republic of Korea</country></aff><aff id="aff15"><label>15</label><institution-wrap><institution-id institution-id-type="ror">https://ror.org/04tsk2644</institution-id><institution>Ruhr University Bochum, Medical Faculty, Department of Molecular GI Oncology</institution></institution-wrap><addr-line><named-content content-type="city">Bochum</named-content></addr-line><country>Germany</country></aff><aff id="aff16"><label>16</label><institution-wrap><institution-id institution-id-type="ror">https://ror.org/00pd74e08</institution-id><institution>Westphalian Wilhelms University Münster, Medical Faculty</institution></institution-wrap><addr-line><named-content content-type="city">Münster</named-content></addr-line><country>Germany</country></aff></contrib-group><contrib-group content-type="section"><contrib contrib-type="editor"><name><surname>Huang</surname><given-names>Christopher L-H</given-names></name><role>Reviewing Editor</role><aff><institution-wrap><institution-id institution-id-type="ror">https://ror.org/013meh722</institution-id><institution>University of Cambridge</institution></institution-wrap><country>United Kingdom</country></aff></contrib><contrib contrib-type="senior_editor"><name><surname>Zaidi</surname><given-names>Mone</given-names></name><role>Senior Editor</role><aff><institution-wrap><institution-id institution-id-type="ror">https://ror.org/04a9tmd77</institution-id><institution>Icahn School of Medicine at Mount Sinai</institution></institution-wrap><country>United States</country></aff></contrib></contrib-group><pub-date publication-format="electronic" date-type="publication"><day>14</day><month>11</month><year>2023</year></pub-date><volume>12</volume><elocation-id>RP87081</elocation-id><history><date date-type="sent-for-review" iso-8601-date="2023-05-02"><day>02</day><month>05</month><year>2023</year></date></history><pub-history><event><event-desc>This manuscript was published as a preprint.</event-desc><date date-type="preprint" iso-8601-date="2023-07-13"><day>13</day><month>07</month><year>2023</year></date><self-uri content-type="preprint" xlink:href="https://doi.org/10.1101/2020.09.14.295832"/></event><event><event-desc>This manuscript was published as a reviewed preprint.</event-desc><date date-type="reviewed-preprint" iso-8601-date="2023-07-20"><day>20</day><month>07</month><year>2023</year></date><self-uri content-type="reviewed-preprint" xlink:href="https://doi.org/10.7554/eLife.87081.1"/></event><event><event-desc>The reviewed preprint was revised.</event-desc><date date-type="reviewed-preprint" iso-8601-date="2023-09-15"><day>15</day><month>09</month><year>2023</year></date><self-uri content-type="reviewed-preprint" xlink:href="https://doi.org/10.7554/eLife.87081.2"/></event></pub-history><permissions><copyright-statement>© 2023, Mavrommatis et al</copyright-statement><copyright-year>2023</copyright-year><copyright-holder>Mavrommatis et al</copyright-holder><ali:free_to_read/><license xlink:href="http://creativecommons.org/licenses/by/4.0/"><ali:license_ref>http://creativecommons.org/licenses/by/4.0/</ali:license_ref><license-p>This article is distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution License</ext-link>, which permits unrestricted use and redistribution provided that the original author and source are credited.</license-p></license></permissions><self-uri content-type="pdf" xlink:href="elife-87081-v1.pdf"/><self-uri content-type="figures-pdf" xlink:href="elife-87081-figures-v1.pdf"/><abstract><p>In vitro culture systems that structurally model human myogenesis and promote PAX7<sup>+</sup> myogenic progenitor maturation have not been established. Here we report that human skeletal muscle organoids can be differentiated from induced pluripotent stem cell lines to contain paraxial mesoderm and neuromesodermal progenitors and develop into organized structures reassembling neural plate border and dermomyotome. Culture conditions instigate neural lineage arrest and promote fetal hypaxial myogenesis toward limb axial anatomical identity, with generation of sustainable uncommitted PAX7 myogenic progenitors and fibroadipogenic (PDGFRa+) progenitor populations equivalent to those from the second trimester of human gestation. Single-cell comparison to human fetal and adult myogenic progenitor /satellite cells reveals distinct molecular signatures for non-dividing myogenic progenitors in activated (<italic>CD44<sup>High</sup></italic>/<italic>CD98<sup>+</sup></italic>/<italic>MYOD1<sup>+</sup></italic>) and dormant (<italic>PAX7<sup>High</sup></italic>/<italic>FBN1<sup>High</sup></italic>/<italic>SPRY1<sup>High</sup></italic>) states. Our approach provides a robust 3D in vitro developmental system for investigating muscle tissue morphogenesis and homeostasis.</p></abstract><abstract abstract-type="plain-language-summary"><title>eLife digest</title><p>Humans contains around 650 skeletal muscles which allow the body to move around and maintain its posture. Skeletal muscles are made up of individual cells that bundle together into highly organized structures. If this group of muscles fail to develop correctly in the embryo and/or fetus, this can lead to muscular disorders that can make it painful and difficult to move<bold>.</bold></p><p>One way to better understand how skeletal muscles are formed, and how this process can go wrong, is to grow them in the laboratory. This can be achieved using induced pluripotent stem cells (iPSCs), human adult cells that have been ‘reprogrammed’ to behave like cells in the embryo that can develop in to almost any cell in the body. The iPSCs can then be converted into specific cell types in the laboratory, including the cells that make up skeletal muscle.</p><p>Here, Mavrommatis et al. created a protocol for developing iPSCs into three-dimensional organoids which resemble how cells of the skeletal muscle look and arrange themselves in the fetus. To form the skeletal muscle organoid, Mavrommatis et al. treated iPSCs that were growing in a three-dimensional environment with various factors that are found early on in development. This caused the iPSCs to organize themselves in to embryonic and fetal structures that will eventually give rise to the parts of the body that contain skeletal muscle, such as the limbs. Within the organoid were cells that produced Pax7, a protein commonly found in myogenic progenitors that specifically mature into skeletal muscle cells in the fetus<bold>.</bold> Pax 7 is also present in ‘satellite cells’ that help to regrow damaged skeletal muscle in adults. Indeed, Mavrommatis et al. found that the myogenic progenitors produced by the organoid were able to regenerate muscle when transplanted in to adult mice.</p><p>These findings suggest that this organoid protocol can generate cells that will give rise to skeletal muscle. In the future, these lab-grown progenitors could potentially be created from cells isolated from patients and used to repair muscle injuries. The organoid model could also provide new insights in to how skeletal muscles develop in the fetus, and how genetic mutations linked with muscular disorders disrupt this process.</p></abstract><kwd-group kwd-group-type="author-keywords"><kwd>skeletal muscle</kwd><kwd>Organoids</kwd><kwd>Myogenesis</kwd><kwd>satellite cells</kwd><kwd>ips cells</kwd><kwd>Pax7</kwd></kwd-group><kwd-group kwd-group-type="research-organism"><title>Research organism</title><kwd>Human</kwd></kwd-group><funding-group><award-group id="fund1"><funding-source><institution-wrap><institution>Deutsche Duchenne Stiftung, Duchenne Deutschland e.V.,</institution></institution-wrap></funding-source><award-id>DFP2018</award-id><principal-award-recipient><name><surname>Brand-Saberi</surname><given-names>Beate</given-names></name><name><surname>Zaehres</surname><given-names>Holm</given-names></name></principal-award-recipient></award-group><award-group id="fund2"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100010275</institution-id><institution>Deutsche Gesellschaft für Muskelkranke</institution></institution-wrap></funding-source><award-id>Za1/1</award-id><principal-award-recipient><name><surname>Zaehres</surname><given-names>Holm</given-names></name></principal-award-recipient></award-group><funding-statement>The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication. Open access funding provided by Max Planck Society.</funding-statement></funding-group><custom-meta-group><custom-meta specific-use="meta-only"><meta-name>Author impact statement</meta-name><meta-value>Skeletal muscle organoids differentiated from human pluripotent stem cells offer a system for investigating myogenesis and satellite cell development with translational potential for muscular dystrophy modeling and therapy development.</meta-value></custom-meta><custom-meta specific-use="meta-only"><meta-name>publishing-route</meta-name><meta-value>prc</meta-value></custom-meta></custom-meta-group></article-meta></front><body><sec id="s1" sec-type="intro"><title>Introduction</title><p>Novel skeletal muscle model systems are required to further elucidate the process of human myogenesis as well as investigate muscular disorders and potential gene, cell, or drug therapies. Two-dimensional (2D) culture conditions guide pluripotent stem cell (PSC) differentiation toward skeletal muscle lineage using sequential growth factor applications and/or conditional PAX7 expression (<xref ref-type="bibr" rid="bib12">Chal et al., 2015</xref>; <xref ref-type="bibr" rid="bib67">Xi et al., 2017</xref>; <xref ref-type="bibr" rid="bib55">Shelton et al., 2014</xref>; <xref ref-type="bibr" rid="bib9">Borchin et al., 2013</xref>; <xref ref-type="bibr" rid="bib17">Darabi et al., 2012</xref>). Further, surface marker expression can be utilized to isolate myogenic progenitors with in vivo repopulation potential (<xref ref-type="bibr" rid="bib35">Magli et al., 2017</xref>; <xref ref-type="bibr" rid="bib26">Hicks et al., 2018</xref>; <xref ref-type="bibr" rid="bib2">Al Tanoury et al., 2020</xref>; <xref ref-type="bibr" rid="bib61">Sun et al., 2022</xref>). While the few described three-dimensional (3D) differentiation approaches have provided cohorts of terminally differentiated myofibers, focus on potential interactions with the vasculature and nervous system has neglected assessment of the developmental identity or sustainability of myogenic progenitors (<xref ref-type="bibr" rid="bib20">Faustino Martins et al., 2020</xref>; <xref ref-type="bibr" rid="bib34">Maffioletti et al., 2018</xref>; <xref ref-type="bibr" rid="bib47">Rao et al., 2018</xref>). Single-cell technologies increasingly provide databases for deciphering myogenic trajectories and expression profiles of myogenic stem and progenitor cells (<xref ref-type="bibr" rid="bib6">Barruet et al., 2020</xref>; <xref ref-type="bibr" rid="bib50">Rubenstein et al., 2020</xref>; <xref ref-type="bibr" rid="bib68">Xi et al., 2020</xref>), enabling full evaluation of the ability of PSC differentiation protocols to mimic human development. Translation to model muscular dystrophies and investigate potential interventions in vitro necessitates methods that provide expandable populations of muscle progenitors while promoting self-renewal and preserving a quiescent, non-dividing, state (<xref ref-type="bibr" rid="bib45">Quarta et al., 2016</xref>; <xref ref-type="bibr" rid="bib39">Montarras et al., 2005</xref>).</p><p>Most vertebrate skeletal muscle progenitors develop from the paraxial mesoderm via transient embryonic developmental structures (somites and dermomyotome) into the skeletal muscle system that spans the whole body. Here, we evaluate human skeletal muscle organoids as a novel system to structurally investigate myogenic differentiation from human induced pluripotent stem cells (iPSCs) in a 3D environment, mimicking pathways described for chicken and mouse (<xref ref-type="bibr" rid="bib10">Buckingham and Rigby, 2014</xref>). We develop a comprehensive supplementation/reduction protocol to first drive differentiation toward paraxial mesoderm through application of the GSK3 inhibitor CHIR99021, BMP inhibitor LDN193189, and bFGF. Subsequent stimulation with WNT1A, SHH, FGF, and HGF is designed to promote derivation of organized structures reassembling neural plate border and dermomyotome. We then aim to arrest neural lineage via FGF removal, while stimulating with HGF to selectively promote propagation of undifferentiated myogenic progenitors and consequent generation of fetal myofibers. Our goal is to provide PAX7<sup>+</sup> myogenic progenitors in a non-dividing quiescent state sustainable over weeks after differentiation induction. Single-cell analysis will position cells along the quiescent-activation myogenic trajectory discriminating dormant (PAX7+, FBN1+, SPRY11+, CHODL1+) and activated (CD44+, CD98+, MYOD1+, VEGFA+) states. We thus seek to develop and validate a new skeletal muscle organoid system for investigating human myogenesis with translational potential for disease modeling and therapy development.</p></sec><sec id="s2" sec-type="results"><title>Results</title><sec id="s2-1"><title>Generation of human fetal skeletal muscle organoids</title><p>Organoid cultures from PSCs often require pre-patterning before Matrigel embedding to promote structural development (<xref ref-type="bibr" rid="bib31">Lancaster et al., 2013</xref>; <xref ref-type="bibr" rid="bib59">Spence et al., 2011</xref>; <xref ref-type="bibr" rid="bib30">Koehler et al., 2017</xref>). In our 3D approach, we provided cells with immediate matrix support upon embryoid body formation to preserve cell state transitions. Initial pre-embedding screening indicated high expression of pluripotent markers <italic>OCT4</italic>, <italic>SOX2,</italic> and <italic>NANOG</italic>, moderate expression of neural tube marker PAX6, and low expression of mesodermal markers <italic>BRACHYURY</italic> and <italic>MSGN1</italic> (<xref ref-type="fig" rid="fig1">Figure 1</xref>, <xref ref-type="fig" rid="fig1s1">Figure 1—figure supplement 1A</xref>). Upon Matrigel embedding, stimulation with CHIR99021, LDN193189, and bFGF promoted paraxial mesoderm formation through derivation of BRACHYURY<sup>+</sup> and TBX6<sup>+</sup> cells (<xref ref-type="fig" rid="fig1">Figure 1A and C</xref>, <xref ref-type="fig" rid="fig1s1">Figure 1—figure supplement 1A</xref>). Immunostaining on day 5 depicted the presence of mesodermal (BRACHYURY<sup>+</sup>), paraxial mesodermal (TBX6<sup>+</sup>), and neuromesodermal (SOX2<sup>+</sup>/BRACHYURY<sup>+</sup>) progenitors (<xref ref-type="bibr" rid="bib23">Gouti et al., 2017</xref>; <xref ref-type="bibr" rid="bib25">Henrique et al., 2015</xref>; <xref ref-type="fig" rid="fig1">Figure 1C</xref>). From this stage, we attempted to mimic determination front formation and promote anterior somitic mesoderm (ASM) (<xref ref-type="bibr" rid="bib4">Aulehla and Pourquié, 2010</xref>; <xref ref-type="bibr" rid="bib56">Shimozono et al., 2013</xref>) by maintaining constant CHIR99021 and LDN193189 levels, reducing bFGF levels to 50% and simultaneously introducing retinoic acid to the culture. Consequently, distinct PAX3<sup>+</sup> but SOX2<sup>-</sup> cells emerged on the organoid surface (<xref ref-type="fig" rid="fig1">Figure 1D</xref>), followed by a significant downregulation of PSM markers <italic>HES7</italic>, <italic>TBX6,</italic> and <italic>MSGN1</italic> (<xref ref-type="fig" rid="fig1">Figure 1E</xref>, <xref ref-type="fig" rid="fig1s1">Figure 1—figure supplement 1A</xref>). Concomitantly, we observed significant upregulation of ASM marker <italic>MEOX2</italic> and neural crest marker <italic>TFAP2A</italic> but not of <italic>SOX2</italic> or <italic>PAX6</italic>, excluding a shift toward neural tube formation (<xref ref-type="fig" rid="fig1">Figure 1E and F</xref>, <xref ref-type="fig" rid="fig1s1">Figure 1—figure supplement 1A</xref>). Up to this stage, inter-organoid sizes showed small variability (<xref ref-type="fig" rid="fig1">Figure 1B</xref>). Dermomyotomal fate was promoted by Sonic Hedgehog (SHH) and WNT1A stimulation, while maintaining BMP inhibition avoided lateral mesoderm formation (<xref ref-type="fig" rid="fig1">Figure 1A</xref>). Expression profiling on day 11 depicted presence of neural tube/crest (<italic>SOX2</italic>, <italic>PAX6</italic>, <italic>TFAP2A</italic>, <italic>SOX10</italic> upregulation) and mesodermal (<italic>UNCX</italic>, <italic>TBX18</italic>, <italic>PAX3</italic>) lineages and further downregulation of PSM markers (<xref ref-type="fig" rid="fig1">Figure 1E and F</xref>, <xref ref-type="fig" rid="fig1s1">Figure 1—figure supplement 1A</xref>). Notably, the dermomyotomal/neural crest marker <italic>PAX7</italic> emerged together with markers that define the dorsomedial (<italic>EN1</italic>) or ventrolateral portion (<italic>SIM1</italic>) of the dermomyotome (<xref ref-type="bibr" rid="bib14">Cheng et al., 2004</xref>; <xref ref-type="fig" rid="fig1">Figure 1D and F</xref>, <xref ref-type="fig" rid="fig1s1">Figure 1—figure supplement 1A</xref>).</p><fig-group><fig id="fig1" position="float"><label>Figure 1.</label><caption><title>Skeletal muscle organoid protocol and correlation to fetal development.</title><p>(<bold>A</bold>) Brightfield images of myogenic development stages, with corresponding cytokines/growth factors protocol applications. (<bold>B</bold>) Graph depicting organoid development in size (day 0, n = 51; day 3, n = 46; day 5, n = 48; day 7, n = 50; day 11, n = 50; day 17, n = 33; for each timepoint organoids from three independent derivations were measured). (<bold>C</bold>) Representative mesodermal T+, neuromesodermal T+, SOX2+, and paraxial mesodermal TBX6+ organoid expression (in live DAPI- cells) on day 5. (<bold>D</bold>) Representative organoid PAX3+, mesodermal SOX2-, and neural SOX2+ expression on day 7; PAX3/PAX7 coexpression on day 11. (<bold>E</bold>) Graph depicting qPCR values for anterior <italic>PAX3/UNCX/MEOX2/TBX18</italic> and posterior <italic>TBX6/HES7</italic> somitic mesodermal markers. (<bold>F</bold>) Graph depicting qPCR values for epaxial and hypaxial dermomyotomal <italic>PAX7/EN1/SIM1/LBX1</italic> and neural crest <italic>TFAP2A/SOX10</italic> markers. (<bold>G</bold>) Representative organoid neural plate border epithelial PAX3+/PAX7+/SOX2+/TFAP2A+, paraxial mesodermal PAX3+/SOX2-, and delaminating specified neural crest progenitor PAX3+/SOX10+ expression on day 17. (<bold>H</bold>) Representative organoid myogenic FastMyHC+, PAX7+, and neural SOX2+/TFAP2A+/SOX10+ expression on day 23. Dashed line represents the location of embryoid body embedded into Matrigel. Statistics: values at each timepoint represent the difference in mean relative expression for each gene (D7 = day 5–day 7, D11 = day 7–day 11, D17 = day 11–day 17, D23 = day 17–day 23) as derived by performing ordinary one-way ANOVA and Tukey’́s multiple-comparison tests (<bold>E, F</bold>). Scale bars: 200 μm (<bold>G</bold>), 100 μm (<bold>A, D, H</bold>), 50 μm.</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-87081-fig1-v1.tif"/></fig><fig id="fig1s1" position="float" specific-use="child-fig"><label>Figure 1—figure supplement 1.</label><caption><title>Lineage representation and organoid culture progression at early stages of differentiation protocol.</title><p>(<bold>A</bold>) qPCR analysis depicts relative expression of pluripotent (<italic>OCT4</italic>, <italic>SOX2</italic>, <italic>NANOG</italic>), mesodermal/posterior somitic (<italic>BRACHYURY</italic>, <italic>MESOGENIN</italic>, <italic>TBX6</italic>, <italic>HES7</italic>), anterior somitic (<italic>PAX3</italic>, <italic>UNCX</italic>, <italic>TBX18</italic>, <italic>MEOX2</italic>), dermomyotomal (<italic>PAX7</italic>, <italic>SIM1</italic>, <italic>EN1</italic>, <italic>LBX1</italic>), and neural tube/crest markers (<italic>SOX2</italic>, <italic>PAX6</italic>, <italic>TFAP2A</italic>, <italic>SOX10</italic>). (<bold>B</bold>) Gating strategies and FACS intracellular quantification of PAX3 and PAX7 markers on days 10 and 16. (<bold>C</bold>) Tile scan overview on day 23 shows neural crest SOX10+ populations close to neural plate border epithelium (<bold>D</bold>) and SOX10-/PAX3+ populations at more outer locations (<bold>E</bold>). For each replicate, six organoids were pooled; gene expression was normalized to housekeeping gene. Statistics: *p&lt;0.05, **p&lt;0.01, ***p&lt;0.001, ****p&lt;0.0001, ns: not significant. FACS plots, yellow: unstained population; red: isotype control; gray: PAX7+ or PAX3+ population. Scale bars, 500 uM (<bold>C</bold>), 200 uM (<bold>D, E</bold>).</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-87081-fig1-figsupp1-v1.tif"/></fig></fig-group><p>Consequently, for favoring myogenesis we stimulated organoid culture with FGF and HGF (<xref ref-type="bibr" rid="bib13">Chargé and Rudnicki, 2004</xref>; <xref ref-type="fig" rid="fig1">Figure 1A</xref>). Surprisingly, on day 17, organoids constituted a mosaic of neural crest and myogenic progenitor cells. Cells with epithelial morphology were TFAP2A<sup>+</sup>, SOX2<sup>+</sup>, PAX3<sup>+</sup>, and PAX7<sup>+</sup>, indicating formation of neural plate border epithelium (<xref ref-type="bibr" rid="bib49">Roellig et al., 2017</xref>; <xref ref-type="fig" rid="fig1">Figure 1G</xref>). In cell clusters with mesenchymal morphology, we detected specified migrating PAX3<sup>+</sup>/SOX10<sup>+</sup> neural crest progenitors and PAX3<sup>+</sup>/SOX2<sup>-</sup>/SOX10<sup>-</sup> cells of myogenic origin (<xref ref-type="fig" rid="fig1">Figure 1G</xref>). At this stage, myogenic lineages appeared to be primarily represented by PAX3<sup>+</sup> (9.35 ± 0.07%) rather than PAX7<sup>+</sup> cells, as the PAX7 expression pattern (15.3 ± 0.1% PAX3<sup>+</sup>/PAX7<sup>+</sup>, 5.11 ± 0.13% PAX7<sup>+</sup>) predominantly overlapped with that of SOX2 and TFAP2A (<xref ref-type="fig" rid="fig1">Figure 1G</xref> and <xref ref-type="fig" rid="fig1s1">Figure 1—figure supplement 1B</xref>). Morphologically, neural plate border and dermomyotomal populations exhibited uneven distribution, and thereby subsequent neural crest and myogenic migration processes introduced organoid size variability (<xref ref-type="fig" rid="fig1">Figure 1B and G</xref>). From day 17 onward, we omitted FGF stimulation to cease neural crest development and promote delamination/migration of PAX3<sup>+</sup>/PAX7<sup>+</sup>/SOX10<sup>-</sup> progenitor cells (<xref ref-type="bibr" rid="bib41">Murphy et al., 1994</xref>; <xref ref-type="fig" rid="fig2">Figure 2A</xref>). Strikingly, until day 23, we observed committed myogenic populations through detection of fast MyHC myofibers in the proximity of PAX7<sup>+</sup> but SOX2<sup>-</sup>/TFAP2A<sup>-</sup>/SOX10<sup>-</sup> negative cells (<xref ref-type="fig" rid="fig1">Figure 1H</xref>, <xref ref-type="fig" rid="fig1s1">Figure 1—figure supplement 1C–E</xref>). Consistently, expression profiling indicated downregulation of neural tube/crest lineage markers and significant upregulation of muscle precursor migrating markers (<xref ref-type="bibr" rid="bib10">Buckingham and Rigby, 2014</xref>), such as LBX1, CXCR4, and MEOX2 (<xref ref-type="fig" rid="fig1">1</xref>,<xref ref-type="fig" rid="fig2">2</xref><xref ref-type="fig" rid="fig1">Figures 1E</xref> and <xref ref-type="fig" rid="fig2">2A</xref>, <xref ref-type="fig" rid="fig2s1">Figure 2—figure supplement 1A</xref> ).</p><fig-group><fig id="fig2" position="float"><label>Figure 2.</label><caption><title>Neural lineage development during skeletal muscle organoid progression.</title><p>(<bold>A</bold>) Stepwise brightfield images depicting delamination/migration of progenitor population during organoid culture progression and corresponding myofiber formation. (<bold>B</bold>) Gene ontology enrichment analysis comparing 4 and 8 wk organoids attributes muscle identity at 8 wk post differentiation and highlights muscle system development and neural lineage arrest among the top upregulated and downregulated gene ontology terms, respectively. (<bold>C–E</bold>) Organoid overview on day 35 indicates predominant expression of FastMyHC<sup>+</sup> and PAX7<sup>+</sup> myogenic populations, while SOX2<sup>+</sup> neural populations demarcate SOX2 neural plate border epithelium location as observed at earlier stages (day 16) (<bold>C</bold>); PAX7 cells are of myogenic origin (PAX7<sup>+</sup>/SOX10<sup>-</sup>), MF20<sup>+</sup> myotubes are in their proximity and MYOD1<sup>+</sup> cells appear at organoid periphery (<bold>D</bold>); TUJ1<sup>+</sup> neurons are restricted to inner organoid areas and close to SOX2<sup>+</sup> epithelium, while FastMyHC<sup>+</sup> myofibers occupy exterior organoid areas (<bold>E</bold>). (<bold>F</bold>) Histographs based on FACS intracellular quantification depicting percentage of PAX7<sup>+</sup> or MYOD1<sup>+</sup> cells through differentiation protocol. For each replicate, 10 organoids were pooled, n = 10. Statistics: *p&lt;0.05, **p&lt;0.01, ***p&lt;0.001, ****p&lt;0.0001, ns: not significant. (<bold>G</bold>) Heatmap of <italic>HOX</italic> gene cluster emphasizes organoid culture limb axial anatomical identity by depicting transition from an initial limb bud (<italic>HOX 9–10</italic>) toward a more distal identity (<italic>HOX 11–13</italic>) at 8 and 16 wk post differentiation, respectively. Scale bars, 500 μm (<bold>C</bold>), 200 μm (<bold>A, D, E</bold>).</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-87081-fig2-v1.tif"/></fig><fig id="fig2s1" position="float" specific-use="child-fig"><label>Figure 2—figure supplement 1.</label><caption><title>Myogenic versus neural fate during organoid development.</title><p>(<bold>A</bold>) Heatmap of limb myogenic progenitor markers emphasizes upregulation through organoid protocol development. (<bold>B</bold>) Differential expression comparison highlights upregulated (n = 5919) and downregulated (n = 5005) genes between 8 vs. 4 wk organoids (Padj&lt;0.001). (<bold>C</bold>) Heatmap of neural tube and neural crest markers during 4, 8, and 16 wk post differentiation highlights neural lineage arrest from 4 wk onward. (<bold>D</bold>) Organoid overview on day 35 indicates the presence of MF20<sup>+</sup> myofibers in proximity of PAX7<sup>+</sup> cells and delamination migration of mainly myogenic cells. SOX2 and TFAP2A expression is restricted toward inner organoid areas. (<bold>E</bold>) Gating strategy applied to quantify MYOD1<sup>+</sup> (committed state) and PAX7<sup>+</sup> (progenitor state) populations at 5 and 8 wk post differentiation. Yellow histogram: unstained population; red: isotype control; gray: PAX7<sup>+</sup> or MYOD<sup>+</sup> population. Scale bars, 500 uM.</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-87081-fig2-figsupp1-v1.tif"/></fig></fig-group><p>At 8 wk, organoids showed profound changes in transcription profiling (<xref ref-type="fig" rid="fig2">Figure 2</xref>, <xref ref-type="fig" rid="fig2s1">Figure 2—figure supplement 1B</xref>). Gene ontology enrichment analysis highlighted an ongoing developmental transition with muscle development, muscle contraction, and myofibril assembly among the top upregulated gene ontology terms and neurogenesis and nervous system development among the top downregulated terms (<xref ref-type="fig" rid="fig2">Figure 2B</xref>). In addition, we detected downregulation of key markers characterizing neural tube and neural crest development (<xref ref-type="bibr" rid="bib58">Soldatov et al., 2019</xref>), such as <italic>PAK3</italic>, <italic>DLX5</italic>, <italic>B3GAT1</italic>, <italic>FOXB1</italic>, <italic>HES5,</italic> and <italic>OLIG3</italic> (<xref ref-type="fig" rid="fig2">Figure 2</xref>, <xref ref-type="fig" rid="fig2s1">Figure 2—figure supplement 1C</xref>). Interestingly, we could spatially visualize this process using immunocytochemistry for SOX2, TFAP2A, and SOX10-expressing cells that were restricted to the inner portion of the organoid, and probably not susceptible to culture stimulation at 5 wk (<xref ref-type="fig" rid="fig1">1</xref>,<xref ref-type="fig" rid="fig2">2</xref><xref ref-type="fig" rid="fig1">Figures 1H</xref>, <xref ref-type="fig" rid="fig2">2C and D</xref> , <xref ref-type="fig" rid="fig2s1">Figure 2—figure supplement 1</xref>). This neural/myogenic lineage spatial orientation could be visualized even on day 84 through the presence of TUJ1<sup>+</sup> neurons confined to inner organoid areas and close to SOX2<sup>+</sup> epithelium, while FastMyHC<sup>+</sup> myofibers occupied exterior areas (<xref ref-type="fig" rid="fig2">Figure 2E</xref>). On the other hand, substantial proportions of migratory cells in proximity of FastMyHC<sup>+</sup>, MF20<sup>+</sup> myofibers expressed PAX7 (40 ± 0.3%) but not SOX2, TFAP2A, SOX10, or MYOD1 (3.55 ± 0.32%) (<xref ref-type="fig" rid="fig2">Figure 2F</xref>, <xref ref-type="fig" rid="fig2s1">Figure 2—figure supplement 1D and E</xref>). This behavior is further illustrated by the presence of MYOD1<sup>+</sup> cells confined to organoid periphery (<xref ref-type="fig" rid="fig2">Figure 2D</xref>).</p><p>Culture progression led to a significant increase in PAX7<sup>+</sup> and MYOD1<sup>+</sup> cells at 8 wk (45.3 ± 3,4% and 49.8 ± 0.62%, respectively) (<xref ref-type="fig" rid="fig2">Figure 2F</xref>, <xref ref-type="fig" rid="fig2s1">Figure 2—figure supplement 1E</xref>), suggesting an interval in which organoid culture predominantly commits to myogenic lineage. Expression profiling at this stage depicted upregulation of markers characteristic for limb migrating myogenic cells, for example, <italic>LBX1</italic>, <italic>PAX7</italic>, <italic>SIX1/4</italic>, <italic>EYA1/4</italic>, <italic>PITX2</italic>, <italic>MYF5</italic>, <italic>TCF4,</italic> and <italic>MSX1</italic> (<xref ref-type="fig" rid="fig2">Figure 2</xref>, <xref ref-type="fig" rid="fig2s1">Figure 2—figure supplement 1A</xref>). Consequently, HOX gene cluster profiling at 4 wk correlated <italic>HOX A9</italic>, <italic>B9</italic>, <italic>C9</italic> upregulation with limb bud site, while upregulation of the <italic>HOX</italic> 10–13 cluster during 8–16 wk attributed later organoid development to a more distal limb axial anatomical identity (<xref ref-type="bibr" rid="bib57">Shubin et al., 1997</xref>; <xref ref-type="bibr" rid="bib69">Xu and Wellik, 2011</xref>; <xref ref-type="bibr" rid="bib46">Raines et al., 2015</xref>; <xref ref-type="fig" rid="fig2">Figure 2G</xref>).</p></sec><sec id="s2-2"><title>Lineage representation and developmental identity for skeletal muscle organoids</title><p>Analysis of organoid culture at single-cell resolution indicated predominant presence of skeletal muscle lineage (n = 3945 cells, 91.26% of total population), complemented with two smaller cell clusters of mesenchymal/‘fibroadipogenic’ (n = 165 cells, 3.82% of total population), and neural (n = 213 cells, 4.93% of total population) origin (<xref ref-type="fig" rid="fig3">Figure 3A</xref>, <xref ref-type="fig" rid="fig3s1">Figure 3—figure supplement 1A</xref>). Skeletal muscle lineages further separated into distinct subclusters: myogenic muscle progenitors in non-dividing (<italic>PAX7<sup>+</sup></italic>/<italic>PAX3<sup>-</sup></italic>) and mitotic states (<italic>PAX7<sup>+</sup></italic>/<italic>CDK1<sup>+</sup></italic>/<italic>KI67<sup>+</sup></italic>), myoblasts (<italic>MYOD1<sup>+</sup></italic>), myocytes (<italic>MYOG<sup>+</sup></italic>), and myotubes (<italic>MYH3<sup>+</sup></italic>) (<xref ref-type="fig" rid="fig3">Figure 3A</xref>, <xref ref-type="fig" rid="fig3s1">Figure 3—figure supplement 1A and B</xref>). Further, investigation of mesenchymal cluster identity suggested fibroadipogenic potential of a distinct cell population with <italic>PDGFRa</italic> among the top upregulated genes (<xref ref-type="bibr" rid="bib64">Uezumi et al., 2010</xref>; <xref ref-type="bibr" rid="bib65">Uezumi et al., 2011</xref>; <xref ref-type="bibr" rid="bib68">Xi et al., 2020</xref>; <xref ref-type="fig" rid="fig3">Figure 3A and F</xref>, <xref ref-type="fig" rid="fig3s1">Figure 3—figure supplement 1A and B</xref>). Consistently, we detected upregulation of fibrotic markers. Moreover, adipogenic potential was highlighted through upregulation of <italic>PREF-1</italic> and <italic>EBF2</italic> (<xref ref-type="fig" rid="fig3">Figure 3F</xref>). Occasionally, we detected structures resembling adipocytes from 9–10 wk onward, with adipogenic nature verified by PRDM16 and Oil red O positive staining (<xref ref-type="fig" rid="fig3">Figure 3B and D</xref>, <xref ref-type="fig" rid="fig3s1">Figure 3—figure supplement 1C and D</xref>). A SOX2<sup>+</sup>/TUBB3<sup>+</sup> positive neural cluster potentially derived from the neural plate border epithelium at younger stages could be located toward organoid interior (<xref ref-type="fig" rid="fig3">Figure 3C</xref>, <xref ref-type="fig" rid="fig3s1">Figure 3—figure supplement 1E</xref>).</p><fig-group><fig id="fig3" position="float"><label>Figure 3.</label><caption><title>Skeletal muscle organoid characterization at single-cell resolution.</title><p>(<bold>A</bold>) <italic>t</italic>-SNE visualization of color-coded clustering (n = 4323 cells) at 12 wk post differentiation highlights the predominant presence of skeletal muscle lineage, represented by clusters corresponding to myogenic progenitors (n = 1625 cells, 37% of total population) in non-dividing (n = 1317 cells) and mitotic (n = 308 cells) state, myoblasts (n = 731 cells), myocytes (n = 1147 cells), and myotubes (n = 442). Additionally, mesenchymal and neural lineages are represented by two smaller clusters of fibroadipogenic (n = 165 cells) and neural (n = 213 cells) progenitors, respectively. (<bold>B</bold>) Immunocytochemistry on day 135 indicates derivation of PRDM16<sup>+</sup> adipocyte clusters distinct from PAX7<sup>+</sup> myogenic progenitors. (<bold>C</bold>) Organoid overview on day 98 depicts expression of PAX7<sup>+</sup> myogenic populations and highlights SOX2<sup>+</sup> neural populations toward organoid interior. (<bold>D</bold>) Positive areas with Oil O Red staining indicate derivation of adipocytes in organoid culture on day 135. (<bold>E</bold>) Violin plots of key markers <italic>PAX7</italic>, <italic>MYOD1</italic>, <italic>MYOG</italic>, <italic>MYH3</italic> from each stage as in (<bold>A</bold>) depict relative expression levels and emphasize gradual transition from myogenic progenitor to myotube subcluster. (<bold>F</bold>) Dot plot showing expression of representative genes related to adipogenesis and fibrogenesis across the seven main clusters. Circle area represents the percentage of gene+ cells in a cluster, color reflects average expression level (gray, low expression; blue, high expression). (<bold>G</bold>) Dot plot showing expression of representative genes related to fetal myogenesis across the seven main clusters. Circle area represents the percentage of gene+ cells in a cluster, color reflects average expression level (gray, low expression; blue, high expression). (<bold>H–J</bold>) Representative organoid overview on day 98 indicates predominant expression of Fast MyHC fetal myofibers (<bold>H, J</bold>), positive for M-Cadherin and in PAX7+ cells proximity (<bold>I, J</bold>). (<bold>K</bold>) Representative recording (n = 6) of acetylcholine (ACh)-induced changes in holding current in a single skeletal muscle cell. ACh (10 μM) was applied as indicated by the bar. Holding potential –90 mV. Downward deflections represent membrane currents in response to depolarizing voltage ramps (duration 500 ms) from –120 mV to +60 mV. Dashed line indicates zero current level. (<bold>L</bold>) I/V curve of nAChR currents obtained by subtraction of voltage ramp-induced changes of current in the presence and absence of ACh (10–5 mol/l), corresponding lowercase letters b – a. (<bold>M</bold>) Summarized FRET recordings from skeletal muscle cells transfected with Twitch2B to monitor the increase in [Ca2+]i during ACh application (h). Scale bars, 1 mm (<bold>C, H</bold>), 200 μm (<bold>B</bold>), 100 μm (<bold>I, J</bold>).</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-87081-fig3-v1.tif"/></fig><fig id="fig3s1" position="float" specific-use="child-fig"><label>Figure 3—figure supplement 1.</label><caption><title>Single-cell RNA-seq expression profiling and lineage representation in organoid culture at week 12.</title><p>(<bold>A</bold>) Gene signatures of <italic>t</italic>-SNE-described clusters based on relative expression levels of the 50 most significant markers for each of the seven clusters. (<bold>B</bold>) <italic>t</italic>-SNE plot of myogenic and fibroadipogenic markers. (<bold>C</bold>) Brightfield image on day 135 highlights the presence of structures reassembling adipocytes. (<bold>D</bold>) Immunocytochemistry on day 135 emphasizing derivation of PRDM16<sup>+</sup> cells in FastMyHC<sup>+</sup> myofibers proximity. (<bold>E</bold>) Organoid overview on day 98 highlights muscle system development at outer and neural lineage representation at more inner sites. (<bold>F</bold>) <italic>t</italic>-SNE plot of key markers <italic>PAX7</italic>, <italic>MYOD1</italic>, <italic>MYOG</italic>, <italic>MYH3</italic> from each stage depicts relative expression levels and emphasizes gradual transition from myogenic progenitor to myotube subcluster. (<bold>G</bold>) Heatmap of embryonic or fetal myogenic markers depicts a fetal environment during 8–16 wk post differentiation. (<bold>H</bold>) Two-dimensional principal component analysis based on gene expression profiling between samples separates skeletal muscle organoid cluster from pluripotent and highlights greater difference in variance between 4 and 8–16 wk subgroups in comparison to 8 and 16 wk subgroups. w.p.d.: weeks post differentiation. Scale bars, 1 mM (<bold>D</bold>), 200 uM (<bold>E, F</bold>).</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-87081-fig3-figsupp1-v1.tif"/></fig><fig id="fig3s2" position="float" specific-use="child-fig"><label>Figure 3—figure supplement 2.</label><caption><title>Skeletal muscle organoid culture maturation and identity.</title><p>(<bold>A</bold>) Differential expression comparison highlights upregulated (n = 2856) and downregulated (n = 2369) genes between 16 and 8 wk organoids (Padj&lt;0.001). (<bold>B, C</bold>) Gene ontology (GO) enrichment analysis at 16 wk depicting top statistically significant upregulated (<bold>B</bold>) and downregulated (<bold>C</bold>) GO terms; (<bold>D</bold>) statistically significant upregulated GO terms further highlights skeletal muscle maturation. (<bold>E</bold>) Gating strategy applied to quantify MYOD1<sup>+</sup> (committed state) and PAX7<sup>+</sup> (progenitor state) population at 14 wk post differentiation. (<bold>F</bold>) Organoid overview on day 98 depicts the high proportion of PAX7+/MYOD+ cells toward outer areas. Yellow histogram: unstained population; red histogram: isotype control; gray histogram: PAX7<sup>+</sup> or MYOD<sup>+</sup> population. Scale bars, 500 uM (<bold>F</bold>).</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-87081-fig3-figsupp2-v1.tif"/></fig><fig id="fig3s3" position="float" specific-use="child-fig"><label>Figure 3—figure supplement 3.</label><caption><title>Functional properties of organoid-derived skeletal muscle myofibers.</title><p>(<bold>A</bold>) Second harmonic generation imaging (SHG) from areas with dense fiber network reveals myofibril formation with distinct sarcomeres (z plane of stack right). (<bold>B</bold>) Electron microscopy depicts myofibrils with well-developed sarcomeres. (<bold>C, D</bold>) Skeletal muscle organoid-derived myofibers expressed LAMININ and DYSTROPHIN. (<bold>E</bold>) Representative recording of acetylcholine (Ach)-induced changes in holding current in a single skeletal muscle cell from organoid-derived skeletal muscle cells from induced pluripotent stem cell (iPSC) lines with Duchenne (DMD_IPS1, DMD_IPSCORE_65_1) and Becker (BMD_IPS1) muscular dystrophy patients. ACh (10 μM) was applied as indicated by the bar. Holding potential –90 mV. Downward deflections represent membrane currents in response to depolarizing voltage ramps (duration 500 ms) from –120 mV to +60 mV. Dashed line indicates zero current level. (<bold>F</bold>) Summarized FRET recordings from organoid-derived skeletal muscle cells from iPSC lines with Duchenne (DMD_IPS1, DMD_IPSCORE_65_1), Becker (BMD_IPS1) transfected with Twitch2B to monitor the increase in [Ca2+]i during ACh application. Scale bars, 100 uM (<bold>C, D</bold>), 20 uM in (<bold>A</bold>), 500 nM (<bold>B</bold>).</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-87081-fig3-figsupp3-v1.tif"/></fig></fig-group><p>Myogenesis progression based on <italic>t</italic>-SNE feature and Violin plots of key markers from each stage indicated gradual transitions from myogenic progenitor to myotube subclusters (<xref ref-type="fig" rid="fig3">Figure 3E</xref>, <xref ref-type="fig" rid="fig3s1">Figure 3—figure supplement 1F</xref>). MyHC expression profiling at single-cell resolution demonstrated predominant presence of embryonic (<italic>MYH3<sup>+</sup></italic>) and perinatal (<italic>MYH8<sup>+</sup></italic>) myofibers, co-expressing β-Enolase and M-cadherin in the vicinity of PAX7<sup>+</sup> cells (<xref ref-type="fig" rid="fig3">Figure 3G–J</xref>). Consistently, we detected MCAM expression on muscle subclusters (<xref ref-type="fig" rid="fig3">Figure 3G</xref>), while bulk RNA-seq at 16 wk highlighted expression of additional <italic>MyHC</italic> isoforms, for example, <italic>MYH2 (IIa</italic>), <italic>MYH4(IIb</italic>) and transcription factor NFIX (<xref ref-type="bibr" rid="bib40">Moore and Walsh, 1993</xref>; <xref ref-type="bibr" rid="bib5">Barbieri et al., 1990</xref>; <xref ref-type="bibr" rid="bib1">Alexander et al., 2016</xref>; <xref ref-type="bibr" rid="bib38">Messina et al., 2010</xref>). At more mature stages, we detected adult <italic>MYH1</italic> or slow <italic>MYH7</italic> isoforms (<xref ref-type="fig" rid="fig3">Figure 3</xref>, <xref ref-type="fig" rid="fig3s1">Figure 3—figure supplement 1G</xref>), presumably due to myofiber stimulation via spontaneous contraction. In agreement, differential expression comparison between 8 and 16 wk organoids indicated less variance in transcription profiling (<xref ref-type="fig" rid="fig3">Figure 3</xref>, <xref ref-type="fig" rid="fig3s1">Figure 3—figure supplement 1H</xref>, <xref ref-type="fig" rid="fig4">Figure 4A</xref>). Consistently, sarcomere organization, ion transport, response to stimulus, and synapse structure maintenance were among the upregulated gene ontology terms and mitosis, cell cycle, DNA packaging, and nuclear division among the top downregulated terms (<xref ref-type="fig" rid="fig3">Figure 3</xref>, <xref ref-type="fig" rid="fig3s2">Figure 3—figure supplement 2B–D</xref>). Notably, ongoing maturation did not affect pool of progenitor cells, as even at 14 wk we could report significant increases in PAX7<sup>+</sup> (50,16 ± 2.19%) and MYOD1<sup>+</sup> (58.53 ± 0.92%) cells (<xref ref-type="fig" rid="fig2">2</xref>,<xref ref-type="fig" rid="fig3">3</xref><xref ref-type="fig" rid="fig2">Figures 2F</xref> and <xref ref-type="fig" rid="fig3">3</xref>, <xref ref-type="fig" rid="fig3s2">Figure 3—figure supplement 2E and F</xref>).</p><fig-group><fig id="fig4" position="float"><label>Figure 4.</label><caption><title>Myogenic progenitor identity and comparison to progenitors derived from fetal and adult muscle tissue.</title><p>(<bold>A</bold>) <italic>t</italic>-SNE plot visualization of color-coded clustering indicates myogenic progenitor subcluster with distinct molecular signatures: ‘dormant’ <italic>PAX7<sup>high</sup></italic>/<italic>CHODL<sup>high</sup></italic>/<italic>FBN1<sup>high</sup></italic>, ‘activated’ <italic>CD44<sup>high</sup></italic>/<italic>CD98<sup>+</sup></italic>/<italic>MYOD1<sup>+</sup>,</italic> and ‘mitotic’ <italic>KI-67<sup>+</sup>/CDK1<sup>+</sup>/TOP2A.</italic> (<bold>B</bold>) Organoid overviews on day 98 illustrate CD44 and PAX7-expressing cells at developing sites, which are more accessible to HGF activation signal, specificity of CD44 on MYOD<sup>+</sup>/PAX7<sup>+</sup> progenitor-expressing cells (arrows) and absence from FastMyHC<sup>+</sup> positive myofibers is highlighted. (<bold>C</bold>) FBN1<sup>+</sup> microfibrils are located toward organoid interior. (<bold>D</bold>) Pseudotime ordering for myogenic progenitors and myoblast corresponding clusters highlights distinct developmental trajectories promoting myogenic commitment and self-renewal. (<bold>E</bold>) Correlation coefficient plot for Log2 fold change (Log2 FC) values for isolated myogenic progenitors from human fetal tissue (17w) and FACS-sorted CXCR4<sup>+</sup>/ITGβ1<sup>+</sup> organoid-derived myogenic progenitors (16w). <italic>PAX7</italic>, <italic>COL1A1</italic>, <italic>COL3A1</italic>, <italic>COL4A1</italic>, <italic>COL5A1</italic>, <italic>COL15A1</italic>, <italic>FBN1,</italic> and <italic>CHODL</italic> and further extracellular matrix-related genes are highlighted on the plot. Pearson’s correlation coefficient, rho = 0.9 for global expression comparison and rho = 0.97 for selected genes. (<bold>F</bold>) UMAP color-based clustering divides non-dividing myogenic progenitors and adult satellite cells into four clusters with distinct molecular signatures: satellite cells characterized by <italic>SPRY1<sup>high</sup></italic>/<italic>ZFP36<sup>high</sup></italic>/<italic>MYF5<sup>high</sup></italic> expression, co-clustered with dormant <italic>SPRY1<sup>high</sup></italic>/<italic>FBN1<sup>high</sup></italic>/<italic>CHODL<sup>high</sup></italic>/<italic>PAX7<sup>high</sup></italic>, activated <italic>CD44<sup>high</sup></italic>/<italic>CD98<sup>high</sup></italic>/<italic>MYOD1<sup>+</sup>,</italic> and committed, <italic>NEB <sup>high</sup></italic>/<italic>MYH3<sup>high</sup></italic>/<italic>MYOD1<sup>high</sup></italic> organoid-derived myogenic progenitors. Dots correspond to adult satellite cells from GSE130646 database, triangles correspond to organoid-derived myogenic progenitors. (<bold>G</bold>) Violin plots depicting relative expression levels of markers specific for quiescent PAX7 or activated MYF5 muscle stem cell state across adult satellite cells (GSE130646) and organoid-derived myogenic progenitors subclusters. (<bold>H</bold>) Ridge plots of developmental score distribution of myogenic progenitors across in vivo or in vitro stages based on the difference between upregulated satellite cell and embryonic markers from human reference atlases for weeks (Wk) 5–18 embryonic and fetal stages, years (Yr) 7–42 adult satellite cells and skeletal muscle (SM) organoid. (<bold>I, J</bold>) In vivo engraftment potential of human myogenic progenitors. 100.000 CD82+ sorted human cells were injected into <italic>Tibialis anterior</italic> muscle of nude mice. (<bold>I</bold>) Control mice were not injected (<bold>J</bold>). Six weeks post transplantation, transverse cryosections of muscle fibers were stained with huLamin A/C (green), dystrophin (red), and DAPI (blue). Human cells appear green and red in contrast to murine cells, which only show a dystrophin-positive red staining. Scale bars 200 μm in (<bold>I, J</bold>).</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-87081-fig4-v1.tif"/></fig><fig id="fig4s1" position="float" specific-use="child-fig"><label>Figure 4—figure supplement 1.</label><caption><title>Subclustering of myogenic progenitors and NOTCH signaling.</title><p>(<bold>A</bold>) Dot plot showing expression of representative genes related to satellite cell identity across the seven main clusters. (<bold>B</bold>) Dot plot showing expression of representative genes related to <italic>NOTCH</italic> signaling, which are identified as regulators of satellite cell quiescence across the seven main clusters. (<bold>C</bold>) Organoid immunohistochemistry on day 98 indicates PAX7 myogenic progenitors that are Ki-67<sup>-</sup>/EdU<sup>-</sup>. (<bold>D</bold>) Gating strategy applied to quantify EdU<sup>+</sup> proliferating cells in organoid culture on day 98 (14 wk); histograph depicting percentage of EdU<sup>+</sup> cells; dot plot, circle area represents percentage of gene<sup>+</sup> cells in a cluster, color reflects average expression level (gray, low expression; blue, high expression). Scale bars, 100 uM in (<bold>C</bold>).</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-87081-fig4-figsupp1-v1.tif"/></fig><fig id="fig4s2" position="float" specific-use="child-fig"><label>Figure 4—figure supplement 2.</label><caption><title>Pseudotime ordering of myogenic progenitor revealing distinct states and cell fate decisions.</title><p>(<bold>A</bold>) Gene signatures of <italic>t</italic>-SNE described clusters based on relative expression levels of the 50 most significant markers for each of the three clusters. (<bold>B</bold>) Expression of selected genes along pseudotime. Group of genes selected for myogenic progenitors: <italic>PAX7</italic>, <italic>SPRY1</italic>, <italic>CHODL</italic> (dormant state), <italic>CD44</italic>, <italic>CD98</italic>, <italic>MYOD1</italic> (activated state), <italic>TOP2A</italic> (mitotic state), and for myoblasts: <italic>MYOD1.</italic> (<bold>C, D</bold>) UMAP feature plots depicting relative expression of extracellular matrix proteins <italic>COL1A2</italic>, <italic>COL5A2</italic>, <italic>COL5A3</italic>, <italic>FN1</italic> (<bold>C</bold>) and selected transcriptional regulators that define dormant (<italic>PAX7</italic>, <italic>FBN1</italic>, <italic>CHODL</italic>, <italic>SPRY1</italic>), activated (<italic>CD44</italic>, <italic>CD98</italic>, <italic>MYOD1</italic>, <italic>VEGFA</italic>), and mitotic (<italic>TOP2A</italic>) state of myogenic progenitor and myoblast (<italic>MYOD1</italic>) clusters (<bold>D</bold>). (<bold>E, F</bold>) UMAP feature plots depicting relative expression of genes regulating asymmetric divisions and self-renewal (<italic>PARD3</italic>, <italic>p38a/b</italic>, <italic>CD9</italic>, <italic>NOTCH3</italic>) (<bold>E</bold>) and extracellular matrix collagens <italic>(COL1A1</italic>, <italic>COL3A1</italic>, <italic>COL4A1</italic>, <italic>COL5A1</italic>, <italic>COL6A1</italic>, <italic>COL15A1</italic>, <italic>COL4A2</italic>, <italic>COL6A2)</italic> (<bold>F</bold>).</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-87081-fig4-figsupp2-v1.tif"/></fig><fig id="fig4s3" position="float" specific-use="child-fig"><label>Figure 4—figure supplement 3.</label><caption><title>Organoid-derived myogenic progenitors and correlation to fetal muscle progenitors.</title><p>(<bold>A</bold>) Gating strategy applied for FACS sorting CD29+/CXCR4+ cells from 15 to 16 wk skeletal muscle organoids. (<bold>B, C</bold>) Re-plating CD29+/CXCR4+ cells and culturing for 14 d highlights fetal myogenic potential, illustrated by brightfield and immunocytochemistry images for Fast MyHC+, TITIN+, and PAX7+ populations. (<bold>D</bold>) <italic>t</italic>-SNE feature plots for <italic>ITGβ1</italic> and <italic>CXCR4</italic> demarcate expression of FACS isolated calls into myogenic progenitor subcluster. (<bold>E</bold>) Gating strategy from (<bold>A</bold>) together with unstained population (yellow), isotype control (red), and CD29+/CXCR4+ (gray) population. (<bold>F</bold>) Correlation coefficient plot for Log2 fold change (Log2 FC) values for isolated myogenic progenitors from human fetal tissue (17w) and FACS-sorted CXCR4+/ ITGβ1+ organoid-derived myogenic progenitors (16w). <italic>PAX7</italic>, <italic>MYF5</italic>, <italic>MYOD1</italic>, <italic>MYOG</italic> are highlighted on the plot. (<bold>G</bold>) Correlation coefficient plot for Log2 FC values for FACS-sorted CXCR4+/ ITGβ1+ organoid-derived myogenic progenitors (16w) from CB CD34+, DMD_IPS1, BMD_iPS1, and iPSCORE_65_1 pluripotent lines. Scale bars, 200 uM (<bold>B</bold>), 100 uM (<bold>C</bold>).</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-87081-fig4-figsupp3-v1.tif"/></fig><fig id="fig4s4" position="float" specific-use="child-fig"><label>Figure 4—figure supplement 4.</label><caption><title>Organoid-derived myogenic progenitors and correlation to adult human satellite cells.</title><p>(<bold>A</bold>) Violin plots highlighting developmental status for organoid-derived myogenic progenitors and satellite cells through relative expression of key signature markers <italic>ZFP36</italic>, <italic>CD44</italic>, <italic>FBN1</italic>, <italic>NEB,</italic> and <italic>SPRY1</italic> for each subcluster. (<bold>B</bold>) Enhanced volcano plot from comparing transcript levels between all adult satellite cells (GSE130646) and organoid-derived myogenic progenitors. Log2 fold-change in normalized gene expression vs. –Log10 adjusted p-value is plotted. Differentially expressed genes: blue, adjusted p-value&lt;0.001; green, adjusted p-value&gt;0.001 and log2 fold-change &gt;1; red, log2 fold-change &gt;1 and adjusted p-value &lt;0.001; gray, no significance. (<bold>C</bold>) Pseudotime ordering for organoid-derived myogenic progenitors and adult satellite cells together with expression of selected genes. (<bold>D</bold>) Expression of genes selected for dormant myogenic progenitors (<italic>PAX7</italic>, <italic>NOTCH3</italic>, <italic>RBPJ</italic>) and activated satellite cells (<italic>MYF5</italic>, <italic>JUN</italic>, <italic>FOS</italic>). (<bold>E</bold>) UMAP feature plots depicting expression of <italic>PAX7</italic>, <italic>CD82+</italic>, <italic>MYF5,</italic> and <italic>NEB</italic> within the myogenic progenitor and adult satellite cell clusters corresponding to <xref ref-type="fig" rid="fig4">Figure 4F</xref>.</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-87081-fig4-figsupp4-v1.tif"/></fig><fig id="fig4s5" position="float" specific-use="child-fig"><label>Figure 4—figure supplement 5.</label><caption><title>Characterization of cell–cell communication network for all clusters at week 12 of human skeletal muscle organoid development.</title><p>(<bold>A</bold>) Circle plot illustrates the aggregated cell–cell communication network for all clusters at week 12 of human skeletal muscle organoids development. Circle sizes are proportional to the number of cells in each cell group and edge width represents the communication probability. (<bold>B</bold>) Heatmap indicating signals contributing most to the outgoing or incoming signaling among activated, mitotic, dormant/specification-resistant myogenic progenitors and fibroadipogenic progenitors, neural progenitors and myofibers-related clusters at week 12 of human skeletal muscle organoid development.</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-87081-fig4-figsupp5-v1.tif"/></fig><fig id="fig4s6" position="float" specific-use="child-fig"><label>Figure 4—figure supplement 6.</label><caption><title>Reproducibility of organoid culture at early and mature stages.</title><p>(<bold>A</bold>) Pseudotemporal ordering of organoids from days 2, 7, and 11 based on qPCR expression profiling of selected 32 genes indicates robust homogeneous development of organoids during WNT activation and BMP Inhibition, while the subsequent development of paraxial mesoderm and neural tube-related lineages via bFGF, retinoic acid (day 7) and WNT1a, hSHH (day 11) stimulation, introduced small variations to the organoid culture system. (<bold>B</bold>) Integrative analysis between datasets of organoids from different lines demonstrates highly conserved lineage representation for all datasets at mature stages (week 12) of human skeletal muscle organoid development. Feature plots on <italic>PAX7</italic>, <italic>CD44</italic>, <italic>FBN1</italic>, <italic>MYH3</italic>, <italic>POSTN</italic>, <italic>SOX2,</italic> as well as <italic>NOTCH3</italic>, <italic>MYOG</italic>, <italic>TOP2A</italic> indicate the presence of dormant, activated, and mitotic myogenic progenitors together with skeletal muscle myofibers, fibroadipogenic progenitors, and neural progenitors-related clusters.</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-87081-fig4-figsupp6-v1.tif"/></fig><fig id="fig4s7" position="float" specific-use="child-fig"><label>Figure 4—figure supplement 7.</label><caption><title>Comparison between 2D in vitro myogenic differentiation protocols and in vivo staging.</title><p>Violin plots highlighting expression of key myogenesis markers: Comparison between myogenic progenitors derived in 2D differentiation protocols (HX protocol, <xref ref-type="bibr" rid="bib67">Xi et al., 2017</xref>; JC protocol, <xref ref-type="bibr" rid="bib12">Chal et al., 2015</xref>; MS protocol, <xref ref-type="bibr" rid="bib55">Shelton et al., 2014</xref>) and in vivo myogenic progenitors (five stages: 1, 2: embryonic; 3, 4: fetal; 5: postnatal). Data were acquired from Pyle ́s LAB UCLA website (<ext-link ext-link-type="uri" xlink:href="https://aprilpylelab.com/datasets/in-vivo-and-in-vitro-multiple-protocols-smpcs-and-scs/">here</ext-link>) and <xref ref-type="bibr" rid="bib68">Xi et al., 2020</xref>.</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-87081-fig4-figsupp7-v1.tif"/></fig></fig-group></sec><sec id="s2-3"><title>Functionality and maturation of organoid-derived myofibers</title><p>Regarding localization and functionality of organoid-derived myofibers, immunocytochemistry revealed positive staining for dystrophin and a continuous laminin sheath around individual muscle fibers. Ultrastructure and two-photon microscopy analysis depicted well-developed sarcomeres (<xref ref-type="fig" rid="fig3">Figure 3</xref>, <xref ref-type="fig" rid="fig3s3">Figure 3—figure supplement 3A–D</xref>). Moreover, patch-clamp experiments, upon superfusion of cells with acetylcholine (ACh), indicated inward current generations that rapidly declined to a low steady-state level (<xref ref-type="fig" rid="fig3">Figure 3K</xref>, <xref ref-type="fig" rid="fig3s3">Figure 3—figure supplement 3E</xref>). The I/V curve of this current component showed almost linear behavior and reversal potential around 0 mV (<xref ref-type="fig" rid="fig3">Figure 3L</xref>). These data are in line with previous studies that described currents with analogous properties as characteristic nAChR currents (<xref ref-type="bibr" rid="bib27">Jahn et al., 2001</xref>; <xref ref-type="bibr" rid="bib53">Shao et al., 1998</xref>). Application of a fluorescent biosensor for monitoring changes in cytosolic Ca<sup>2+</sup> (Twitch2B) revealed nAChR efficiency in modulating intracellular [Ca<sup>2+</sup>]. Summarized FRET recordings (<xref ref-type="fig" rid="fig3">Figure 3M</xref>, <xref ref-type="fig" rid="fig3s3">Figure 3—figure supplement 3F</xref>), following application of ACh (10 μM), illustrated a rapid increase in FRET ratio that gradually declined in the presence of ACh, probably reflecting desensitization of nAChRs. These results demonstrated that nAChR in skeletal muscle cells are functional in terms of inducing Ca<sup>2+</sup> release from intracellular stores.</p><p>Using our organoid protocol, we successfully derived fetal muscle progenitors and electrophysiologically functional myofibers from hiPSC lines with wild type and Duchenne muscular dystrophy genetic backgrounds (<xref ref-type="fig" rid="fig3">Figure 3</xref>, <xref ref-type="fig" rid="fig3s3">Figure 3—figure supplement 3E and F</xref>).</p></sec><sec id="s2-4"><title>Identity and sustainability of organoid-derived PAX7 myogenic progenitors</title><p>Skeletal muscle organoids remarkably foster sustainable propagation of PAX7<sup>+</sup> progenitors (<xref ref-type="fig" rid="fig2">Figures 2F</xref> and <xref ref-type="fig" rid="fig3">3A</xref>). Initial screening of PAX7<sup>+</sup> progenitors indicated expression of several satellite cell markers (<xref ref-type="bibr" rid="bib21">Fukada et al., 2007</xref>), such as <italic>CD82</italic>, <italic>CAV1</italic>, <italic>FGFR1</italic>, <italic>FGFR4</italic>, <italic>EGFR</italic>, <italic>M-Cadherin</italic>, <italic>NCAM</italic>, <italic>FZD7</italic>, <italic>CXCR4</italic>, <italic>ITGβ1</italic>, <italic>ITGA7</italic>, <italic>SCD2,</italic> and <italic>SCD4</italic> (<xref ref-type="fig" rid="fig4">Figure 4</xref>, <xref ref-type="fig" rid="fig4s1">Figure 4—figure supplement 1A</xref>). Further investigation verified NOTCH signaling activity (<italic>HES1</italic>, <italic>HEYL</italic>, <italic>HEY1,</italic> and <italic>NRARP</italic>) in the myogenic subcluster, while dormant myogenic progenitors exhibited high expression of <italic>SPRY1</italic> and cell cycle inhibitors <italic>p57 (CDKN1C</italic>), <italic>p21,</italic> and <italic>PMP22</italic> (<xref ref-type="bibr" rid="bib68">Xi et al., 2020</xref>; <xref ref-type="bibr" rid="bib21">Fukada et al., 2007</xref>; <xref ref-type="bibr" rid="bib7">Bjornson et al., 2012</xref>; <xref ref-type="bibr" rid="bib54">Shea et al., 2010</xref>; <xref ref-type="fig" rid="fig4">Figure 4</xref>, <xref ref-type="fig" rid="fig4s1">Figure 4—figure supplement 1B</xref>, <xref ref-type="fig" rid="fig4s2">Figure 4—figure supplement 2A and D</xref>). Moreover, proliferation assays performed at the same stage (14 wk) demonstrated 4.78 ± 0.28% edU<sup>+</sup> cells, while substantial proportions of PAX7<sup>+</sup> myogenic progenitors remained quiescent (<xref ref-type="fig" rid="fig4">Figure 4</xref>, <xref ref-type="fig" rid="fig4s1">Figure 4—figure supplement 1C and D</xref>). <italic>t</italic>-SNE clustering divided myogenic progenitors into three distinct groups with unique molecular signatures: ‘<italic>CD44<sup>high</sup></italic>,’ ‘<italic>FBN1<sup>high</sup>,’</italic> and ‘<italic>CDK1<sup>+</sup>’</italic> clusters (<xref ref-type="fig" rid="fig4">Figure 4A</xref>, <xref ref-type="fig" rid="fig4s2">Figure 4—figure supplement 2A</xref>). The ‘<italic>CD44high’</italic> cluster, further characterized by <italic>CD98</italic> upregulation, adopted a molecular signature similar to activated satellite cell state (<xref ref-type="bibr" rid="bib44">Porpiglia et al., 2017</xref>; <xref ref-type="fig" rid="fig4">Figure 4A and B</xref>, <xref ref-type="fig" rid="fig4s2">Figure 4—figure supplement 2A and D</xref>). In this state, myogenic progenitors expressed <italic>VEGFA</italic> (<xref ref-type="fig" rid="fig4s2">Figure 4—figure supplement 2A and D</xref>) as previously described for murine satellite cells (<xref ref-type="bibr" rid="bib66">Verma et al., 2018</xref>). Consistently, the CD44<sup>+</sup>/PAX7<sup>+</sup> ‘activated’ myogenic population located at sites more accessible to HGF signaling, for example, exterior organoid areas and forming bulges (<xref ref-type="fig" rid="fig4">Figure 4B</xref>). The ‘<italic>FBN1<sup>High</sup>’</italic> subcluster was further characterized by ‘<italic>PAX7<sup>high</sup></italic>/<italic>SPRY1<sup>high</sup></italic>/<italic>CHODL<sup>high</sup></italic>/<italic>FBN1<sup>high</sup>’</italic> expression (<xref ref-type="fig" rid="fig4">Figure 4A</xref>, <xref ref-type="fig" rid="fig4s2">Figure 4—figure supplement 2A and D</xref>). <italic>PAX7high</italic> cells within the dormant state co-expressed <italic>NOTCH3</italic>, <italic>JAG1,</italic> and <italic>LNFG</italic>, together with <italic>CHODL</italic> markers. Further, we verified the presence of FBN1<sup>+</sup> microfibrils, which, compared to CD44<sup>+</sup> cells, occupied areas without direct access to activation signals (<xref ref-type="fig" rid="fig4">Figure 4C</xref>). Lastly, the ‘<italic>CDK1<sup>+</sup>’</italic> cluster was the only proliferative population, further expressing markers mediating satellite cell activation and proliferation, such as <italic>DEK</italic> and <italic>EZH2</italic> (<xref ref-type="bibr" rid="bib15">Cheung et al., 2012</xref>; <xref ref-type="bibr" rid="bib29">Juan et al., 2011</xref>; <xref ref-type="fig" rid="fig4">Figure 4A and D</xref>, <xref ref-type="fig" rid="fig4s1">Figure 4—figure supplement 1A</xref>, <xref ref-type="fig" rid="fig4s2">Figure 4—figure supplement 2A and B</xref>).</p><p>Pseudotemporal ordering of myogenic progenitors indicated that the ‘<italic>FBN1<sup>High</sup>’</italic> subcluster was the main progenitor population residing in dormant state, which by downregulating <italic>PAX7</italic>, <italic>FBN1,</italic> and <italic>CHODL</italic> and upregulating <italic>CD44</italic>, <italic>MYOD1</italic>, <italic>CD98 (SLC3A2</italic>), and <italic>VEGF</italic> generated activated state (<xref ref-type="fig" rid="fig4">Figure 4D</xref>, <xref ref-type="fig" rid="fig4s2">Figure 4—figure supplement 2B</xref>). In activated state, myogenic progenitors that upregulate <italic>MYOD1</italic> entered mitosis, proliferated, and followed a trajectory leading to myogenic commitment (<xref ref-type="fig" rid="fig4">Figure 4D</xref>, <xref ref-type="fig" rid="fig4s2">Figure 4—figure supplement 2B</xref>). This commitment was further accompanied by <italic>PARD3</italic>, <italic>p38a MAPK,</italic> and <italic>CD9</italic> expression (<xref ref-type="bibr" rid="bib44">Porpiglia et al., 2017</xref>; <xref ref-type="bibr" rid="bib63">Troy et al., 2012</xref>; <xref ref-type="fig" rid="fig4s2">Figure 4—figure supplement 2E</xref>). Conversely, myogenic progenitors that upregulated <italic>NOTCH3</italic>, <italic>SPRY1,</italic> and <italic>PAX7</italic> followed a loop trajectory that reinstated dormant stem cell state (<xref ref-type="fig" rid="fig4s2">Figure 4—figure supplement 2D and E</xref>). Interestingly, the ‘<italic>FBN1<sup>high</sup>’</italic> cluster highly expressed extracellular matrix collagens, for example, <italic>COL4A1</italic>, <italic>COL4A2</italic>, <italic>COL5A1</italic>, <italic>COL5A2</italic>, <italic>COL5A3,</italic> and <italic>COL15A1</italic>. Notably, such expression declined upon commitment and differentiation (<xref ref-type="fig" rid="fig4s2">Figure 4—figure supplement 2C and F</xref>).</p></sec><sec id="s2-5"><title>Organoid-derived myogenic progenitor comparison to human fetal and adult progenitor/stem cells</title><p>To evaluate developmental identity of the myogenic cluster, we isolated ITGβ1<sup>+</sup>/CXCR4<sup>+</sup> organoid-derived myogenic progenitors via FACS (<xref ref-type="bibr" rid="bib22">Garcia et al., 2018</xref>) and compared to human fetal muscle progenitors, demonstrating high similarity (Pearson’́s correlation co-efficiency, rho = 0.9), with myogenic markers such as <italic>PAX7</italic>, <italic>MYF5</italic>, <italic>MYOG,</italic> and <italic>MYOD1</italic> at comparable expression levels (<xref ref-type="fig" rid="fig4s3">Figure 4—figure supplement 3A–F</xref>). Differential expression comparison verified expression of extracellular matrix collagens and proteins, such as <italic>COL4A1</italic>, <italic>COL5A1</italic>, <italic>COL6A1</italic>, <italic>COL15A1</italic>, <italic>FBN1,</italic> and <italic>CHODL</italic>, in myogenic progenitors similar to 17th week human fetal tissue (Pearson’́s correlation co-efficiency, rho = 0.97) (<xref ref-type="fig" rid="fig4">Figure 4E</xref>). Further, to evaluate myogenic potency in vitro, isolated ITGβ1<sup>+</sup>/CXCR4<sup>+</sup> organoid-derived myogenic progenitor cells were re-plated and allowed to differentiate under the same organoid culture protocol, which demonstrated capacity to generate FastMyHC+ and PAX7+ populations within 10 d (<xref ref-type="fig" rid="fig4s3">Figure 4—figure supplement 3B and C</xref>). Subsequently, comparison to available transcriptomic dataset of human adult satellite cells at single-cell resolution divided myogenic progenitors and adult satellite cells into four clusters with distinct molecular signatures (<xref ref-type="fig" rid="fig4">Figure 4F</xref>). Interestingly, myogenic progenitors were enriched for extracellular matrix proteins, while satellite cells mainly upregulated genes repressing transcription/translation, such as <italic>ZFP36</italic> and <italic>TSC22D1</italic>, or related to early activation response, such as <italic>MYF5</italic>, <italic>JUN,</italic> and <italic>FOS</italic> (<xref ref-type="fig" rid="fig4s4">Figure 4—figure supplement 4A and B</xref>). In line, organoid-derived myogenic progenitors exhibited higher <italic>NOTCH</italic> signaling activity in comparison to satellite cells, with <italic>NOTCH3</italic> and <italic>RBPJ</italic> being among enriched markers (<xref ref-type="fig" rid="fig4s4">Figure 4—figure supplement 4B</xref>). In contrast, adult satellite cells exhibited <italic>PAX7<sup>low</sup></italic>/<italic>MYF5<sup>high</sup></italic> expression profiling, presumably due to tissue dissociation, thereby indicating a tendency for activation rather than preservation or reinstatement of quiescency (<xref ref-type="bibr" rid="bib33">Machado et al., 2017</xref>; <xref ref-type="bibr" rid="bib51">Seale et al., 2000</xref>; <xref ref-type="fig" rid="fig4">Figure 4G</xref>). Pseudotime ordering showed two distinct clusters, with adult satellite cells downstream from non-dividing myogenic progenitors (<xref ref-type="fig" rid="fig4s4">Figure 4—figure supplement 4C</xref>). Consistently, downregulation of genes promoting quiescence like <italic>PAX7</italic>, <italic>NOTCH3,</italic> and <italic>RBP,</italic> and upregulation of activation genes like <italic>MYF5</italic>, <italic>JUN,</italic> and <italic>FOS</italic> along the trajectory (<xref ref-type="fig" rid="fig4s4">Figure 4—figure supplement 4D</xref>), was a further indication that organoid-derived myogenic progenitors resided in dormant non-dividing state and that our organoid platform promoted sustainability of myogenic progenitors.</p><p>Cell–cell communication analysis of organoids at 12 wk indicates that myogenic progenitors influence their own fate, mainly with extracellular matrix (ECM)-related signals, as well as receive signals predominantly from the mesenchyme but not the neural progenitor cluster (<xref ref-type="fig" rid="fig4s5">Figure 4—figure supplement 5</xref>).</p><p>To evaluate for reproducibility of organoid development, we applied diffusion map analysis on qPCR-based expression analysis of 32 genes at early stages and integrative analysis on scRNAseq datasets of mature stages of organoid development. The data indicate highly conserved cluster representation of myogenic progenitors at all states, together with skeletal muscle myofibers, fibroadipogenic progenitors, and neural progenitors-related clusters (<xref ref-type="fig" rid="fig4s6">Figure 4—figure supplement 6</xref>).</p><p>Organoid-derived myogenic progenitors exhibited expression profiling similar to that of stage 4 myogenic progenitors, correlating to 17th–18th week human fetal development, as reported in the human skeletal muscle atlas (<xref ref-type="bibr" rid="bib68">Xi et al., 2020</xref>). <italic>SPRY1</italic>, <italic>PLAGL1</italic>, <italic>POU4F1</italic>, <italic>TCF4</italic>, <italic>PAX7</italic>, <italic>CD82,</italic> and <italic>CD44</italic> markers, as well as ECM proteins, nuclear factor I family members (<italic>NFIA</italic>, <italic>NFIB</italic>, <italic>NFIC</italic>), and <italic>NOTCH</italic> signaling, are specifically upregulated markers. Furthermore, in comparison to 2D culture protocols, our organoid approach preserved myogenic progenitor dormancy without activating MYOD1 and exhibited higher expression of ECM proteins and key markers characterizing stage 4 fetal myogenic progenitors (<xref ref-type="fig" rid="fig4s7">Figure 4—figure supplement 7</xref>). <italic>ERBB3</italic> and <italic>NGFR</italic> markers (<xref ref-type="bibr" rid="bib26">Hicks et al., 2018</xref>) demarcate populations of earlier developmental stages and were not upregulated either in organoid-derived or stage 4 fetal myogenic progenitors (<xref ref-type="fig" rid="fig4s7">Figure 4—figure supplement 7</xref>). In addition, organoid myogenic progenitors and stage 4 fetal myogenic progenitors both downregulated cycling genes like <italic>MKI67</italic>, <italic>TOP2A</italic>, <italic>EZH2,</italic> and <italic>PCNA</italic> (<xref ref-type="fig" rid="fig4s7">Figure 4—figure supplement 7</xref>).</p><p>In addition, we have performed a developmental score distribution of myogenic progenitors based on the difference between upregulated satellite cell and embryonic markers from the human reference myogenic atlases (<xref ref-type="bibr" rid="bib68">Xi et al., 2020</xref>) and adult satellite cell data (<xref ref-type="bibr" rid="bib50">Rubenstein et al., 2020</xref>; <xref ref-type="bibr" rid="bib68">Xi et al., 2020</xref>) in comparison to our organoid protocol (<xref ref-type="fig" rid="fig4">Figure 4H</xref>). Organoid-derived myogenic progenitors represent the late fetal stage of maturation partially overlapping with adult satellite cell scoring. We note the heterogeneity of adult satellite cell populations when performing developmental scoring in line with recent reports (<xref ref-type="bibr" rid="bib6">Barruet et al., 2020</xref>).</p><p>Finally, we transplanted CD82-positive progenitors from our organoids into the <italic>Tibialis anterior</italic> (TA) muscle of immunodeficient mice to complement our study with an in vivo experiment (<xref ref-type="bibr" rid="bib1">Alexander et al., 2016</xref>; <xref ref-type="bibr" rid="bib36">Marg et al., 2019</xref>; <xref ref-type="bibr" rid="bib2">Al Tanoury et al., 2020</xref>). The CD82 positivity used for FACS selection of myogenic progenitors prior to transplantation almost exclusively overlaps with Pax7-positive cells, being a subcluster of them (<xref ref-type="fig" rid="fig4s4">Figure 4—figure supplement 4E</xref>). Six weeks post transplantation, we could verify clusters of human Lamin A/C-positive cells in the transplanted but not in the control group (<xref ref-type="fig" rid="fig4">Figure 4I and J</xref>). We have measured the size of myotubes with 41 ± 6 µm for the human and 63 ± 7 µm for the mice mean diameters (n = 15 each).</p></sec></sec><sec id="s3" sec-type="discussion"><title>Discussion</title><p>Human skeletal muscle organoids offer a new cell culture system to study human myogenesis, in particular fetal myogenic progenitors. We demonstrate that modulation of Matrigel-embedded embryonic bodies with WNT, BMP, and FGF signaling at early stages leads to paraxial mesoderm formation (<xref ref-type="fig" rid="fig1">Figure 1B</xref>). Further, under guided differentiation, we could promote concomitant development of neural and paraxial mesodermal lineages and derive mesodermal populations with somitic and dermomyotomal origin (<xref ref-type="fig" rid="fig1">Figure 1C–F</xref>). With WNT1A and SHH stimulation, neural lineage is directed toward dorsal neural tube/crest development which benchmarks the structural recapitulation of neural plate border epithelium (<xref ref-type="fig" rid="fig1">Figure 1G</xref>). In vitro neural plate border can be utilized to assess transcriptomic networks and cell fate decision during human neural crest formation.</p><p>Delaminating from the dermomyotome, undifferentiated PAX3 progenitor cells reorientate and align in the cranio-caudal axis to form the underlying myotome or completely detach from the dermomyotome and migrate into the surrounding mesenchyme at the limb sites, where they propagate and become committed to skeletal muscle progenitors (<xref ref-type="bibr" rid="bib48">Relaix et al., 2005</xref>). By stimulating organoid culture at the neural plate border/dermomyotomal stage with bFGF/HGF, we could further visualize both migration of myogenic progenitors and migration/specification of neural crest populations (<xref ref-type="fig" rid="fig1">Figures 1A, G, H</xref>, <xref ref-type="fig" rid="fig2">2A</xref>). Further, by omitting FGF during organoid development, we could detect a continuous upregulation of genes involved in the myogenic migration process, such as <italic>LBX1</italic>, <italic>PAX3</italic>, <italic>PAX7</italic> and <italic>CXCR4</italic>, but not in genes characterizing neural tube or neural crest development, such as <italic>SOX10</italic>, <italic>TFAP2A, PAK3</italic>, <italic>DLX5</italic>, <italic>B3GAT1</italic>, <italic>FOXB1</italic>, <italic>HES5,</italic> and <italic>OLIG3</italic>. This indicates that organoid culture conditions and specifically stimulation with HGF favored skeletal muscle over neural lineage (<xref ref-type="fig" rid="fig2">Figure 2C–E</xref>). Interestingly, we could show that by stimulating organoid culture with SF/HGF, an essential signal for detachment and subsequent migration, but not for specification of the cells at the lateral lip of the dermomyotome (<xref ref-type="bibr" rid="bib18">Dietrich et al., 1999</xref>), we could preserve the PAX3+/PAX7+ myogenic migratory population in an undifferentiated and uncommitted state (<xref ref-type="fig" rid="fig2">Figure 2D and E</xref>). Strikingly, expression profiling based on HOX gene cluster supported this notion as over time the organoid culture adopted more distal than proximal limb axial anatomical identity (<xref ref-type="fig" rid="fig2">Figure 2F</xref>).</p><p>Fetal development is characterized by PAX3+ to PAX7+ myogenic progenitor transition (<xref ref-type="bibr" rid="bib51">Seale et al., 2000</xref>; <xref ref-type="bibr" rid="bib48">Relaix et al., 2005</xref>), which we were able to demonstrate in our organoid culture. Our data further support organoid culture representing fetal stages as we could detect NFIX upregulation and verify the presence of myofibers expressing fetal MyHC isoform as well as NCAM, M-Cad, or MCAM in the proximity of PAX7 progenitors (<xref ref-type="fig" rid="fig3">Figure 3G–J</xref>). Consequently, transcriptome comparison indicated high similarity to human fetal muscle tissue (17 wk, Pearson correlation, rho = 0.9) (<xref ref-type="fig" rid="fig4">Figure 4E</xref>), as well as expression of several satellite cell markers (<xref ref-type="fig" rid="fig4s1">Figure 4—figure supplement 1A</xref>). This was further verified by comparison to a single-cell dataset from the human skeletal muscle cell atlas (<xref ref-type="fig" rid="fig4">Figure 4</xref>, <xref ref-type="fig" rid="fig4s4">Figure 4—figure supplement 4</xref>) Interestingly, single-cell resolution showed adult satellite cell clusters with organoid-derived myogenic progenitors (<xref ref-type="fig" rid="fig4">Figure 4F</xref>). In addition, pseudotime ordering indicated that organoid-derived myogenic progenitors reside developmentally upstream of activated satellite cells, upregulating markers associated with quiescence such as NOTCH signaling and extracellular matrix proteins (<xref ref-type="fig" rid="fig4s2">Figure 4—figure supplement 2E and F</xref>). Preservation of myogenic progenitors in a non-dividing state without activating MYOD1 and self-renewal (<xref ref-type="fig" rid="fig4">Figure 4D</xref>, <xref ref-type="fig" rid="fig4s2">Figure 4—figure supplement 2E and F</xref>) appeared to be responsible for the observed sustainable propagation of PAX7 progenitor cells even 14 wk post differentiation (<xref ref-type="fig" rid="fig2">2</xref>,<xref ref-type="fig" rid="fig3">3</xref><xref ref-type="fig" rid="fig2">Figures 2F</xref> and <xref ref-type="fig" rid="fig3">3A</xref>).</p><p>Patterning in our 3D protocol provides progenitors in a more mature late fetal state partially overlapping with adult satellite cell developmental scoring (<xref ref-type="fig" rid="fig4">Figure 4H</xref>). The ‘uncommitted’ Pax7 progenitor status is demonstrated by our precursor populations bulkRNAseq and scRNAseq profiling (<xref ref-type="fig" rid="fig4">Figure 4A, E and F</xref>). In this context, we could observe high expression of extracellular matrix proteins and upregulated NOTCH signaling in dormant non-dividing myogenic progenitors (<xref ref-type="fig" rid="fig4s2">Figure 4—figure supplement 2A and E</xref>). This phenotype is similarly described for human fetal tissue myogenic progenitors (<xref ref-type="fig" rid="fig4">Figure 4E</xref>, Pearson correlation, rho = 0.97, <xref ref-type="fig" rid="fig4s5">Figure 4—figure supplement 5</xref>). Studies evaluating engraftment potential of satellite cells and fetal muscle progenitors propose that muscle stem cells in a quiescent non-committed state exhibit enhanced engraftment potential (<xref ref-type="bibr" rid="bib26">Hicks et al., 2018</xref>; <xref ref-type="bibr" rid="bib45">Quarta et al., 2016</xref>; <xref ref-type="bibr" rid="bib39">Montarras et al., 2005</xref>; <xref ref-type="bibr" rid="bib62">Tierney et al., 2016</xref>). Our data demonstrate that upon activation and commitment dormant myogenic progenitors downregulate extracellular matrix proteins and upregulate expression of morphogens/receptors that make them susceptible to signals, like VEGFA, that communicates with vasculature during tissue reconstitution, or CD9, CD44, CD98 participating in cellular activation (<xref ref-type="bibr" rid="bib44">Porpiglia et al., 2017</xref>; <xref ref-type="fig" rid="fig2s1">Figure 2—figure supplement 1B and D</xref>). Cell–cell communication analysis revealed that myogenic progenitors influence their own fate mainly with ECM-related signals (<xref ref-type="fig" rid="fig4s5">Figure 4—figure supplement 5</xref>). This finding is in line with the nature of in vivo fetal myogenic progenitors (<xref ref-type="bibr" rid="bib62">Tierney et al., 2016</xref>) but also indicates that investigation at the myogenic progenitor level could provide new insights into ECM-related congenital muscular dystrophies. One example is the Ullrich congenital muscular dystrophy, where the ECM alters the muscle environment with progressive dystrophic changes, fibrosis, and evidence for increased apoptosis (<xref ref-type="bibr" rid="bib8">Bönnemann, 2011</xref>).</p><p>CD82+ populations from our organoids engraft in the TA muscle of immunodeficient mice (<xref ref-type="fig" rid="fig4">Figure 4I and J</xref>). It would be of interest for future studies to investigate whether increased engraftment can be achieved in 3D protocols (<xref ref-type="bibr" rid="bib20">Faustino Martins et al., 2020</xref>; <xref ref-type="bibr" rid="bib52">Shahriyari et al., 2022</xref>; ours) versus 2D patterned progenitor cells and to which degree this is attributed to high expression of extracellular matrix proteins. In particular, high Fibrillin1 expression on dormant non-dividing myogenic progenitors could potentially contribute to avoidance of fibrosis by myogenic progenitors through regulation of TGF-β signaling (<xref ref-type="bibr" rid="bib16">Cohn et al., 2007</xref>).</p><p>Different phases of human fetal myogenesis have been modeled with 2D differentiation protocols (<xref ref-type="bibr" rid="bib55">Shelton et al., 2014</xref>; <xref ref-type="bibr" rid="bib12">Chal et al., 2015</xref>; <xref ref-type="bibr" rid="bib67">Xi et al., 2017</xref>). Our 3D differentiation protocol does not go beyond these protocols when it comes to provide maturated physiologically responsive skeletal muscle cells, which we illustrate with the electrophysiological recording of organoid-derived cells of different origins (<xref ref-type="fig" rid="fig3">Figure 3K, L and M</xref>, <xref ref-type="fig" rid="fig3s3">Figure 3—figure supplement 3E and F</xref>). Structural distinctions like the posterior paraxial mesoderm on day 5 specified neural crest dermomytome on day 17, myogenic progenitor migration on day 23, and neural crest lineage arrest on day 35 (<xref ref-type="fig" rid="fig1">Figures 1C–H</xref>–<xref ref-type="fig" rid="fig2">2C</xref>) cannot be similarly observed in 2D protocols. In addition, our 3D organoid protocol provides myogenic progenitors in dormant and activated states for at least 14 wk in culture. We demonstrate that organoid culture sustains uncommitted MyoD1-negative, Pax7-positive myogenic progenitors as well as fibroadipogenic (PDGFRa+) progenitors, both resembling their fetal counterpart. This supply of muscle progenitors preserved in a quiescent state indicates translative potential of the approach. Future work will elucidate signaling transduction pathways during skeletal muscle organoid development to model and understand human myogenesis in more detail.</p></sec><sec id="s4" sec-type="materials|methods"><title>Materials and methods</title><sec id="s4-1"><title>hiPSCs culture</title><p>hiPSC lines, Cord Blood iPSC (CB CD34+, passages 15–35), Duchenne muscle dystrophy iPSC patient line iPSCORE_65_1 (WiCell, Cat# WB60393, passages 22–30), and DMD_iPS1 (passages 21–30) and BMD_iPS1 (passages 17–25) (Boston Children’s Hospital Stem Cell Core Facility), LGMD2A iPSC, and LGMD2A-isogenic iPSC (<xref ref-type="bibr" rid="bib19">Dorn et al., 2015</xref>; <xref ref-type="bibr" rid="bib37">Mavrommatis et al., 2020</xref>; <xref ref-type="bibr" rid="bib42">Panopoulos et al., 2017</xref>; <xref ref-type="bibr" rid="bib43">Park et al., 2008</xref>) were cultured in TESR-E8 (StemCell Technologies) on Matrigel GFR (Corning)-coated 6-well plates. Cells have been tested negative for mycoplasma. No experiments on human participants were performed. The use of reprogrammed human iPSC lines for research was performed after ethical approval from the ethics commission of the Ruhr-University Bochum, Medical Faculty (15-5401, August 2015).</p></sec><sec id="s4-2"><title>Human skeletal muscle organoid differentiation protocol</title><p>Prior differentiation, undifferentiated human PSCs, 60–70% confluent, were enzymatically detached and dissociated into single cells using TrypLE Select (Thermo Fisher Scientific). Embryoid bodies formed via hanging drop approach with each droplet containing 3–4 × 10<sup>3</sup> human single PSCs in 20 μl were cultured hanging on TESR-E8 supplemented with polyvinyl alcohol (PVA) at 4 mg/ml (Sigma-Aldrich) and rock inhibitor (Y-27632) at 10 μM (StemCell Technologies) at the lid of Petri dishes. At the beginning of skeletal muscle organoid differentiation, embryoid bodies at the size of 250–300 μm were embedded into Matrigel and cultured in DMEM/F12 basal media (Thermo Fisher Scientific) supplemented with glutamine (Thermo Fisher Scientific), non-essential amino acids (Thermo Fisher Scientific), 100× ITS-G (Thermo Fisher Scientific), (Basal Media) 3 μM CHIR99021 (Sigma-Aldrich), and 0.5 μM LDN193189 (Sigma-Aldrich). On day 3, human recombinant basic fibroblast growth factor (bFGF) (PeproTech) at 10 ng/μl final concentration was added to the media. Subsequently, on day 5, the concentration of bFGF was reduced to 5 ng/μl and the media was further supplemented with 10 nM retinoic acid (Sigma-Aldrich). The differentiation media, on day 7, was supplemented only with human recombinant Sonic Hedgehog (hShh) (PeproTech) at 34 ng/μl, human recombinant WNT1A (PeproTech) at 20 ng/μl, and 0.5 μM LDN193189. On day 11, the cytokine composition of the media was changed to 10 ng/μl of bFGF and human recombinant hepatocyte growth factor (HGF) at 10 ng/μl (PeproTech). From day 15 onward, the basal media was supplemented with ITS-X (Thermo Fisher Scientific) and human recombinant HGF at 10 ng/μl. The first three days of the differentiation the media were changed on a daily basis, from 3rd to 30th every second day, while from day 30 onward every 3rd day. The organoid approach was evaluated with six hiPSCs lines with independent genetic backgrounds, with more than five independent derivations per line, especially for the control line (CB CD34+) more than 20 derivation, obtaining always similar results. Per derivation and upon embryoid body Matrigel embedding, cultures exhibited high reproducibility. Upon migration and skeletal muscle formation, organoids are occupying whole Matrigel droplet and through generation of additional bulge reach sizes of 4–5 mM. Concomitantly, myogenic progenitors fall off the organoid and generate a sheath of myogenic organoids and muscle fibers at the surface of the culture plate. For all lines, functional myofibers and PAX7-positive myogenic populations could be evaluated. Myogenic populations from different lines exhibit high similarity (Pearson correlation, rho = 0.94–0,95, <xref ref-type="fig" rid="fig4s3">Figure 4—figure supplement 3G</xref>).</p></sec><sec id="s4-3"><title>Immunocytochemistry</title><sec id="s4-3-1"><title>Cryosection immunochemistry</title><p>Organoids from different stages were fixed on 4% paraformaldehyde overnight at 4°C under shaking conditions, dehydrated (30% sucrose overnight incubation), and embedded in OCT freezing media. Cryosections were acquired on a Leica CM3050s Cryostat. For the immunostaining process, cryosections were rehydrated with PBS, followed by permeabilization once with 0.1% Tween-20 in PBS (rinsed 3× with PBS), and then with 0.1% Triton-X in PBS (rinsed 3× with PBS). Subsequently, the sections were blocked with 1% BSA/10% NGS in PBS for 1 hr at room temperature (RT). Primary antibody incubations were performed from 1 to 2 d at 4°C, with secondary antibody incubations for 2 hr at RT.</p></sec><sec id="s4-3-2"><title>EdU staining</title><p>At 12 wk post differentiation, control organoids were incubated with 2.5 μM BrdU final concentration overnight. To detect EdU, the sections were processed with Click-iT EdU Alexa Fluor 488 cell proliferation kit (Invitrogen) following the manufacturer’s instructions. The samples were incubated with secondary antibodies after the click reaction for detecting EdU. <italic>Primary antibodies</italic>: anti-Brachyury (R&amp;D Systems, 1:250), anti-TBX6 (Abcam, 1:200), anti-PAX3 (DHSB, 1:250), anti-PAX7 (DHSB, 1:250), anti-SOX10 (R&amp;D Systems, 1:125), anti-KI67 (Thermo Fisher Scientific, clone SolA15, 1:100), anti-TITIN (DHSB, 9D-10, 1:300), anti-MyHC (DHSB, MF20, 1:300), anti-MYOD1 (Santa Cruz Biotechnologies, clone 5.8A, 1:200), anti-PRDM16 (Abcam, ab106410, 1:200), anti-TFAP2A (DHSB, 3B5, 1:100), anti-dystrophin (Novocastra/Leica Biosystems, clone DY4/6D3, 1:200), anti-Laminin (Sigma-Aldrich, 1:200), anti-FastMyHC (Sigma-Aldrich, clone MY-32, 1:300), anti-M-Cadherin (Cell Signaling Technology, 1:200) anti-SOX2 (Thermo Fisher Scientific, clone Btjce, 1:100), anti-CD44 (eBioscience, clone IM7, 1:100), and anti-Fibrillin1 (Invitrogen, clone 11C1.3, 1:100).</p></sec><sec id="s4-3-3"><title>Secondary antibodies</title><p>Alexa Fluor 647 AffiniPure Fab Fragment Goat Anti-Mouse IgM, μ Chain specific (Jackson ImmunoResearch Laboratories, 1:100), Rhodamine RedTM-X (RRX) AffiniPure Goat Anti-Mouse IgG, Fcγ Subclass 1 specific (Jackson ImmunoResearch Laboratories, 1:100), Alexa Fluor 488 AffiniPure Goat Anti-Mouse IgG, Fcγ subclass 2a specific (Jackson ImmunoResearch Laboratories, 1:100), Alexa Fluor 488, Goat Anti-Rat IgG (H+L) Cross-Adsorbed Secondary Antibody (Thermo Fisher Scientific, 1:500), Alexa Fluor 488, Donkey Anti-Mouse IgG (H+L) Cross-Adsorbed Secondary Antibody (Thermo Fisher Scientific, 1:500), Alexa Fluor 647, Donkey Anti-Goat IgG (H+L) Cross-Adsorbed Secondary Antibody (Thermo Fisher Scientific, 1:500), Alexa Fluor 488, Donkey Anti-Goat IgG (H+L) Cross-Adsorbed Secondary Antibody (Thermo Fisher Scientific, 1:500), and Alexa Fluor 568, Donkey Anti-Rabbit IgG (H+L) Cross-Adsorbed Secondary Antibody (Thermo Fisher Scientific, 1:500). Images were acquired on a ZEISS LSM780 inverted confocal microscope.</p></sec></sec><sec id="s4-4"><title>Oil O Red staining</title><p>For histological visualization of adipocytes within the organoids, Oil O Red Stain kit (Abcam, ab150678) was applied on frozen sections derived from PFA-fixated organoids following the manufacturer’s recommended protocol. Organoid sections upon staining with Oil O Red were visualized with an Olympus BX61 upright microscope.</p></sec><sec id="s4-5"><title>Flow cytometry</title><sec id="s4-5-1"><title>FACS intracellular staining</title><p>Organoids during the 2nd, 5th, 9th, and 14th week of differentiation were dissociated into single cells by incubating them till dissociating at 37°C within papain solution under shaking conditions. Then, the cells were pelleted at 400 × <italic>g</italic> for 5 min, followed by incubation with TryplE Select for 10 min to ensure dissociation into single cells. Further, the cells were passed through 70 μM (2nd week) to 100 μM (5th, 9th, 14th week) cell strainers to avoid aggregates. For both digesting steps, 10% FBS/DMEM-F12 as digesting deactivation solution was applied to the cells. Then, for intracellular flow cytometric staining analysis the Transcription Factor Buffer set (BD Pharmigen) was applied and the cells were analyzed using flow cytometer (BD Biosciences FACS ARIAII). Primary antibodies used in this study: anti-PAX7, anti- MYOD1, anti-Pax3 in total amount of 400 μg per staining; secondary antibodies: Rhodamine RedTM-X (RRX) AffiniPure Goat Anti-Mouse IgG, Fcγ Subclass 1 specific (Jackson ImmunoResearch Laboratories), Alexa Fluor 488 AffiniPure Goat Anti-Mouse IgG, Fcγ subclass 2a specific (Jackson ImmunoResearch Laboratories) in 1:50 dilution. As isotype controls, Mouse IgG1 kappa Isotype Control (Invitrogen, clone P3.6.2.8.1) and Mouse IgG2a kappa Isotype Control (Invitrogen, clone eBM2a) were used at 400 μg total amount per staining.</p></sec><sec id="s4-5-2"><title>FACS EdU assay</title><p>At 15 wk post differentiation, organoids were incubated overnight with 5 μM EdU final concentration. The next day, organoids were dissociated into single cells by incubation at 37°C within papain solution for 1–2 hr, followed by incubation with TryplE Select for 10 min to ensure single-cell dissociation. Then, the dissociated cells were passed through a 70 μm cell culture strainer to remove any remaining aggregates. To detect EdU, the cells were processed with Click- iT EdU Alexa Fluor 488 Flow Cytometry Assay Kit (Invitrogen) according to the manufacturer’s instructions and then analyzed using the 488 channel of a BD Biosciences FACSAria Fusion flow cytometer.</p></sec><sec id="s4-5-3"><title>FACS isolation of ITGβ1<sup>+</sup>/CXCR4<sup>+</sup> myogenic cell population for RNA sequencing</title><p>Organoids from Duchenne and Control iPSC lines and during 15th–16th week post differentiation were dissociated into single cells during incubation, with Papain solution dissociation upon gentle shaking (1–2 hr) was observed. To acquire singlets, the cells were filtered through 40 μm cell strainers and upon washing with 1% BSA solution prepared for surface antigen staining. For surface antigen staining, 20 min incubation with the Alexa Fluor 488 anti-human CD29 (BioLegend, clone TS2/16) and PE anti-human CD184[CXCR4] (BioLegend, clone 12G5) was applied together with the corresponding isotype controls: PE Mouse IgG2a, κ Isotype Ctrl antibody (BioLegend, clone MOPC-173) and 488 Mouse IgG1, κ Isotype Ctrl antibody (Invitrogen, clone P3.6.2.8.1). For removing residual antibodies, the cells were washed twice with 1% BSA staining solution and processed by BD Biosciences FACSAria Fusion flow cytometer. Briefly before FACS sorting to discriminate between dead and alive cells, DAPI was added to the samples and then DAPI<sup>-</sup>/CD29<sup>+</sup> /CXCR4<sup>+</sup> cell populations were collected into tubes containing RLT buffer supplemented with b-mercaptoethanol to avoid RNA degradation. The FACS gating strategy is further depicted in <xref ref-type="fig" rid="fig4s3">Figure 4—figure supplement 3A</xref>.</p></sec></sec><sec id="s4-6"><title>Bulk RNA sequencing</title><sec id="s4-6-1"><title>RNA extraction</title><p>Total RNA was extracted from single organoids or cultured cells by using the RNAeasy Micro Kit (QIAGEN) according to the manufacturer’s instructions. Subsequently, before library preparation, the RNA integrity was evaluated on an Agilent 2100 Bioanalyzer by using the RNA 6000 Pico kit (Agilent). <italic>cDNA library preparation</italic>: For 4 and 8 wk organoids, cDNA library was prepared by using the whole transcriptome Illumina TruSeq Stranded Total RNA Library Prep Kit Gold (Illumina), followed by evaluation on an Agilent 2100 Bioanalyzer by using the DNA 1000 kit. The resulting mRNA library was sequenced as 2 × 75 bp paired-end reads on a NextSeq 500 sequencer (Illumina). For 16 wk and ITGβ1<sup>+</sup>/CXCR4<sup>+</sup> sorted cells, cDNA library was prepared using the whole transcriptome Ovation Solo RNA seq Library Preparation Kit (TECAN, NuGEN), followed by evaluation on an Agilent 2100 Bioanalyzer by using the DNA 1000 Chip. The resulting mRNA library was sequenced as 1 × 150 bp single reads on a HiSeq 3000 sequencer (Illumina).</p></sec></sec><sec id="s4-7"><title>Bulk RNA-seq bioinformatic analysis</title><p>Sequenced reads were aligned to the human reference genome (hg38) with TopHat2 (version 2.1.1), and the aligned reads were used to quantify mRNA expression by using HTSeq-count (version 0.11.2). DESeq2 (<xref ref-type="bibr" rid="bib32">Love et al., 2014</xref>) was used to identify differentially expressed genes (DEGs) across the samples. ITGβ1<sup>+</sup>/CXCR4<sup>+</sup> organoid-derived myogenic cell populations were compared to already available transcriptomic dataset of human fetal muscle progenitors (GSM2328841-2) (<xref ref-type="bibr" rid="bib26">Hicks et al., 2018</xref>).</p></sec><sec id="s4-8"><title>scRNA sequencing</title><sec id="s4-8-1"><title>Sample and cDNA library preparation</title><p>Single cells were acquired upon incubation for 1 hr with solution containing papain and EDTA. Upon dissociation, the cell number and viability were estimated. Then, cells were resuspended in a solution containing 0.5% BSA in PBS to reach a concentration of 390 cells per μl. The cDNA library was prepared using the Chromium Single Cell 3′ Reagent Kits (v3): Single Cell 3′ Library &amp; Gel Bead Kit v3 (PN-1000075), Single Cell B Chip Kit (PN-1000073), and i7 Multiplex Kit (PN-120262) (10x Genomics) according to the manufacturer’s instructions. Then, the cDNA library was run on an Illumina HiSeq 3000 as 150 bp paired-end reads.</p></sec></sec><sec id="s4-9"><title>Single-cell RNA-seq bioinformatic analysis</title><p>Sequencing data were processed with UMI-tools (version 1.0.0), aligned to the human reference genome (hg38) with STAR (version 2.7.1a), and quantified with Subread featureCounts (version 1.6.4). Data normalization and further analysis were performed using Seurat (version 3.1.3, <xref ref-type="bibr" rid="bib60">Stuart et al., 2019</xref>). For initial quality control of the extracted gene–cell matrices, cells were filtered with parameters low threshold = 500, high threshold = 6000 for number of genes per cell (nFeature_RNA), high threshold = 5 for percentage of mitochondrial genes (percent.mito), and genes with parameter min.cells = 3. Filtered matrices were normalized by the LogNormalize method with scale factor = 10,000. Variable genes were found with parameters of selection.method = ‘vst,’ nfeatures = 2000, trimmed for the genes related to cell cycle (KEGG cell cycle, hsa04110) and then used for principal component analysis (PCA). Statistically significant principal components were determined by the JackStraw method and the first five principal components were used for nonlinear dimensional reduction (tSNE and UMAP) and clustering analysis with resolution = 0.2. Monocle3 (version 0.2.0, <xref ref-type="bibr" rid="bib11">Cao et al., 2019</xref>) was used for pseudotime trajectory analysis. The data matrix of Seurat objects (assays[[“RNA”]]@counts) was imported to the Monocle R package, then dimensionality reduction with the PCA method with parameters max_components = 2 was performed and then cluster_cells, learn_graph and order_cells functions were performed subsequently. Organoid-derived myogenic progenitors were compared to already available transcriptomic dataset of adult satellite cells (GSE130646) (<xref ref-type="bibr" rid="bib50">Rubenstein et al., 2020</xref>).</p><p>For integrative analysis, we used the Seurat (version 4, <xref ref-type="bibr" rid="bib24">Hao et al., 2021</xref>) package. For each dataset, cells with &gt;6000 or &lt;300 detected genes, as well as those with mitochondrial transcripts proportion &gt;5–10%, were excluded. For finding anchors between control and DMD datasets using 5000 anchors and regressing out cell cycle genes, sequencing depth and stress-related genes were carried out before integration.</p><p>Developmental score was calculated as described in <xref ref-type="bibr" rid="bib68">Xi et al., 2020</xref>. Briefly, we used the ‘‘AddModuleScore’’ function to calculate the embryonic and adult score using a list of DEGs between adult and embryonic myogenic progenitor clusters. DEGs were selected from the Supplementary information in <xref ref-type="bibr" rid="bib68">Xi et al., 2020</xref> table mmc3. The developmental score was further calculated by subtracting embryonic from the adult score. Embryonic and fetal datasets were filtered using a low threshold = 500 and adult datasets were filtered using a low threshold = 250 for genes per cell. In addition, scaling the data (‘‘S.Score,’ ‘G2M.Score,’ ‘Stress,’ and ‘total Count’ to the vars.to.regress’ argument) was used to regress out the effects of the cell cycle, dissociation-related stress, as well as cell size/sequencing depth to all datasets. Myogenic subpopulation of SMO and adult satellite cell datasets were selected by ‘PAX7’ expression. Embryonic and fetal (weeks 5–18) and adult satellite cell (years 7, 11, 34, and 42) scRNAseq data are from <xref ref-type="bibr" rid="bib68">Xi et al., 2020</xref> (GSE147457), adult satellite cell (year 25) scRNAseq data are from <xref ref-type="bibr" rid="bib50">Rubenstein et al., 2020</xref> (GSE130646).</p></sec><sec id="s4-10"><title>Cell−cell communication analysis</title><p>To investigate cell−cell communications among activated, mitotic and dormant myogenic progenitors, fibroadipogenic and neural progenitors, and myofiber-related clusters from 12 wk organoids, the CellChat R package (<xref ref-type="bibr" rid="bib28">Jin et al., 2021</xref>) was applied.</p></sec><sec id="s4-11"><title>qPCR expression analysis</title><p>By pooling three organoids per sample, total RNA was extracted using the RNAeasy Mini Plus Kit (QIAGEN). For first-strand cDNA synthesis, the High Capacity RNA to cDNA Kit (Applied Biosystems) was applied using as template 2 μg of total RNA. For setting qPCR reactions, the GoTaq qPCR Master Mix (Promega) was used with input template 4 ng cDNA per reaction while the reaction was detected on a CFX 96 Real-Time PCR detection system (Bio-Rad). The relative quantification (ΔCT) method was applied for detecting changes in gene expression of pluripotent, neural tube, neural crest, posterior/anterior somitic, and dermomyotomal markers, between different time points along the differentiation. qPCR primers applied for each marker for evaluating organoid development are listed in <xref ref-type="supplementary-material" rid="supp1">Supplementary file 1a</xref>.</p></sec><sec id="s4-12"><title>Diffusion map analysis</title><p>By pooling 3–5 organoids per sample, total RNA was extracted using the RNAeasy Mini Plus Kit (QIAGEN) and further processed as described under qPCR expression analysis. Normalized Ct values of the selected genes for each sample were used as input for generating eigenvector values using the destiny package (<xref ref-type="bibr" rid="bib3">Angerer et al., 2016</xref>). Then, all samples were ordered by their Diffusion Component 1 at specific timepoints during early culture development (day 2–day 11). Ct values &gt;30 were not considered for subsequent analysis. qPCR primers applied for each marker for diffusion map analysis are listed in <xref ref-type="supplementary-material" rid="supp1">Supplementary file 1b</xref>.</p></sec><sec id="s4-13"><title>Transmission electron microscopy (TEM)</title><p>Skeletal muscle organoids were fixed for 4 hr at RT in 2.5% glutaraldehyde (Sigma-Aldrich) in 0.1 M cacodylate buffer pH 7,4 (Sciences Services, Germany), subsequently washed in 0.1 M cacodylate buffer pH 7,4, post-fixed for 2 hr at RT in 1% osmium tetroxide (Sciences Services, Germany) in 0.1 M cacodylate buffer pH 7,4, dehydrated stepwise in a graded ethanol series, and embedded in Epon 812 (Fluka, Buchs, Switzerland). Ultrathin sections (70 nm, ultramicrotome EM UC7, Leica, Wetzlar, Germany) were afterward stained for 30 min in 1% aqueous uranyl acetate (Leica, Germany) and 20 min in 3% lead citrate (Leica). TEM images were acquired with a 200 kV TEM JEM 2100Plus (Jeol, Japan), transmission electron microscope.</p></sec><sec id="s4-14"><title>Second harmonic generation (SHG) imaging using multi-photon microscopy</title><p>A TriM Scope II multi-photon system from LaVision BioTec was used to visualize skeletal muscle fiber organization inside organoids and distinct sarcomeres. The microscope setup is a single-beam instrument with an upright Olympus BX51 WI microscope stand equipped with highly sensitive non-descanned detectors close to the objective lens. The TriM Scope II is fitted with a Coherent Scientific Chameleon Ultra II Ti:Sapphire laser (tuning range 680–1080 nm) and a Coherent Chameleon Compact OPO (automated wavelength extension from 1000 nm to 1600 nm). A 20× IR objective lens (Olympus XLUMPlanFl 20×/1.0W) with a working distance of 2.0 mm was used. Muscle fiber SHG signals were detected in forward direction using TiSa light at 850 nm, a 420/40 band pass filter, and a blue-sensitive photomultiplier (Hamamatsu H67080-01). 3D images were acquired and processed with LaVision BioTec ImSpector Software.</p></sec><sec id="s4-15"><title>Electrophysiology</title><sec id="s4-15-1"><title>Current measurement</title><p>Membrane currents were measured at ambient temperature (22–24°C) using standard whole-cell patch clamp software ISO2 (MFK, Niedernhausen, Germany). Cells were voltage-clamped at a holding potential of –90 mV, that is, negative to EnAChR, resulting in inward Na<sup>+</sup> currents. Every 10 s, voltage ramps (duration 500 ms) from –120 mV to +60 mV were applied to assess the stability of the recording conditions and generate I/V curves (membrane currents in response to depolarizing voltage ramps are shown as downward deflections). Signals were filtered (corner frequency, 1 kHz), digitally sampled at 1 kHz, and stored on a computer equipped with the hardware/software package ISO2 for voltage control, data acquisition, and data analysis. Rapid exposure to a solution containing acetylcholine was performed by means of a custom-made solenoid-operated flow system permitting a change of solution around an individual cell with a half-time of about 100 ms. For measurements, cells devoid of contact with neighboring cells were selected. Cells originated from organoids at week 8.</p></sec><sec id="s4-15-2"><title>Fluorescence microscopy and imaging</title><p>To monitor changes in [Ca2<sup>+</sup>]i, skeletal muscle cells were transiently transfected with pcDNA3[Twitch-2B] (Addgene, 49531) (0.25 μg per 35 mm culture dish). Skeletal muscle cells were transfected using either poly-ethyleneimine (PEI) or Lipofectamine (Invitrogen) according to the manufacturer’s instructions. Prior to experiments, cells were seeded on sterile, poly-L-lysine-coated glass coverslips and analyzed for 48 hr after transfections. All experiments were performed using single cells at ambient temperature. Fluorescence was recorded using an inverted microscope (Zeiss Axiovert 200, Carl Zeiss AG, Göttingen, Germany) equipped with a Zeiss oil immersion objective (100×/1.4), a Polychrome V illumination source, and a photodiode-based dual-emission photometry system suitable for CFP/YFP-FRET (FEI Munich GmbH, Germany). For FRET measurements, single cells were excited at 435 nm wavelength with light pulses of variable duration (20–50 ms; frequency: 5 Hz) to minimize photo-bleaching. Corresponding emitted fluorescence from CFP (F480 or FCFP) or from YFP (F535 or FYFP) was acquired simultaneously, and FRET was defined as the ratio of FYFP/FCFP. Fluorescent signals were recorded and digitized using a commercial hardware/software package (EPC10 amplifier with an integrated D/A board and Patch-master software, HEKA, HEKA Elektronik, Germany). The individual FRET traces were normalized to the initial ratio value before agonist application (FRET/FRET0).</p></sec><sec id="s4-15-3"><title>Solutions and chemicals</title><p>For FRET measurements, an extracellular solution of the following composition was used (mmol/l): NaCl 137; KCl 5.4; CaCl<sub>2</sub> 2; MgCl<sub>2</sub> 1.0; HEPES/NaOH 10.0, pH 7.4. For whole-cell measurements of membrane currents, an extracellular solution of the following composition was used (in mmol/l): NaCl 120, KCl 20, CaCl<sub>2</sub> 0.5, MgCl<sub>2</sub> 1.0, HEPES/NaOH 10.0 (pH 7.4). The pipette solution contained (in mmol/l): K-aspartate 100, KCl 40, NaCl 5.0, MgCl<sub>2</sub> 2.0, Na2ATP 5.0, BAPTA 5.0, GTP 0.025, and HEPES/KOH 20.0, pH 7.4. Standard chemicals were from Merck. EGTA, HEPES, Na2ATP, GTP, and acetylcholine chloride were from Sigma-Aldrich.</p></sec></sec><sec id="s4-16"><title>Transplantation experiments</title><sec id="s4-16-1"><title>Flow cytometry</title><p>The organoid culture was dissociated using TrypLe (Thermo Fisher Scientific, 12563011) and filtered through 70–40 μm cell strainer. Single-cell suspension was stained with PE anti-human CD82 Antibody (BioLegend, 342103) in 2% BSA and 2 mM EDTA and sorted using FACS sorter (Beckman Coulter, MoFlo Astrios Zellsortierer). For gating, unstained single cells from the same organoid culture were used as a baseline control. Sorted cells were further processed for transplantation experiments.</p></sec><sec id="s4-16-2"><title>Transplantation of skeletal muscle progenitors into murine TA muscle</title><p>Twelve-week-old organoids were dissociated and single cells were sorted using FACS (CD82<sup>+</sup>). Cell transplantation was carried out as described before (<xref ref-type="bibr" rid="bib1">Alexander et al., 2016</xref>; <xref ref-type="bibr" rid="bib36">Marg et al., 2019</xref>; <xref ref-type="bibr" rid="bib2">Al Tanoury et al., 2020</xref>). Briefly, 24 hr before transplantation, Cardiotoxin (10 µl CTX, 40 ng/ml, Sigma-Aldrich, 217503-1MG) was injected into TA of 2–3-month-old male HsdCpb:NMRI-<italic>Foxn1<sup>nu</sup></italic> mice. Under anesthesia, 1 * 10<sup>5</sup> cells were injected into the TA muscle on one side. Six weeks after transplantation, the mice were killed and the TA was fixed and sliced using cryosections. Immunofluorescence analyses were carried out using recombinant Anti-Lamin A + Lamin C antibody and anti-dystrophin antibody.</p><p>All animal experiments were approved by the local authorities (81-02.04.2020.A476, Ruhr University Bochum) and performed in accordance with the guidelines for Ethical Conduct in the Care and Use of Animals.</p></sec><sec id="s4-16-3"><title>Cryosection immunochemistry</title><p>TA from mice was fixed on 4% paraformaldehyde overnight at 4°C and kept in increasing sucrose solutions (10, 20, and 30%) at 4°C until the tissue sinked down (usually 24 hr) and embedded in Tissue-Tek O.C.T. Compound media. Cross-sections of TA with 10–20 μm thickness were acquired on CryoStar NX50 (Thermo Scientific). Sections were stored on objectives at –20°C.</p><p>Cryosections were rehydrated with PBS, followed by an antigen retrieval, an AffiniPure Fab Fragment Goat Anti-Mouse IgG treatment to prevent unspecific bindings during the staining process and permeabilized once with 1% (vol/vol) Triton-X100 and 125 mM glycine in PBS (rinsed 3× with PBS). Subsequently, the sections were blocked with 5% BSA/10% NGS in PBS for 1 hr at room temperature. Primary antibody incubations were performed for 1 d at 4°C, and secondary antibody incubations for 2 hr at room temperature.</p><p>Primary antibodies: anti-dystrophin (Leica, NCLDYS1, 1:20), recombinant Anti-Lamin A + Lamin C antibody (Abcam, ab108595, 1:150). Secondary antibodies: Goat Anti-Rabbit IgG (H+L) Highly Cross-Adsorbed Secondary Antibody, Alexa Fluor Plus 488 (1:1000), Goat Anti-Mouse IgG (H+L) Cross-Adsorbed Secondary Antibody, Alexa Fluor 568 (1:1000).</p><p>Images were acquired on a Zeiss Scan.Z1. Images were processed using Zen Lite Blue version 4.0.3.</p></sec></sec><sec id="s4-17"><title>Statistics</title><p>All statistical analyses were conducted using GraphPad Prism6 software. For qPCR analysis, one-way ANOVA with Tukey’́s multiple-comparisons test for each marker was performed. For the FACS intracellular staining quantification, one-way ANOVA with Sidak’́s multiple-comparisons test between the different time points was performed. Significance asterisks represent *p&lt;0.05, **p&lt;0.01, ***p&lt;0.001, ****p&lt;0.0001, ns: not significant.</p></sec></sec></body><back><sec sec-type="additional-information" id="s5"><title>Additional information</title><fn-group content-type="competing-interest"><title>Competing interests</title><fn fn-type="COI-statement" id="conf1"><p>No competing interests declared</p></fn><fn fn-type="COI-statement" id="conf2"><p>is partially employed by Next &amp; Bio Inc</p></fn></fn-group><fn-group content-type="author-contribution"><title>Author contributions</title><fn fn-type="con" id="con1"><p>Conceptualization, Resources, Data curation, Formal analysis, Validation, Investigation, Visualization, Methodology, Writing – original draft, Project administration</p></fn><fn fn-type="con" id="con2"><p>Data curation, Software, Formal analysis, Investigation, Methodology, Writing – original draft</p></fn><fn fn-type="con" id="con3"><p>Data curation, Software, Formal analysis, Investigation, Methodology</p></fn><fn fn-type="con" id="con4"><p>Data curation, Formal analysis, Investigation, Methodology</p></fn><fn fn-type="con" id="con5"><p>Data curation, Formal analysis, Investigation, Methodology</p></fn><fn fn-type="con" id="con6"><p>Data curation, Formal analysis, Investigation, Methodology</p></fn><fn fn-type="con" id="con7"><p>Data curation, Formal analysis, Investigation, Methodology</p></fn><fn fn-type="con" id="con8"><p>Data curation, Formal analysis, Investigation, Methodology</p></fn><fn fn-type="con" id="con9"><p>Data curation, Formal analysis, Investigation, Methodology</p></fn><fn fn-type="con" id="con10"><p>Data curation, Formal analysis, Investigation, Methodology</p></fn><fn fn-type="con" id="con11"><p>Data curation, Formal analysis, Investigation, Methodology</p></fn><fn fn-type="con" id="con12"><p>Data curation, Software, Formal analysis</p></fn><fn fn-type="con" id="con13"><p>Data curation, Software, Formal analysis</p></fn><fn fn-type="con" id="con14"><p>Resources, Data curation, Software, Formal analysis</p></fn><fn fn-type="con" id="con15"><p>Data curation, Software, Formal analysis</p></fn><fn fn-type="con" id="con16"><p>Resources, Data curation, Formal analysis</p></fn><fn fn-type="con" id="con17"><p>Resources, Data curation, Formal analysis, Investigation</p></fn><fn fn-type="con" id="con18"><p>Resources, Supervision</p></fn><fn fn-type="con" id="con19"><p>Resources, Data curation, Supervision</p></fn><fn fn-type="con" id="con20"><p>Resources, Data curation, Formal analysis, Supervision</p></fn><fn fn-type="con" id="con21"><p>Resources, Supervision, Writing - review and editing</p></fn><fn fn-type="con" id="con22"><p>Conceptualization, Resources, Data curation, Formal analysis, Supervision, Funding acquisition, Validation, Investigation, Visualization, Methodology, Writing – original draft, Project administration, Writing - review and editing</p></fn></fn-group><fn-group content-type="ethics-information"><title>Ethics</title><fn fn-type="other"><p>All animal experiments were approved by the local authorities (81-02.04.2020.A476, Ruhr University Bochum) and performed in accordance with the guidelines for Ethical Conduct in the Care and Use of Animals.</p></fn></fn-group></sec><sec sec-type="supplementary-material" id="s6"><title>Additional files</title><supplementary-material id="supp1"><label>Supplementary file 1.</label><caption><title>Tables of qPCR primer pairs.</title><p>(<bold>a</bold>) qPCR primer pairs applied to detect relative expression of key markers during skeletal muscle organoid development. (<bold>b</bold>) qPCR primer pairs applied for diffusion map analysis of early skeletal muscle organoid development.</p></caption><media xlink:href="elife-87081-supp1-v1.docx" mimetype="application" mime-subtype="docx"/></supplementary-material><supplementary-material id="mdar"><label>MDAR checklist</label><media xlink:href="elife-87081-mdarchecklist1-v1.docx" mimetype="application" mime-subtype="docx"/></supplementary-material></sec><sec sec-type="data-availability" id="s7"><title>Data availability</title><p>RNA sequencing datasets produced in this study are deposited in the Gene Expression Omnibus (GEO) under accession code GSE147514. Data and code availability section’ or you can replace it with &quot;All the analysis scripts are available from vignettes of original software webpage of Seurat (<ext-link ext-link-type="uri" xlink:href="https://satijalab.org/seurat/">https://satijalab.org/seurat/</ext-link>) and Monocle (<ext-link ext-link-type="uri" xlink:href="https://cole-trapnell-lab.github.io/monocle3/">https://cole-trapnell-lab.github.io/monocle3/</ext-link>). No custom code or mathematical algorithm other than variable assignment was used in this study. To review GEO accession GSE147514:Go to <ext-link ext-link-type="uri" xlink:href="https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE147514">https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE147514</ext-link>.</p><p>The following dataset was generated:</p><p><element-citation publication-type="data" specific-use="isSupplementedBy" id="dataset1"><person-group person-group-type="author"><name><surname>Jeong</surname><given-names>H-W</given-names></name><name><surname>Mavrommatis</surname><given-names>L</given-names></name><name><surname>Zaehres</surname><given-names>H</given-names></name></person-group><year iso-8601-date="2023">2023</year><data-title>Transcriptome profiling of human skeletal muscle organoids</data-title><source>NCBI Gene Expression Omnibus</source><pub-id pub-id-type="accession" xlink:href="https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE147514">GSE147514</pub-id></element-citation></p><p>The following previously published datasets were used:</p><p><element-citation publication-type="data" specific-use="references" id="dataset2"><person-group person-group-type="author"><collab>Xi et al.</collab></person-group><year iso-8601-date="2020">2020</year><data-title>Single Cell RNA-Sequencing of Human Limb Skeletal Muscle across Development and Myogenic Culture from Pluripotent Stem Cells</data-title><source>NCBI Gene Expression Omnibus</source><pub-id pub-id-type="accession" xlink:href="https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE147457">GSE147457</pub-id></element-citation></p><p><element-citation publication-type="data" specific-use="references" id="dataset3"><person-group person-group-type="author"><collab>Rubinstein et al.</collab></person-group><year iso-8601-date="2020">2020</year><data-title>Single-cell transcriptional profiles in human skeletal muscle</data-title><source>NCBI Gene Expression Omnibus</source><pub-id pub-id-type="accession" xlink:href="https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE130646">GSE130646</pub-id></element-citation></p><p><element-citation publication-type="data" specific-use="references" id="dataset4"><person-group person-group-type="author"><name><surname>Eskin</surname><given-names>A</given-names></name></person-group><year iso-8601-date="2016">2016</year><data-title>1_Fresh_W17_0_Imm_Sort_S6</data-title><source>NCBI Gene Expression Omnibus</source><pub-id pub-id-type="accession" xlink:href="https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSM2328841">GSM2328841</pub-id></element-citation></p></sec><ack id="ack"><title>Acknowledgements</title><p>We are grateful to Drs. Karl Köhrer, Tobias Lautwein, Patrick Petzsch, and Thorsten Wachtmeister, Genomics &amp; Transcriptomics Laboratory, Heinrich-Heine-University Düsseldorf for performing single-cell and bulk RNAseq experiments with their Illumina HiSeq platform and data provision. We are further grateful to Dr. Oliver Griesbeck for the pcDNA3[Twitch-2B] plasmid. We would like to thank Ingrid Gelker and Martina Sinn, Max Planck Institute Münster as well as Eva-Maria Konieczny, Rana Houmany, and Boris Burr, Ruhr-University Bochum, for their technical assistance. We thank Dr. Johnny Kim, Max Planck Institute Bad Nauheim, for discussions and Dr. Elisabeth Stevens, <italic>English Scientific</italic>, Düsseldorf, for scientific editing of the manuscript. Electron microscopy experiments were supported by the Deutsche Forschungsgemeinschaft SFB 944. We thank Drs. George Q Daley and Thorsten Schlaeger, Boston Children’s Hospital, for providing the Duchenne Muscular Dystrophy patient-derived iPS cell lines DMD-iPS1 and BMD-iPS1 in the course of our study. Our study was supported by research grants from FoRUM F873-16, Medical Faculty, Ruhr University Bochum, from Deutsche Gesellschaft für Muskelkranke e.V. (DGM Foundation), Freiburg, Georg E und Marianne Kosing-Stiftung, Deutsches Stiftungszentrum, Essen and Deutsche Duchenne Stiftung, Duchenne Deutschland e.V.</p></ack><ref-list><title>References</title><ref id="bib1"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Alexander</surname><given-names>MS</given-names></name><name><surname>Rozkalne</surname><given-names>A</given-names></name><name><surname>Colletta</surname><given-names>A</given-names></name><name><surname>Spinazzola</surname><given-names>JM</given-names></name><name><surname>Johnson</surname><given-names>S</given-names></name><name><surname>Rahimov</surname><given-names>F</given-names></name><name><surname>Meng</surname><given-names>H</given-names></name><name><surname>Lawlor</surname><given-names>MW</given-names></name><name><surname>Estrella</surname><given-names>E</given-names></name><name><surname>Kunkel</surname><given-names>LM</given-names></name><name><surname>Gussoni</surname><given-names>E</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>CD82 is a marker for prospective isolation of human muscle satellite cells and is linked to muscular dystrophies</article-title><source>Cell Stem Cell</source><volume>19</volume><fpage>800</fpage><lpage>807</lpage><pub-id pub-id-type="doi">10.1016/j.stem.2016.08.006</pub-id><pub-id pub-id-type="pmid">27641304</pub-id></element-citation></ref><ref id="bib2"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Al Tanoury</surname><given-names>Z</given-names></name><name><surname>Rao</surname><given-names>J</given-names></name><name><surname>Tassy</surname><given-names>O</given-names></name><name><surname>Gobert</surname><given-names>B</given-names></name><name><surname>Gapon</surname><given-names>S</given-names></name><name><surname>Garnier</surname><given-names>J-M</given-names></name><name><surname>Wagner</surname><given-names>E</given-names></name><name><surname>Hick</surname><given-names>A</given-names></name><name><surname>Hall</surname><given-names>A</given-names></name><name><surname>Gussoni</surname><given-names>E</given-names></name><name><surname>Pourquié</surname><given-names>O</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>Differentiation of the human PAX7-positive myogenic precursors/satellite cell lineage <italic>in vitro</italic></article-title><source>Development</source><volume>147</volume><elocation-id>dev187344</elocation-id><pub-id pub-id-type="doi">10.1242/dev.187344</pub-id><pub-id pub-id-type="pmid">32541004</pub-id></element-citation></ref><ref id="bib3"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Angerer</surname><given-names>P</given-names></name><name><surname>Haghverdi</surname><given-names>L</given-names></name><name><surname>Büttner</surname><given-names>M</given-names></name><name><surname>Theis</surname><given-names>FJ</given-names></name><name><surname>Marr</surname><given-names>C</given-names></name><name><surname>Buettner</surname><given-names>F</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>destiny: diffusion maps for large-scale single-cell data in R</article-title><source>Bioinformatics</source><volume>32</volume><fpage>1241</fpage><lpage>1243</lpage><pub-id pub-id-type="doi">10.1093/bioinformatics/btv715</pub-id><pub-id pub-id-type="pmid">26668002</pub-id></element-citation></ref><ref id="bib4"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Aulehla</surname><given-names>A</given-names></name><name><surname>Pourquié</surname><given-names>O</given-names></name></person-group><year iso-8601-date="2010">2010</year><article-title>Signaling gradients during paraxial mesoderm development</article-title><source>Cold Spring Harbor Perspectives in Biology</source><volume>2</volume><elocation-id>a000869</elocation-id><pub-id pub-id-type="doi">10.1101/cshperspect.a000869</pub-id><pub-id pub-id-type="pmid">20182616</pub-id></element-citation></ref><ref id="bib5"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Barbieri</surname><given-names>G</given-names></name><name><surname>De Angelis</surname><given-names>L</given-names></name><name><surname>Feo</surname><given-names>S</given-names></name><name><surname>Cossu</surname><given-names>G</given-names></name><name><surname>Giallongo</surname><given-names>A</given-names></name></person-group><year iso-8601-date="1990">1990</year><article-title>Differential expression of muscle-specific enolase in embryonic and fetal myogenic cells during mouse development</article-title><source>Differentiation</source><volume>45</volume><fpage>179</fpage><lpage>184</lpage><pub-id pub-id-type="doi">10.1111/j.1432-0436.1990.tb00471.x</pub-id></element-citation></ref><ref id="bib6"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Barruet</surname><given-names>E</given-names></name><name><surname>Garcia</surname><given-names>SM</given-names></name><name><surname>Striedinger</surname><given-names>K</given-names></name><name><surname>Wu</surname><given-names>J</given-names></name><name><surname>Lee</surname><given-names>S</given-names></name><name><surname>Byrnes</surname><given-names>L</given-names></name><name><surname>Wong</surname><given-names>A</given-names></name><name><surname>Xuefeng</surname><given-names>S</given-names></name><name><surname>Tamaki</surname><given-names>S</given-names></name><name><surname>Brack</surname><given-names>AS</given-names></name><name><surname>Pomerantz</surname><given-names>JH</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>Functionally heterogeneous human satellite cells identified by single cell RNA sequencing</article-title><source>eLife</source><volume>9</volume><elocation-id>e51576</elocation-id><pub-id pub-id-type="doi">10.7554/eLife.51576</pub-id><pub-id pub-id-type="pmid">32234209</pub-id></element-citation></ref><ref id="bib7"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bjornson</surname><given-names>CRR</given-names></name><name><surname>Cheung</surname><given-names>TH</given-names></name><name><surname>Liu</surname><given-names>L</given-names></name><name><surname>Tripathi</surname><given-names>PV</given-names></name><name><surname>Steeper</surname><given-names>KM</given-names></name><name><surname>Rando</surname><given-names>TA</given-names></name></person-group><year iso-8601-date="2012">2012</year><article-title>Notch signaling is necessary to maintain quiescence in adult muscle stem cells</article-title><source>Stem Cells</source><volume>30</volume><fpage>232</fpage><lpage>242</lpage><pub-id pub-id-type="doi">10.1002/stem.773</pub-id><pub-id pub-id-type="pmid">22045613</pub-id></element-citation></ref><ref id="bib8"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bönnemann</surname><given-names>CG</given-names></name></person-group><year iso-8601-date="2011">2011</year><article-title>The collagen VI-related myopathies: muscle meets its matrix</article-title><source>Nature Reviews. Neurology</source><volume>7</volume><fpage>379</fpage><lpage>390</lpage><pub-id pub-id-type="doi">10.1038/nrneurol.2011.81</pub-id><pub-id pub-id-type="pmid">21691338</pub-id></element-citation></ref><ref id="bib9"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Borchin</surname><given-names>B</given-names></name><name><surname>Chen</surname><given-names>J</given-names></name><name><surname>Barberi</surname><given-names>T</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>Derivation and FACS-mediated purification of PAX3+/PAX7+ skeletal muscle precursors from human pluripotent stem cells</article-title><source>Stem Cell Reports</source><volume>1</volume><fpage>620</fpage><lpage>631</lpage><pub-id pub-id-type="doi">10.1016/j.stemcr.2013.10.007</pub-id><pub-id pub-id-type="pmid">24371814</pub-id></element-citation></ref><ref id="bib10"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Buckingham</surname><given-names>M</given-names></name><name><surname>Rigby</surname><given-names>PWJ</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>Gene regulatory networks and transcriptional mechanisms that control myogenesis</article-title><source>Developmental Cell</source><volume>28</volume><fpage>225</fpage><lpage>238</lpage><pub-id pub-id-type="doi">10.1016/j.devcel.2013.12.020</pub-id><pub-id pub-id-type="pmid">24525185</pub-id></element-citation></ref><ref id="bib11"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cao</surname><given-names>J</given-names></name><name><surname>Spielmann</surname><given-names>M</given-names></name><name><surname>Qiu</surname><given-names>X</given-names></name><name><surname>Huang</surname><given-names>X</given-names></name><name><surname>Ibrahim</surname><given-names>DM</given-names></name><name><surname>Hill</surname><given-names>AJ</given-names></name><name><surname>Zhang</surname><given-names>F</given-names></name><name><surname>Mundlos</surname><given-names>S</given-names></name><name><surname>Christiansen</surname><given-names>L</given-names></name><name><surname>Steemers</surname><given-names>FJ</given-names></name><name><surname>Trapnell</surname><given-names>C</given-names></name><name><surname>Shendure</surname><given-names>J</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>The single-cell transcriptional landscape of mammalian organogenesis</article-title><source>Nature</source><volume>566</volume><fpage>496</fpage><lpage>502</lpage><pub-id pub-id-type="doi">10.1038/s41586-019-0969-x</pub-id><pub-id pub-id-type="pmid">30787437</pub-id></element-citation></ref><ref id="bib12"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chal</surname><given-names>J</given-names></name><name><surname>Oginuma</surname><given-names>M</given-names></name><name><surname>Al Tanoury</surname><given-names>Z</given-names></name><name><surname>Gobert</surname><given-names>B</given-names></name><name><surname>Sumara</surname><given-names>O</given-names></name><name><surname>Hick</surname><given-names>A</given-names></name><name><surname>Bousson</surname><given-names>F</given-names></name><name><surname>Zidouni</surname><given-names>Y</given-names></name><name><surname>Mursch</surname><given-names>C</given-names></name><name><surname>Moncuquet</surname><given-names>P</given-names></name><name><surname>Tassy</surname><given-names>O</given-names></name><name><surname>Vincent</surname><given-names>S</given-names></name><name><surname>Miyanari</surname><given-names>A</given-names></name><name><surname>Bera</surname><given-names>A</given-names></name><name><surname>Garnier</surname><given-names>J-M</given-names></name><name><surname>Guevara</surname><given-names>G</given-names></name><name><surname>Hestin</surname><given-names>M</given-names></name><name><surname>Kennedy</surname><given-names>L</given-names></name><name><surname>Hayashi</surname><given-names>S</given-names></name><name><surname>Drayton</surname><given-names>B</given-names></name><name><surname>Cherrier</surname><given-names>T</given-names></name><name><surname>Gayraud-Morel</surname><given-names>B</given-names></name><name><surname>Gussoni</surname><given-names>E</given-names></name><name><surname>Relaix</surname><given-names>F</given-names></name><name><surname>Tajbakhsh</surname><given-names>S</given-names></name><name><surname>Pourquié</surname><given-names>O</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>Differentiation of pluripotent stem cells to muscle fiber to model Duchenne muscular dystrophy</article-title><source>Nature Biotechnology</source><volume>33</volume><fpage>962</fpage><lpage>969</lpage><pub-id pub-id-type="doi">10.1038/nbt.3297</pub-id><pub-id pub-id-type="pmid">26237517</pub-id></element-citation></ref><ref id="bib13"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chargé</surname><given-names>SBP</given-names></name><name><surname>Rudnicki</surname><given-names>MA</given-names></name></person-group><year iso-8601-date="2004">2004</year><article-title>Cellular and molecular regulation of muscle regeneration</article-title><source>Physiological Reviews</source><volume>84</volume><fpage>209</fpage><lpage>238</lpage><pub-id pub-id-type="doi">10.1152/physrev.00019.2003</pub-id><pub-id pub-id-type="pmid">14715915</pub-id></element-citation></ref><ref id="bib14"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cheng</surname><given-names>L</given-names></name><name><surname>Alvares</surname><given-names>LE</given-names></name><name><surname>Ahmed</surname><given-names>MU</given-names></name><name><surname>El-Hanfy</surname><given-names>AS</given-names></name><name><surname>Dietrich</surname><given-names>S</given-names></name></person-group><year iso-8601-date="2004">2004</year><article-title>The epaxial-hypaxial subdivision of the avian somite</article-title><source>Developmental Biology</source><volume>274</volume><fpage>348</fpage><lpage>369</lpage><pub-id pub-id-type="doi">10.1016/j.ydbio.2004.07.020</pub-id><pub-id pub-id-type="pmid">15385164</pub-id></element-citation></ref><ref id="bib15"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cheung</surname><given-names>TH</given-names></name><name><surname>Quach</surname><given-names>NL</given-names></name><name><surname>Charville</surname><given-names>GW</given-names></name><name><surname>Liu</surname><given-names>L</given-names></name><name><surname>Park</surname><given-names>L</given-names></name><name><surname>Edalati</surname><given-names>A</given-names></name><name><surname>Yoo</surname><given-names>B</given-names></name><name><surname>Hoang</surname><given-names>P</given-names></name><name><surname>Rando</surname><given-names>TA</given-names></name></person-group><year iso-8601-date="2012">2012</year><article-title>Maintenance of muscle stem-cell quiescence by microRNA-489</article-title><source>Nature</source><volume>482</volume><fpage>524</fpage><lpage>528</lpage><pub-id pub-id-type="doi">10.1038/nature10834</pub-id><pub-id pub-id-type="pmid">22358842</pub-id></element-citation></ref><ref id="bib16"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cohn</surname><given-names>RD</given-names></name><name><surname>van Erp</surname><given-names>C</given-names></name><name><surname>Habashi</surname><given-names>JP</given-names></name><name><surname>Soleimani</surname><given-names>AA</given-names></name><name><surname>Klein</surname><given-names>EC</given-names></name><name><surname>Lisi</surname><given-names>MT</given-names></name><name><surname>Gamradt</surname><given-names>M</given-names></name><name><surname>ap Rhys</surname><given-names>CM</given-names></name><name><surname>Holm</surname><given-names>TM</given-names></name><name><surname>Loeys</surname><given-names>BL</given-names></name><name><surname>Ramirez</surname><given-names>F</given-names></name><name><surname>Judge</surname><given-names>DP</given-names></name><name><surname>Ward</surname><given-names>CW</given-names></name><name><surname>Dietz</surname><given-names>HC</given-names></name></person-group><year iso-8601-date="2007">2007</year><article-title>Angiotensin II type 1 receptor blockade attenuates TGF-β–induced failure of muscle regeneration in multiple myopathic states</article-title><source>Nature Medicine</source><volume>13</volume><fpage>204</fpage><lpage>210</lpage><pub-id pub-id-type="doi">10.1038/nm1536</pub-id></element-citation></ref><ref id="bib17"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Darabi</surname><given-names>R</given-names></name><name><surname>Arpke</surname><given-names>RW</given-names></name><name><surname>Irion</surname><given-names>S</given-names></name><name><surname>Dimos</surname><given-names>JT</given-names></name><name><surname>Grskovic</surname><given-names>M</given-names></name><name><surname>Kyba</surname><given-names>M</given-names></name><name><surname>Perlingeiro</surname><given-names>RCR</given-names></name></person-group><year iso-8601-date="2012">2012</year><article-title>Human ES- and iPS-derived myogenic progenitors restore DYSTROPHIN and improve contractility upon transplantation in dystrophic mice</article-title><source>Cell Stem Cell</source><volume>10</volume><fpage>610</fpage><lpage>619</lpage><pub-id pub-id-type="doi">10.1016/j.stem.2012.02.015</pub-id><pub-id pub-id-type="pmid">22560081</pub-id></element-citation></ref><ref id="bib18"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dietrich</surname><given-names>S</given-names></name><name><surname>Abou-Rebyeh</surname><given-names>F</given-names></name><name><surname>Brohmann</surname><given-names>H</given-names></name><name><surname>Bladt</surname><given-names>F</given-names></name><name><surname>Sonnenberg-Riethmacher</surname><given-names>E</given-names></name><name><surname>Yamaai</surname><given-names>T</given-names></name><name><surname>Lumsden</surname><given-names>A</given-names></name><name><surname>Brand-Saberi</surname><given-names>B</given-names></name><name><surname>Birchmeier</surname><given-names>C</given-names></name></person-group><year iso-8601-date="1999">1999</year><article-title>The role of SF/HGF and c-Met in the development of skeletal muscle</article-title><source>Development</source><volume>126</volume><fpage>1621</fpage><lpage>1629</lpage><pub-id pub-id-type="doi">10.1242/dev.126.8.1621</pub-id><pub-id pub-id-type="pmid">10079225</pub-id></element-citation></ref><ref id="bib19"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dorn</surname><given-names>I</given-names></name><name><surname>Klich</surname><given-names>K</given-names></name><name><surname>Arauzo-Bravo</surname><given-names>MJ</given-names></name><name><surname>Radstaak</surname><given-names>M</given-names></name><name><surname>Santourlidis</surname><given-names>S</given-names></name><name><surname>Ghanjati</surname><given-names>F</given-names></name><name><surname>Radke</surname><given-names>TF</given-names></name><name><surname>Psathaki</surname><given-names>OE</given-names></name><name><surname>Hargus</surname><given-names>G</given-names></name><name><surname>Kramer</surname><given-names>J</given-names></name><name><surname>Einhaus</surname><given-names>M</given-names></name><name><surname>Kim</surname><given-names>JB</given-names></name><name><surname>Kögler</surname><given-names>G</given-names></name><name><surname>Wernet</surname><given-names>P</given-names></name><name><surname>Schöler</surname><given-names>HR</given-names></name><name><surname>Schlenke</surname><given-names>P</given-names></name><name><surname>Zaehres</surname><given-names>H</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>Erythroid differentiation of human induced pluripotent stem cells is independent of donor cell type of origin</article-title><source>Haematologica</source><volume>100</volume><fpage>32</fpage><lpage>41</lpage><pub-id pub-id-type="doi">10.3324/haematol.2014.108068</pub-id><pub-id pub-id-type="pmid">25326431</pub-id></element-citation></ref><ref id="bib20"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Faustino Martins</surname><given-names>JM</given-names></name><name><surname>Fischer</surname><given-names>C</given-names></name><name><surname>Urzi</surname><given-names>A</given-names></name><name><surname>Vidal</surname><given-names>R</given-names></name><name><surname>Kunz</surname><given-names>S</given-names></name><name><surname>Ruffault</surname><given-names>PL</given-names></name><name><surname>Kabuss</surname><given-names>L</given-names></name><name><surname>Hube</surname><given-names>I</given-names></name><name><surname>Gazzerro</surname><given-names>E</given-names></name><name><surname>Birchmeier</surname><given-names>C</given-names></name><name><surname>Spuler</surname><given-names>S</given-names></name><name><surname>Sauer</surname><given-names>S</given-names></name><name><surname>Gouti</surname><given-names>M</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>Self-Organizing 3D human trunk neuromuscular organoids</article-title><source>Cell Stem Cell</source><volume>27</volume><elocation-id>498</elocation-id><pub-id pub-id-type="doi">10.1016/j.stem.2020.08.011</pub-id><pub-id pub-id-type="pmid">32888426</pub-id></element-citation></ref><ref id="bib21"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fukada</surname><given-names>S</given-names></name><name><surname>Uezumi</surname><given-names>A</given-names></name><name><surname>Ikemoto</surname><given-names>M</given-names></name><name><surname>Masuda</surname><given-names>S</given-names></name><name><surname>Segawa</surname><given-names>M</given-names></name><name><surname>Tanimura</surname><given-names>N</given-names></name><name><surname>Yamamoto</surname><given-names>H</given-names></name><name><surname>Miyagoe-Suzuki</surname><given-names>Y</given-names></name><name><surname>Takeda</surname><given-names>S</given-names></name></person-group><year iso-8601-date="2007">2007</year><article-title>Molecular signature of quiescent satellite cells in adult skeletal muscle</article-title><source>Stem Cells</source><volume>25</volume><fpage>2448</fpage><lpage>2459</lpage><pub-id pub-id-type="doi">10.1634/stemcells.2007-0019</pub-id><pub-id pub-id-type="pmid">17600112</pub-id></element-citation></ref><ref id="bib22"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Garcia</surname><given-names>SM</given-names></name><name><surname>Tamaki</surname><given-names>S</given-names></name><name><surname>Lee</surname><given-names>S</given-names></name><name><surname>Wong</surname><given-names>A</given-names></name><name><surname>Jose</surname><given-names>A</given-names></name><name><surname>Dreux</surname><given-names>J</given-names></name><name><surname>Kouklis</surname><given-names>G</given-names></name><name><surname>Sbitany</surname><given-names>H</given-names></name><name><surname>Seth</surname><given-names>R</given-names></name><name><surname>Knott</surname><given-names>PD</given-names></name><name><surname>Heaton</surname><given-names>C</given-names></name><name><surname>Ryan</surname><given-names>WR</given-names></name><name><surname>Kim</surname><given-names>EA</given-names></name><name><surname>Hansen</surname><given-names>SL</given-names></name><name><surname>Hoffman</surname><given-names>WY</given-names></name><name><surname>Pomerantz</surname><given-names>JH</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>High-yield purification, preservation, and serial transplantation of human satellite cells</article-title><source>Stem Cell Reports</source><volume>10</volume><fpage>1160</fpage><lpage>1174</lpage><pub-id pub-id-type="doi">10.1016/j.stemcr.2018.01.022</pub-id><pub-id pub-id-type="pmid">29478895</pub-id></element-citation></ref><ref id="bib23"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gouti</surname><given-names>M</given-names></name><name><surname>Delile</surname><given-names>J</given-names></name><name><surname>Stamataki</surname><given-names>D</given-names></name><name><surname>Wymeersch</surname><given-names>FJ</given-names></name><name><surname>Huang</surname><given-names>Y</given-names></name><name><surname>Kleinjung</surname><given-names>J</given-names></name><name><surname>Wilson</surname><given-names>V</given-names></name><name><surname>Briscoe</surname><given-names>J</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>A gene regulatory network balances neural and mesoderm specification during vertebrate trunk development</article-title><source>Developmental Cell</source><volume>41</volume><fpage>243</fpage><lpage>261</lpage><pub-id pub-id-type="doi">10.1016/j.devcel.2017.04.002</pub-id><pub-id pub-id-type="pmid">28457792</pub-id></element-citation></ref><ref id="bib24"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hao</surname><given-names>Y</given-names></name><name><surname>Hao</surname><given-names>S</given-names></name><name><surname>Andersen-Nissen</surname><given-names>E</given-names></name><name><surname>Mauck</surname><given-names>WM</given-names><suffix>III</suffix></name><name><surname>Zheng</surname><given-names>S</given-names></name><name><surname>Butler</surname><given-names>A</given-names></name><name><surname>Lee</surname><given-names>MJ</given-names></name><name><surname>Wilk</surname><given-names>AJ</given-names></name><name><surname>Darby</surname><given-names>C</given-names></name><name><surname>Zager</surname><given-names>M</given-names></name><name><surname>Hoffman</surname><given-names>P</given-names></name><name><surname>Stoeckius</surname><given-names>M</given-names></name><name><surname>Papalexi</surname><given-names>E</given-names></name><name><surname>Mimitou</surname><given-names>EP</given-names></name><name><surname>Jain</surname><given-names>J</given-names></name><name><surname>Srivastava</surname><given-names>A</given-names></name><name><surname>Stuart</surname><given-names>T</given-names></name><name><surname>Fleming</surname><given-names>LM</given-names></name><name><surname>Yeung</surname><given-names>B</given-names></name><name><surname>Rogers</surname><given-names>AJ</given-names></name><name><surname>McElrath</surname><given-names>JM</given-names></name><name><surname>Blish</surname><given-names>CA</given-names></name><name><surname>Gottardo</surname><given-names>R</given-names></name><name><surname>Smibert</surname><given-names>P</given-names></name><name><surname>Satija</surname><given-names>R</given-names></name></person-group><year iso-8601-date="2021">2021</year><article-title>Integrated analysis of multimodal single-cell data</article-title><source>Cell</source><volume>184</volume><fpage>3573</fpage><lpage>3587</lpage><pub-id pub-id-type="doi">10.1016/j.cell.2021.04.048</pub-id></element-citation></ref><ref id="bib25"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Henrique</surname><given-names>D</given-names></name><name><surname>Abranches</surname><given-names>E</given-names></name><name><surname>Verrier</surname><given-names>L</given-names></name><name><surname>Storey</surname><given-names>KG</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>Neuromesodermal progenitors and the making of the spinal cord</article-title><source>Development</source><volume>142</volume><fpage>2864</fpage><lpage>2875</lpage><pub-id pub-id-type="doi">10.1242/dev.119768</pub-id><pub-id pub-id-type="pmid">26329597</pub-id></element-citation></ref><ref id="bib26"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hicks</surname><given-names>MR</given-names></name><name><surname>Hiserodt</surname><given-names>J</given-names></name><name><surname>Paras</surname><given-names>K</given-names></name><name><surname>Fujiwara</surname><given-names>W</given-names></name><name><surname>Eskin</surname><given-names>A</given-names></name><name><surname>Jan</surname><given-names>M</given-names></name><name><surname>Xi</surname><given-names>H</given-names></name><name><surname>Young</surname><given-names>CS</given-names></name><name><surname>Evseenko</surname><given-names>D</given-names></name><name><surname>Nelson</surname><given-names>SF</given-names></name><name><surname>Spencer</surname><given-names>MJ</given-names></name><name><surname>Handel</surname><given-names>BV</given-names></name><name><surname>Pyle</surname><given-names>AD</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>ERBB3 and NGFR mark a distinct skeletal muscle progenitor cell in human development and hPSCs</article-title><source>Nature Cell Biology</source><volume>20</volume><fpage>46</fpage><lpage>57</lpage><pub-id pub-id-type="doi">10.1038/s41556-017-0010-2</pub-id><pub-id pub-id-type="pmid">29255171</pub-id></element-citation></ref><ref id="bib27"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jahn</surname><given-names>K</given-names></name><name><surname>Mohammadi</surname><given-names>B</given-names></name><name><surname>Krampfl</surname><given-names>K</given-names></name><name><surname>Abicht</surname><given-names>A</given-names></name><name><surname>Lochmüller</surname><given-names>H</given-names></name><name><surname>Bufler</surname><given-names>J</given-names></name></person-group><year iso-8601-date="2001">2001</year><article-title>Deactivation and desensitization of mouse embryonic- and adult-type nicotinic receptor channel currents</article-title><source>Neuroscience Letters</source><volume>307</volume><fpage>89</fpage><lpage>92</lpage><pub-id pub-id-type="doi">10.1016/s0304-3940(01)01929-2</pub-id><pub-id pub-id-type="pmid">11427307</pub-id></element-citation></ref><ref id="bib28"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jin</surname><given-names>S</given-names></name><name><surname>Guerrero-Juarez</surname><given-names>CF</given-names></name><name><surname>Zhang</surname><given-names>L</given-names></name><name><surname>Chang</surname><given-names>I</given-names></name><name><surname>Ramos</surname><given-names>R</given-names></name><name><surname>Kuan</surname><given-names>CH</given-names></name><name><surname>Myung</surname><given-names>P</given-names></name><name><surname>Plikus</surname><given-names>MV</given-names></name><name><surname>Nie</surname><given-names>Q</given-names></name></person-group><year iso-8601-date="2021">2021</year><article-title>Inference and analysis of cell-cell communication using CellChat</article-title><source>Nature Communications</source><volume>12</volume><elocation-id>1088</elocation-id><pub-id pub-id-type="doi">10.1038/s41467-021-21246-9</pub-id></element-citation></ref><ref id="bib29"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Juan</surname><given-names>AH</given-names></name><name><surname>Derfoul</surname><given-names>A</given-names></name><name><surname>Feng</surname><given-names>X</given-names></name><name><surname>Ryall</surname><given-names>JG</given-names></name><name><surname>Dell’Orso</surname><given-names>S</given-names></name><name><surname>Pasut</surname><given-names>A</given-names></name><name><surname>Zare</surname><given-names>H</given-names></name><name><surname>Simone</surname><given-names>JM</given-names></name><name><surname>Rudnicki</surname><given-names>MA</given-names></name><name><surname>Sartorelli</surname><given-names>V</given-names></name></person-group><year iso-8601-date="2011">2011</year><article-title>Polycomb EZH2 controls self-renewal and safeguards the transcriptional identity of skeletal muscle stem cells</article-title><source>Genes &amp; Development</source><volume>25</volume><fpage>789</fpage><lpage>794</lpage><pub-id pub-id-type="doi">10.1101/gad.2027911</pub-id></element-citation></ref><ref id="bib30"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Koehler</surname><given-names>KR</given-names></name><name><surname>Nie</surname><given-names>J</given-names></name><name><surname>Longworth-Mills</surname><given-names>E</given-names></name><name><surname>Liu</surname><given-names>X-P</given-names></name><name><surname>Lee</surname><given-names>J</given-names></name><name><surname>Holt</surname><given-names>JR</given-names></name><name><surname>Hashino</surname><given-names>E</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>Generation of inner ear organoids containing functional hair cells from human pluripotent stem cells</article-title><source>Nature Biotechnology</source><volume>35</volume><fpage>583</fpage><lpage>589</lpage><pub-id pub-id-type="doi">10.1038/nbt.3840</pub-id></element-citation></ref><ref id="bib31"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lancaster</surname><given-names>MA</given-names></name><name><surname>Renner</surname><given-names>M</given-names></name><name><surname>Martin</surname><given-names>CA</given-names></name><name><surname>Wenzel</surname><given-names>D</given-names></name><name><surname>Bicknell</surname><given-names>LS</given-names></name><name><surname>Hurles</surname><given-names>ME</given-names></name><name><surname>Homfray</surname><given-names>T</given-names></name><name><surname>Penninger</surname><given-names>JM</given-names></name><name><surname>Jackson</surname><given-names>AP</given-names></name><name><surname>Knoblich</surname><given-names>JA</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>Cerebral organoids model human brain development and microcephaly</article-title><source>Nature</source><volume>501</volume><fpage>373</fpage><lpage>379</lpage><pub-id pub-id-type="doi">10.1038/nature12517</pub-id><pub-id pub-id-type="pmid">23995685</pub-id></element-citation></ref><ref id="bib32"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Love</surname><given-names>MI</given-names></name><name><surname>Huber</surname><given-names>W</given-names></name><name><surname>Anders</surname><given-names>S</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2</article-title><source>Genome Biology</source><volume>15</volume><elocation-id>550</elocation-id><pub-id pub-id-type="doi">10.1186/s13059-014-0550-8</pub-id></element-citation></ref><ref id="bib33"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Machado</surname><given-names>L</given-names></name><name><surname>Esteves de Lima</surname><given-names>J</given-names></name><name><surname>Fabre</surname><given-names>O</given-names></name><name><surname>Proux</surname><given-names>C</given-names></name><name><surname>Legendre</surname><given-names>R</given-names></name><name><surname>Szegedi</surname><given-names>A</given-names></name><name><surname>Varet</surname><given-names>H</given-names></name><name><surname>Ingerslev</surname><given-names>LR</given-names></name><name><surname>Barrès</surname><given-names>R</given-names></name><name><surname>Relaix</surname><given-names>F</given-names></name><name><surname>Mourikis</surname><given-names>P</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>In situ fixation redefines quiescence and early activation of skeletal muscle stem cells</article-title><source>Cell Reports</source><volume>21</volume><fpage>1982</fpage><lpage>1993</lpage><pub-id pub-id-type="doi">10.1016/j.celrep.2017.10.080</pub-id><pub-id pub-id-type="pmid">29141227</pub-id></element-citation></ref><ref id="bib34"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Maffioletti</surname><given-names>SM</given-names></name><name><surname>Sarcar</surname><given-names>S</given-names></name><name><surname>Henderson</surname><given-names>ABH</given-names></name><name><surname>Mannhardt</surname><given-names>I</given-names></name><name><surname>Pinton</surname><given-names>L</given-names></name><name><surname>Moyle</surname><given-names>LA</given-names></name><name><surname>Steele-Stallard</surname><given-names>H</given-names></name><name><surname>Cappellari</surname><given-names>O</given-names></name><name><surname>Wells</surname><given-names>KE</given-names></name><name><surname>Ferrari</surname><given-names>G</given-names></name><name><surname>Mitchell</surname><given-names>JS</given-names></name><name><surname>Tyzack</surname><given-names>GE</given-names></name><name><surname>Kotiadis</surname><given-names>VN</given-names></name><name><surname>Khedr</surname><given-names>M</given-names></name><name><surname>Ragazzi</surname><given-names>M</given-names></name><name><surname>Wang</surname><given-names>W</given-names></name><name><surname>Duchen</surname><given-names>MR</given-names></name><name><surname>Patani</surname><given-names>R</given-names></name><name><surname>Zammit</surname><given-names>PS</given-names></name><name><surname>Wells</surname><given-names>DJ</given-names></name><name><surname>Eschenhagen</surname><given-names>T</given-names></name><name><surname>Tedesco</surname><given-names>FS</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>Three-dimensional human ipsc-derived artificial skeletal muscles model muscular dystrophies and enable multilineage tissue engineering</article-title><source>Cell Reports</source><volume>23</volume><fpage>899</fpage><lpage>908</lpage><pub-id pub-id-type="doi">10.1016/j.celrep.2018.03.091</pub-id><pub-id pub-id-type="pmid">29669293</pub-id></element-citation></ref><ref id="bib35"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Magli</surname><given-names>A</given-names></name><name><surname>Incitti</surname><given-names>T</given-names></name><name><surname>Kiley</surname><given-names>J</given-names></name><name><surname>Swanson</surname><given-names>SA</given-names></name><name><surname>Darabi</surname><given-names>R</given-names></name><name><surname>Rinaldi</surname><given-names>F</given-names></name><name><surname>Selvaraj</surname><given-names>S</given-names></name><name><surname>Yamamoto</surname><given-names>A</given-names></name><name><surname>Tolar</surname><given-names>J</given-names></name><name><surname>Yuan</surname><given-names>C</given-names></name><name><surname>Stewart</surname><given-names>R</given-names></name><name><surname>Thomson</surname><given-names>JA</given-names></name><name><surname>Perlingeiro</surname><given-names>RCR</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>PAX7 Targets, CD54, Integrin α9β1, and SDC2, Allow Isolation of Human ESC/iPSC-Derived Myogenic Progenitors</article-title><source>Cell Reports</source><volume>19</volume><fpage>2867</fpage><lpage>2877</lpage><pub-id pub-id-type="doi">10.1016/j.celrep.2017.06.005</pub-id><pub-id pub-id-type="pmid">28658631</pub-id></element-citation></ref><ref id="bib36"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Marg</surname><given-names>A</given-names></name><name><surname>Escobar</surname><given-names>H</given-names></name><name><surname>Karaiskos</surname><given-names>N</given-names></name><name><surname>Grunwald</surname><given-names>SA</given-names></name><name><surname>Metzler</surname><given-names>E</given-names></name><name><surname>Kieshauer</surname><given-names>J</given-names></name><name><surname>Sauer</surname><given-names>S</given-names></name><name><surname>Pasemann</surname><given-names>D</given-names></name><name><surname>Malfatti</surname><given-names>E</given-names></name><name><surname>Mompoint</surname><given-names>D</given-names></name><name><surname>Quijano-Roy</surname><given-names>S</given-names></name><name><surname>Boltengagen</surname><given-names>A</given-names></name><name><surname>Schneider</surname><given-names>J</given-names></name><name><surname>Schülke</surname><given-names>M</given-names></name><name><surname>Kunz</surname><given-names>S</given-names></name><name><surname>Carlier</surname><given-names>R</given-names></name><name><surname>Birchmeier</surname><given-names>C</given-names></name><name><surname>Amthor</surname><given-names>H</given-names></name><name><surname>Spuler</surname><given-names>A</given-names></name><name><surname>Kocks</surname><given-names>C</given-names></name><name><surname>Rajewsky</surname><given-names>N</given-names></name><name><surname>Spuler</surname><given-names>S</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>Human muscle-derived CLEC14A-positive cells regenerate muscle independent of PAX7</article-title><source>Nature Communications</source><volume>10</volume><elocation-id>5776</elocation-id><pub-id pub-id-type="doi">10.1038/s41467-019-13650-z</pub-id><pub-id pub-id-type="pmid">31852888</pub-id></element-citation></ref><ref id="bib37"><element-citation publication-type="preprint"><person-group person-group-type="author"><name><surname>Mavrommatis</surname><given-names>L</given-names></name><name><surname>Jeong</surname><given-names>HW</given-names></name><name><surname>Kindler</surname><given-names>U</given-names></name><name><surname>Gomez-Giro</surname><given-names>G</given-names></name><name><surname>Kienitz</surname><given-names>MC</given-names></name><name><surname>Stehling</surname><given-names>M</given-names></name><name><surname>Psathaki</surname><given-names>OE</given-names></name><name><surname>Zeuschner</surname><given-names>D</given-names></name><name><surname>Gabriele Bixel</surname><given-names>M</given-names></name><name><surname>Han</surname><given-names>D</given-names></name><name><surname>Morosan-Puopolo</surname><given-names>G</given-names></name><name><surname>Gerovska</surname><given-names>D</given-names></name><name><surname>Yang</surname><given-names>JH</given-names></name><name><surname>Kim</surname><given-names>JB</given-names></name><name><surname>Araúzo-Bravo</surname><given-names>MJ</given-names></name><name><surname>Schwamborn</surname><given-names>JC</given-names></name><name><surname>Hahn</surname><given-names>SA</given-names></name><name><surname>Adams</surname><given-names>RH</given-names></name><name><surname>Schöler</surname><given-names>HR</given-names></name><name><surname>Vorgerd</surname><given-names>M</given-names></name><name><surname>Brand-Saberi</surname><given-names>B</given-names></name><name><surname>Zaehres</surname><given-names>H</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>Human Skeletal Muscle Organoids Model Fetal Myogenesis and Sustain Uncommitted PAX7 Myogenic Progenitors</article-title><source>bioRxiv</source><pub-id pub-id-type="doi">10.1101/2020.09.14.295832</pub-id></element-citation></ref><ref id="bib38"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Messina</surname><given-names>G</given-names></name><name><surname>Biressi</surname><given-names>S</given-names></name><name><surname>Monteverde</surname><given-names>S</given-names></name><name><surname>Magli</surname><given-names>A</given-names></name><name><surname>Cassano</surname><given-names>M</given-names></name><name><surname>Perani</surname><given-names>L</given-names></name><name><surname>Roncaglia</surname><given-names>E</given-names></name><name><surname>Tagliafico</surname><given-names>E</given-names></name><name><surname>Starnes</surname><given-names>L</given-names></name><name><surname>Campbell</surname><given-names>CE</given-names></name><name><surname>Grossi</surname><given-names>M</given-names></name><name><surname>Goldhamer</surname><given-names>DJ</given-names></name><name><surname>Gronostajski</surname><given-names>RM</given-names></name><name><surname>Cossu</surname><given-names>G</given-names></name></person-group><year iso-8601-date="2010">2010</year><article-title>Nfix regulates fetal-specific transcription in developing skeletal muscle</article-title><source>Cell</source><volume>140</volume><fpage>554</fpage><lpage>566</lpage><pub-id pub-id-type="doi">10.1016/j.cell.2010.01.027</pub-id><pub-id pub-id-type="pmid">20178747</pub-id></element-citation></ref><ref id="bib39"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Montarras</surname><given-names>D</given-names></name><name><surname>Morgan</surname><given-names>J</given-names></name><name><surname>Collins</surname><given-names>C</given-names></name><name><surname>Relaix</surname><given-names>F</given-names></name><name><surname>Zaffran</surname><given-names>S</given-names></name><name><surname>Cumano</surname><given-names>A</given-names></name><name><surname>Partridge</surname><given-names>T</given-names></name><name><surname>Buckingham</surname><given-names>M</given-names></name></person-group><year iso-8601-date="2005">2005</year><article-title>Direct isolation of satellite cells for skeletal muscle regeneration</article-title><source>Science</source><volume>309</volume><fpage>2064</fpage><lpage>2067</lpage><pub-id pub-id-type="doi">10.1126/science.1114758</pub-id><pub-id pub-id-type="pmid">16141372</pub-id></element-citation></ref><ref id="bib40"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Moore</surname><given-names>R</given-names></name><name><surname>Walsh</surname><given-names>FS</given-names></name></person-group><year iso-8601-date="1993">1993</year><article-title>The cell adhesion molecule M-cadherin is specifically expressed in developing and regenerating, but not denervated skeletal muscle</article-title><source>Development</source><volume>117</volume><fpage>1409</fpage><lpage>1420</lpage><pub-id pub-id-type="doi">10.1242/dev.117.4.1409</pub-id><pub-id pub-id-type="pmid">8404540</pub-id></element-citation></ref><ref id="bib41"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Murphy</surname><given-names>M</given-names></name><name><surname>Reid</surname><given-names>K</given-names></name><name><surname>Ford</surname><given-names>M</given-names></name><name><surname>Furness</surname><given-names>JB</given-names></name><name><surname>Bartlett</surname><given-names>PF</given-names></name></person-group><year iso-8601-date="1994">1994</year><article-title>FGF2 regulates proliferation of neural crest cells, with subsequent neuronal differentiation regulated by LIF or related factors</article-title><source>Development</source><volume>120</volume><fpage>3519</fpage><lpage>3528</lpage><pub-id pub-id-type="doi">10.1242/dev.120.12.3519</pub-id><pub-id pub-id-type="pmid">7821219</pub-id></element-citation></ref><ref id="bib42"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Panopoulos</surname><given-names>AD</given-names></name><name><surname>D’Antonio</surname><given-names>M</given-names></name><name><surname>Benaglio</surname><given-names>P</given-names></name><name><surname>Williams</surname><given-names>R</given-names></name><name><surname>Hashem</surname><given-names>SI</given-names></name><name><surname>Schuldt</surname><given-names>BM</given-names></name><name><surname>DeBoever</surname><given-names>C</given-names></name><name><surname>Arias</surname><given-names>AD</given-names></name><name><surname>Garcia</surname><given-names>M</given-names></name><name><surname>Nelson</surname><given-names>BC</given-names></name><name><surname>Harismendy</surname><given-names>O</given-names></name><name><surname>Jakubosky</surname><given-names>DA</given-names></name><name><surname>Donovan</surname><given-names>MKR</given-names></name><name><surname>Greenwald</surname><given-names>WW</given-names></name><name><surname>Farnam</surname><given-names>K</given-names></name><name><surname>Cook</surname><given-names>M</given-names></name><name><surname>Borja</surname><given-names>V</given-names></name><name><surname>Miller</surname><given-names>CA</given-names></name><name><surname>Grinstein</surname><given-names>JD</given-names></name><name><surname>Drees</surname><given-names>F</given-names></name><name><surname>Okubo</surname><given-names>J</given-names></name><name><surname>Diffenderfer</surname><given-names>KE</given-names></name><name><surname>Hishida</surname><given-names>Y</given-names></name><name><surname>Modesto</surname><given-names>V</given-names></name><name><surname>Dargitz</surname><given-names>CT</given-names></name><name><surname>Feiring</surname><given-names>R</given-names></name><name><surname>Zhao</surname><given-names>C</given-names></name><name><surname>Aguirre</surname><given-names>A</given-names></name><name><surname>McGarry</surname><given-names>TJ</given-names></name><name><surname>Matsui</surname><given-names>H</given-names></name><name><surname>Li</surname><given-names>H</given-names></name><name><surname>Reyna</surname><given-names>J</given-names></name><name><surname>Rao</surname><given-names>F</given-names></name><name><surname>O’Connor</surname><given-names>DT</given-names></name><name><surname>Yeo</surname><given-names>GW</given-names></name><name><surname>Evans</surname><given-names>SM</given-names></name><name><surname>Chi</surname><given-names>NC</given-names></name><name><surname>Jepsen</surname><given-names>K</given-names></name><name><surname>Nariai</surname><given-names>N</given-names></name><name><surname>Müller</surname><given-names>F-J</given-names></name><name><surname>Goldstein</surname><given-names>LSB</given-names></name><name><surname>Izpisua Belmonte</surname><given-names>JC</given-names></name><name><surname>Adler</surname><given-names>E</given-names></name><name><surname>Loring</surname><given-names>JF</given-names></name><name><surname>Berggren</surname><given-names>WT</given-names></name><name><surname>D’Antonio-Chronowska</surname><given-names>A</given-names></name><name><surname>Smith</surname><given-names>EN</given-names></name><name><surname>Frazer</surname><given-names>KA</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>iPSCORE: A Resource of 222 iPSC Lines Enabling Functional Characterization of Genetic Variation across A Variety of Cell Types</article-title><source>Stem Cell Reports</source><volume>8</volume><fpage>1086</fpage><lpage>1100</lpage><pub-id pub-id-type="doi">10.1016/j.stemcr.2017.03.012</pub-id></element-citation></ref><ref id="bib43"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Park</surname><given-names>IH</given-names></name><name><surname>Arora</surname><given-names>N</given-names></name><name><surname>Huo</surname><given-names>H</given-names></name><name><surname>Maherali</surname><given-names>N</given-names></name><name><surname>Ahfeldt</surname><given-names>T</given-names></name><name><surname>Shimamura</surname><given-names>A</given-names></name><name><surname>Lensch</surname><given-names>MW</given-names></name><name><surname>Cowan</surname><given-names>C</given-names></name><name><surname>Hochedlinger</surname><given-names>K</given-names></name><name><surname>Daley</surname><given-names>GQ</given-names></name></person-group><year iso-8601-date="2008">2008</year><article-title>Disease-specific induced pluripotent stem cells</article-title><source>Cell</source><volume>134</volume><fpage>877</fpage><lpage>886</lpage><pub-id pub-id-type="doi">10.1016/j.cell.2008.07.041</pub-id><pub-id pub-id-type="pmid">18691744</pub-id></element-citation></ref><ref id="bib44"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Porpiglia</surname><given-names>E</given-names></name><name><surname>Samusik</surname><given-names>N</given-names></name><name><surname>Ho</surname><given-names>ATV</given-names></name><name><surname>Cosgrove</surname><given-names>BD</given-names></name><name><surname>Mai</surname><given-names>T</given-names></name><name><surname>Davis</surname><given-names>KL</given-names></name><name><surname>Jager</surname><given-names>A</given-names></name><name><surname>Nolan</surname><given-names>GP</given-names></name><name><surname>Bendall</surname><given-names>SC</given-names></name><name><surname>Fantl</surname><given-names>WJ</given-names></name><name><surname>Blau</surname><given-names>HM</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>High-resolution myogenic lineage mapping by single-cell mass cytometry</article-title><source>Nature Cell Biology</source><volume>19</volume><fpage>558</fpage><lpage>567</lpage><pub-id pub-id-type="doi">10.1038/ncb3507</pub-id><pub-id pub-id-type="pmid">28414312</pub-id></element-citation></ref><ref id="bib45"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Quarta</surname><given-names>M</given-names></name><name><surname>Brett</surname><given-names>JO</given-names></name><name><surname>DiMarco</surname><given-names>R</given-names></name><name><surname>De Morree</surname><given-names>A</given-names></name><name><surname>Boutet</surname><given-names>SC</given-names></name><name><surname>Chacon</surname><given-names>R</given-names></name><name><surname>Gibbons</surname><given-names>MC</given-names></name><name><surname>Garcia</surname><given-names>VA</given-names></name><name><surname>Su</surname><given-names>J</given-names></name><name><surname>Shrager</surname><given-names>JB</given-names></name><name><surname>Heilshorn</surname><given-names>S</given-names></name><name><surname>Rando</surname><given-names>TA</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>An artificial niche preserves the quiescence of muscle stem cells and enhances their therapeutic efficacy</article-title><source>Nature Biotechnology</source><volume>34</volume><fpage>752</fpage><lpage>759</lpage><pub-id pub-id-type="doi">10.1038/nbt.3576</pub-id><pub-id pub-id-type="pmid">27240197</pub-id></element-citation></ref><ref id="bib46"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Raines</surname><given-names>AM</given-names></name><name><surname>Magella</surname><given-names>B</given-names></name><name><surname>Adam</surname><given-names>M</given-names></name><name><surname>Potter</surname><given-names>SS</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>Key pathways regulated by HoxA9,10,11/HoxD9,10,11 during limb development</article-title><source>BMC Developmental Biology</source><volume>15</volume><elocation-id>28</elocation-id><pub-id pub-id-type="doi">10.1186/s12861-015-0078-5</pub-id><pub-id pub-id-type="pmid">26186931</pub-id></element-citation></ref><ref id="bib47"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rao</surname><given-names>L</given-names></name><name><surname>Qian</surname><given-names>Y</given-names></name><name><surname>Khodabukus</surname><given-names>A</given-names></name><name><surname>Ribar</surname><given-names>T</given-names></name><name><surname>Bursac</surname><given-names>N</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>Engineering human pluripotent stem cells into a functional skeletal muscle tissue</article-title><source>Nature Communications</source><volume>9</volume><elocation-id>126</elocation-id><pub-id pub-id-type="doi">10.1038/s41467-017-02636-4</pub-id><pub-id pub-id-type="pmid">29317646</pub-id></element-citation></ref><ref id="bib48"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Relaix</surname><given-names>F</given-names></name><name><surname>Rocancourt</surname><given-names>D</given-names></name><name><surname>Mansouri</surname><given-names>A</given-names></name><name><surname>Buckingham</surname><given-names>M</given-names></name></person-group><year iso-8601-date="2005">2005</year><article-title>A Pax3/Pax7-dependent population of skeletal muscle progenitor cells</article-title><source>Nature</source><volume>435</volume><fpage>948</fpage><lpage>953</lpage><pub-id pub-id-type="doi">10.1038/nature03594</pub-id><pub-id pub-id-type="pmid">15843801</pub-id></element-citation></ref><ref id="bib49"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Roellig</surname><given-names>D</given-names></name><name><surname>Tan-Cabugao</surname><given-names>J</given-names></name><name><surname>Esaian</surname><given-names>S</given-names></name><name><surname>Bronner</surname><given-names>ME</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>Dynamic transcriptional signature and cell fate analysis reveals plasticity of individual neural plate border cells</article-title><source>eLife</source><volume>6</volume><elocation-id>e21620</elocation-id><pub-id pub-id-type="doi">10.7554/eLife.21620</pub-id><pub-id pub-id-type="pmid">28355135</pub-id></element-citation></ref><ref id="bib50"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rubenstein</surname><given-names>AB</given-names></name><name><surname>Smith</surname><given-names>GR</given-names></name><name><surname>Raue</surname><given-names>U</given-names></name><name><surname>Begue</surname><given-names>G</given-names></name><name><surname>Minchev</surname><given-names>K</given-names></name><name><surname>Ruf-Zamojski</surname><given-names>F</given-names></name><name><surname>Nair</surname><given-names>VD</given-names></name><name><surname>Wang</surname><given-names>X</given-names></name><name><surname>Zhou</surname><given-names>L</given-names></name><name><surname>Zaslavsky</surname><given-names>E</given-names></name><name><surname>Trappe</surname><given-names>TA</given-names></name><name><surname>Trappe</surname><given-names>S</given-names></name><name><surname>Sealfon</surname><given-names>SC</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>Single-cell transcriptional profiles in human skeletal muscle</article-title><source>Scientific Reports</source><volume>10</volume><elocation-id>229</elocation-id><pub-id pub-id-type="doi">10.1038/s41598-019-57110-6</pub-id><pub-id pub-id-type="pmid">31937892</pub-id></element-citation></ref><ref id="bib51"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Seale</surname><given-names>P</given-names></name><name><surname>Sabourin</surname><given-names>LA</given-names></name><name><surname>Girgis-Gabardo</surname><given-names>A</given-names></name><name><surname>Mansouri</surname><given-names>A</given-names></name><name><surname>Gruss</surname><given-names>P</given-names></name><name><surname>Rudnicki</surname><given-names>MA</given-names></name></person-group><year iso-8601-date="2000">2000</year><article-title>Pax7 is required for the specification of myogenic satellite cells</article-title><source>Cell</source><volume>102</volume><fpage>777</fpage><lpage>786</lpage><pub-id pub-id-type="doi">10.1016/s0092-8674(00)00066-0</pub-id><pub-id pub-id-type="pmid">11030621</pub-id></element-citation></ref><ref id="bib52"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shahriyari</surname><given-names>M</given-names></name><name><surname>Islam</surname><given-names>MR</given-names></name><name><surname>Sakib</surname><given-names>SM</given-names></name><name><surname>Rinn</surname><given-names>M</given-names></name><name><surname>Rika</surname><given-names>A</given-names></name><name><surname>Krüger</surname><given-names>D</given-names></name><name><surname>Kaurani</surname><given-names>L</given-names></name><name><surname>Gisa</surname><given-names>V</given-names></name><name><surname>Winterhoff</surname><given-names>M</given-names></name><name><surname>Anandakumar</surname><given-names>H</given-names></name><name><surname>Shomroni</surname><given-names>O</given-names></name><name><surname>Schmidt</surname><given-names>M</given-names></name><name><surname>Salinas</surname><given-names>G</given-names></name><name><surname>Unger</surname><given-names>A</given-names></name><name><surname>Linke</surname><given-names>WA</given-names></name><name><surname>Zschüntzsch</surname><given-names>J</given-names></name><name><surname>Schmidt</surname><given-names>J</given-names></name><name><surname>Bassel-Duby</surname><given-names>R</given-names></name><name><surname>Olson</surname><given-names>EN</given-names></name><name><surname>Fischer</surname><given-names>A</given-names></name><name><surname>Zimmermann</surname><given-names>WH</given-names></name><name><surname>Tiburcy</surname><given-names>M</given-names></name></person-group><year iso-8601-date="2022">2022</year><article-title>Engineered skeletal muscle recapitulates human muscle development, regeneration and dystrophy</article-title><source>Journal of Cachexia, Sarcopenia and Muscle</source><volume>13</volume><fpage>3106</fpage><lpage>3121</lpage><pub-id pub-id-type="doi">10.1002/jcsm.13094</pub-id><pub-id pub-id-type="pmid">36254806</pub-id></element-citation></ref><ref id="bib53"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shao</surname><given-names>Z</given-names></name><name><surname>Mellor</surname><given-names>IR</given-names></name><name><surname>Brierley</surname><given-names>MJ</given-names></name><name><surname>Harris</surname><given-names>J</given-names></name><name><surname>Usherwood</surname><given-names>PN</given-names></name></person-group><year iso-8601-date="1998">1998</year><article-title>Potentiation and inhibition of nicotinic acetylcholine receptors by spermine in the TE671 human muscle cell line</article-title><source>The Journal of Pharmacology and Experimental Therapeutics</source><volume>286</volume><fpage>1269</fpage><lpage>1276</lpage><pub-id pub-id-type="pmid">9732388</pub-id></element-citation></ref><ref id="bib54"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shea</surname><given-names>KL</given-names></name><name><surname>Xiang</surname><given-names>W</given-names></name><name><surname>LaPorta</surname><given-names>VS</given-names></name><name><surname>Licht</surname><given-names>JD</given-names></name><name><surname>Keller</surname><given-names>C</given-names></name><name><surname>Basson</surname><given-names>MA</given-names></name><name><surname>Brack</surname><given-names>AS</given-names></name></person-group><year iso-8601-date="2010">2010</year><article-title>Sprouty1 regulates reversible quiescence of a self-renewing adult muscle stem cell pool during regeneration</article-title><source>Cell Stem Cell</source><volume>6</volume><fpage>117</fpage><lpage>129</lpage><pub-id pub-id-type="doi">10.1016/j.stem.2009.12.015</pub-id><pub-id pub-id-type="pmid">20144785</pub-id></element-citation></ref><ref id="bib55"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shelton</surname><given-names>M</given-names></name><name><surname>Metz</surname><given-names>J</given-names></name><name><surname>Liu</surname><given-names>J</given-names></name><name><surname>Carpenedo</surname><given-names>RL</given-names></name><name><surname>Demers</surname><given-names>SP</given-names></name><name><surname>Stanford</surname><given-names>WL</given-names></name><name><surname>Skerjanc</surname><given-names>IS</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>Derivation and expansion of PAX7-positive muscle progenitors from human and mouse embryonic stem cells</article-title><source>Stem Cell Reports</source><volume>3</volume><fpage>516</fpage><lpage>529</lpage><pub-id pub-id-type="doi">10.1016/j.stemcr.2014.07.001</pub-id><pub-id pub-id-type="pmid">25241748</pub-id></element-citation></ref><ref id="bib56"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shimozono</surname><given-names>S</given-names></name><name><surname>Iimura</surname><given-names>T</given-names></name><name><surname>Kitaguchi</surname><given-names>T</given-names></name><name><surname>Higashijima</surname><given-names>S-I</given-names></name><name><surname>Miyawaki</surname><given-names>A</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>Visualization of an endogenous retinoic acid gradient across embryonic development</article-title><source>Nature</source><volume>496</volume><fpage>363</fpage><lpage>366</lpage><pub-id pub-id-type="doi">10.1038/nature12037</pub-id><pub-id pub-id-type="pmid">23563268</pub-id></element-citation></ref><ref id="bib57"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shubin</surname><given-names>N</given-names></name><name><surname>Tabin</surname><given-names>C</given-names></name><name><surname>Carroll</surname><given-names>S</given-names></name></person-group><year iso-8601-date="1997">1997</year><article-title>Fossils, genes and the evolution of animal limbs</article-title><source>Nature</source><volume>388</volume><fpage>639</fpage><lpage>648</lpage><pub-id pub-id-type="doi">10.1038/41710</pub-id><pub-id pub-id-type="pmid">9262397</pub-id></element-citation></ref><ref id="bib58"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Soldatov</surname><given-names>R</given-names></name><name><surname>Kaucka</surname><given-names>M</given-names></name><name><surname>Kastriti</surname><given-names>ME</given-names></name><name><surname>Petersen</surname><given-names>J</given-names></name><name><surname>Chontorotzea</surname><given-names>T</given-names></name><name><surname>Englmaier</surname><given-names>L</given-names></name><name><surname>Akkuratova</surname><given-names>N</given-names></name><name><surname>Yang</surname><given-names>Y</given-names></name><name><surname>Häring</surname><given-names>M</given-names></name><name><surname>Dyachuk</surname><given-names>V</given-names></name><name><surname>Bock</surname><given-names>C</given-names></name><name><surname>Farlik</surname><given-names>M</given-names></name><name><surname>Piacentino</surname><given-names>ML</given-names></name><name><surname>Boismoreau</surname><given-names>F</given-names></name><name><surname>Hilscher</surname><given-names>MM</given-names></name><name><surname>Yokota</surname><given-names>C</given-names></name><name><surname>Qian</surname><given-names>X</given-names></name><name><surname>Nilsson</surname><given-names>M</given-names></name><name><surname>Bronner</surname><given-names>ME</given-names></name><name><surname>Croci</surname><given-names>L</given-names></name><name><surname>Hsiao</surname><given-names>W-Y</given-names></name><name><surname>Guertin</surname><given-names>DA</given-names></name><name><surname>Brunet</surname><given-names>J-F</given-names></name><name><surname>Consalez</surname><given-names>GG</given-names></name><name><surname>Ernfors</surname><given-names>P</given-names></name><name><surname>Fried</surname><given-names>K</given-names></name><name><surname>Kharchenko</surname><given-names>PV</given-names></name><name><surname>Adameyko</surname><given-names>I</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>Spatiotemporal structure of cell fate decisions in murine neural crest</article-title><source>Science</source><volume>364</volume><elocation-id>eaas9536</elocation-id><pub-id pub-id-type="doi">10.1126/science.aas9536</pub-id><pub-id pub-id-type="pmid">31171666</pub-id></element-citation></ref><ref id="bib59"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Spence</surname><given-names>JR</given-names></name><name><surname>Mayhew</surname><given-names>CN</given-names></name><name><surname>Rankin</surname><given-names>SA</given-names></name><name><surname>Kuhar</surname><given-names>MF</given-names></name><name><surname>Vallance</surname><given-names>JE</given-names></name><name><surname>Tolle</surname><given-names>K</given-names></name><name><surname>Hoskins</surname><given-names>EE</given-names></name><name><surname>Kalinichenko</surname><given-names>VV</given-names></name><name><surname>Wells</surname><given-names>SI</given-names></name><name><surname>Zorn</surname><given-names>AM</given-names></name><name><surname>Shroyer</surname><given-names>NF</given-names></name><name><surname>Wells</surname><given-names>JM</given-names></name></person-group><year iso-8601-date="2011">2011</year><article-title>Directed differentiation of human pluripotent stem cells into intestinal tissue in vitro</article-title><source>Nature</source><volume>470</volume><fpage>105</fpage><lpage>109</lpage><pub-id pub-id-type="doi">10.1038/nature09691</pub-id><pub-id pub-id-type="pmid">21151107</pub-id></element-citation></ref><ref id="bib60"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Stuart</surname><given-names>T</given-names></name><name><surname>Butler</surname><given-names>A</given-names></name><name><surname>Hoffman</surname><given-names>P</given-names></name><name><surname>Hafemeister</surname><given-names>C</given-names></name><name><surname>Papalexi</surname><given-names>E</given-names></name><name><surname>Mauck</surname><given-names>WM</given-names></name><name><surname>Hao</surname><given-names>Y</given-names></name><name><surname>Stoeckius</surname><given-names>M</given-names></name><name><surname>Smibert</surname><given-names>P</given-names></name><name><surname>Satija</surname><given-names>R</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>Comprehensive integration of single-cell data</article-title><source>Cell</source><volume>177</volume><fpage>1888</fpage><lpage>1902</lpage><pub-id pub-id-type="doi">10.1016/j.cell.2019.05.031</pub-id><pub-id pub-id-type="pmid">31178118</pub-id></element-citation></ref><ref id="bib61"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sun</surname><given-names>C</given-names></name><name><surname>Kannan</surname><given-names>S</given-names></name><name><surname>Choi</surname><given-names>IY</given-names></name><name><surname>Lim</surname><given-names>H</given-names></name><name><surname>Zhang</surname><given-names>H</given-names></name><name><surname>Chen</surname><given-names>GS</given-names></name><name><surname>Zhang</surname><given-names>N</given-names></name><name><surname>Park</surname><given-names>S-H</given-names></name><name><surname>Serra</surname><given-names>C</given-names></name><name><surname>Iyer</surname><given-names>SR</given-names></name><name><surname>Lloyd</surname><given-names>TE</given-names></name><name><surname>Kwon</surname><given-names>C</given-names></name><name><surname>Lovering</surname><given-names>RM</given-names></name><name><surname>Lim</surname><given-names>SB</given-names></name><name><surname>Andersen</surname><given-names>P</given-names></name><name><surname>Wagner</surname><given-names>KR</given-names></name><name><surname>Lee</surname><given-names>G</given-names></name></person-group><year iso-8601-date="2022">2022</year><article-title>Human pluripotent stem cell-derived myogenic progenitors undergo maturation to quiescent satellite cells upon engraftment</article-title><source>Cell Stem Cell</source><volume>29</volume><fpage>610</fpage><lpage>619</lpage><pub-id pub-id-type="doi">10.1016/j.stem.2022.03.004</pub-id></element-citation></ref><ref id="bib62"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tierney</surname><given-names>MT</given-names></name><name><surname>Gromova</surname><given-names>A</given-names></name><name><surname>Sesillo</surname><given-names>FB</given-names></name><name><surname>Sala</surname><given-names>D</given-names></name><name><surname>Spenlé</surname><given-names>C</given-names></name><name><surname>Orend</surname><given-names>G</given-names></name><name><surname>Sacco</surname><given-names>A</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>Autonomous extracellular matrix remodeling controls a progressive adaptation in muscle stem cell regenerative capacity during development</article-title><source>Cell Reports</source><volume>14</volume><fpage>1940</fpage><lpage>1952</lpage><pub-id pub-id-type="doi">10.1016/j.celrep.2016.01.072</pub-id><pub-id pub-id-type="pmid">26904948</pub-id></element-citation></ref><ref id="bib63"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Troy</surname><given-names>A</given-names></name><name><surname>Cadwallader</surname><given-names>AB</given-names></name><name><surname>Fedorov</surname><given-names>Y</given-names></name><name><surname>Tyner</surname><given-names>K</given-names></name><name><surname>Tanaka</surname><given-names>KK</given-names></name><name><surname>Olwin</surname><given-names>BB</given-names></name></person-group><year iso-8601-date="2012">2012</year><article-title>Coordination of satellite cell activation and self-renewal by Par-complex-dependent asymmetric activation of p38α/β MAPK</article-title><source>Cell Stem Cell</source><volume>11</volume><fpage>541</fpage><lpage>553</lpage><pub-id pub-id-type="doi">10.1016/j.stem.2012.05.025</pub-id><pub-id pub-id-type="pmid">23040480</pub-id></element-citation></ref><ref id="bib64"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Uezumi</surname><given-names>A</given-names></name><name><surname>Fukada</surname><given-names>S</given-names></name><name><surname>Yamamoto</surname><given-names>N</given-names></name><name><surname>Takeda</surname><given-names>S</given-names></name><name><surname>Tsuchida</surname><given-names>K</given-names></name></person-group><year iso-8601-date="2010">2010</year><article-title>Mesenchymal progenitors distinct from satellite cells contribute to ectopic fat cell formation in skeletal muscle</article-title><source>Nature Cell Biology</source><volume>12</volume><fpage>143</fpage><lpage>152</lpage><pub-id pub-id-type="doi">10.1038/ncb2014</pub-id><pub-id pub-id-type="pmid">20081842</pub-id></element-citation></ref><ref id="bib65"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Uezumi</surname><given-names>A</given-names></name><name><surname>Ito</surname><given-names>T</given-names></name><name><surname>Morikawa</surname><given-names>D</given-names></name><name><surname>Shimizu</surname><given-names>N</given-names></name><name><surname>Yoneda</surname><given-names>T</given-names></name><name><surname>Segawa</surname><given-names>M</given-names></name><name><surname>Yamaguchi</surname><given-names>M</given-names></name><name><surname>Ogawa</surname><given-names>R</given-names></name><name><surname>Matev</surname><given-names>MM</given-names></name><name><surname>Miyagoe-Suzuki</surname><given-names>Y</given-names></name><name><surname>Takeda</surname><given-names>S</given-names></name><name><surname>Tsujikawa</surname><given-names>K</given-names></name><name><surname>Tsuchida</surname><given-names>K</given-names></name><name><surname>Yamamoto</surname><given-names>H</given-names></name><name><surname>Fukada</surname><given-names>S</given-names></name></person-group><year iso-8601-date="2011">2011</year><article-title>Fibrosis and adipogenesis originate from a common mesenchymal progenitor in skeletal muscle</article-title><source>Journal of Cell Science</source><volume>124</volume><fpage>3654</fpage><lpage>3664</lpage><pub-id pub-id-type="doi">10.1242/jcs.086629</pub-id><pub-id pub-id-type="pmid">22045730</pub-id></element-citation></ref><ref id="bib66"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Verma</surname><given-names>M</given-names></name><name><surname>Asakura</surname><given-names>Y</given-names></name><name><surname>Murakonda</surname><given-names>BSR</given-names></name><name><surname>Pengo</surname><given-names>T</given-names></name><name><surname>Latroche</surname><given-names>C</given-names></name><name><surname>Chazaud</surname><given-names>B</given-names></name><name><surname>McLoon</surname><given-names>LK</given-names></name><name><surname>Asakura</surname><given-names>A</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>Muscle satellite cell cross-talk with a vascular niche maintains quiescence via VEGF and notch signaling</article-title><source>Cell Stem Cell</source><volume>23</volume><fpage>530</fpage><lpage>543</lpage><pub-id pub-id-type="doi">10.1016/j.stem.2018.09.007</pub-id><pub-id pub-id-type="pmid">30290177</pub-id></element-citation></ref><ref id="bib67"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Xi</surname><given-names>H</given-names></name><name><surname>Fujiwara</surname><given-names>W</given-names></name><name><surname>Gonzalez</surname><given-names>K</given-names></name><name><surname>Jan</surname><given-names>M</given-names></name><name><surname>Liebscher</surname><given-names>S</given-names></name><name><surname>Van Handel</surname><given-names>B</given-names></name><name><surname>Schenke-Layland</surname><given-names>K</given-names></name><name><surname>Pyle</surname><given-names>AD</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>In vivo human somitogenesis guides somite development from hPSCs</article-title><source>Cell Reports</source><volume>18</volume><fpage>1573</fpage><lpage>1585</lpage><pub-id pub-id-type="doi">10.1016/j.celrep.2017.01.040</pub-id><pub-id pub-id-type="pmid">28178531</pub-id></element-citation></ref><ref id="bib68"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Xi</surname><given-names>H</given-names></name><name><surname>Langerman</surname><given-names>J</given-names></name><name><surname>Sabri</surname><given-names>S</given-names></name><name><surname>Chien</surname><given-names>P</given-names></name><name><surname>Young</surname><given-names>CS</given-names></name><name><surname>Younesi</surname><given-names>S</given-names></name><name><surname>Hicks</surname><given-names>M</given-names></name><name><surname>Gonzalez</surname><given-names>K</given-names></name><name><surname>Fujiwara</surname><given-names>W</given-names></name><name><surname>Marzi</surname><given-names>J</given-names></name><name><surname>Liebscher</surname><given-names>S</given-names></name><name><surname>Spencer</surname><given-names>M</given-names></name><name><surname>Van Handel</surname><given-names>B</given-names></name><name><surname>Evseenko</surname><given-names>D</given-names></name><name><surname>Schenke-Layland</surname><given-names>K</given-names></name><name><surname>Plath</surname><given-names>K</given-names></name><name><surname>Pyle</surname><given-names>AD</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>A human skeletal muscle atlas identifies the trajectories of stem and progenitor cells across development and from human pluripotent stem cells</article-title><source>Cell Stem Cell</source><volume>27</volume><fpage>181</fpage><lpage>185</lpage><pub-id pub-id-type="doi">10.1016/j.stem.2020.06.006</pub-id><pub-id pub-id-type="pmid">32619514</pub-id></element-citation></ref><ref id="bib69"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Xu</surname><given-names>B</given-names></name><name><surname>Wellik</surname><given-names>DM</given-names></name></person-group><year iso-8601-date="2011">2011</year><article-title>Axial Hox9 activity establishes the posterior field in the developing forelimb</article-title><source>PNAS</source><volume>108</volume><fpage>4888</fpage><lpage>4891</lpage><pub-id pub-id-type="doi">10.1073/pnas.1018161108</pub-id><pub-id pub-id-type="pmid">21383175</pub-id></element-citation></ref></ref-list></back><sub-article article-type="editor-report" id="sa0"><front-stub><article-id pub-id-type="doi">10.7554/eLife.87081.3.sa0</article-id><title-group><article-title>eLife assessment</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Huang</surname><given-names>Christopher L-H</given-names></name><role specific-use="editor">Reviewing Editor</role><aff><institution>University of Cambridge</institution><country>United Kingdom</country></aff></contrib></contrib-group><kwd-group kwd-group-type="evidence-strength"><kwd>Convincing</kwd></kwd-group><kwd-group kwd-group-type="claim-importance"><kwd>Useful</kwd></kwd-group></front-stub><body><p>The authors develop a cell culture system for studies of muscle tissue development and homeostasis. They <bold>convincingly</bold> validate a novel 3D cell model. Their thorough molecular and functional characterization will make this <bold>useful</bold> for future workers in the field.</p></body></sub-article><sub-article article-type="referee-report" id="sa1"><front-stub><article-id pub-id-type="doi">10.7554/eLife.87081.3.sa1</article-id><title-group><article-title>Reviewer #1 (Public Review):</article-title></title-group><contrib-group><contrib contrib-type="author"><anonymous/><role specific-use="referee">Reviewer</role></contrib></contrib-group></front-stub><body><p>The authors aimed to establish a cell culture system to investigate muscle tissue development and homeostasis. They successfully developed a complex 3D cell model and conducted a comprehensive molecular and functional characterization. This approach represents a critical initial step towards using human cells, rather than animals, to study muscular disorders in vitro. Although the current protocol is time-consuming and the fetal cell model may not be mature enough to study adult-onset diseases, it nonetheless provides a valuable foundation for future disease modeling studies using isogenic iPSC lines or patient-derived cells with specific mutations. The manuscript does not explore whether or how this stem cell model can advance our understanding of muscular diseases, which would be an exciting avenue for future research. Overall, the detailed protocol presented in this paper will be useful for informing future studies and provide a valuable resource to the stem cells community. Future work could focus on disease modeling using isogenic iPSC lines or patient-derived cells.</p></body></sub-article><sub-article article-type="referee-report" id="sa2"><front-stub><article-id pub-id-type="doi">10.7554/eLife.87081.3.sa2</article-id><title-group><article-title>Reviewer #2 (Public Review):</article-title></title-group><contrib-group><contrib contrib-type="author"><anonymous/><role specific-use="referee">Reviewer</role></contrib></contrib-group></front-stub><body><p>This paper illustrates that PSCs can model myogenesis in vitro by mimicking the in vivo development of the somite and dermomyotome. The advantages of this 3D system include (1) better structural distinctions, (2) the persistence of progenitors, and (3) the spatial distribution (e.g. migration, confinement) of progenitors. The finding is important with the implication in disease modeling. Indeed the authors tried DMD model although it suffered the lack of deeper characterization.</p><p>The differentiation protocol is based on a current understanding of myogenesis and is compelling. They characterized the organoids in depth (e.g. many time points and immunofluorescence). The evidence is solid.</p></body></sub-article><sub-article article-type="author-comment" id="sa3"><front-stub><article-id pub-id-type="doi">10.7554/eLife.87081.3.sa3</article-id><title-group><article-title>Author Response</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Mavrommatis</surname><given-names>Lampros</given-names></name><role specific-use="author">Author</role><aff><institution>Ruhr University Bochum</institution><addr-line><named-content content-type="city">Bochum</named-content></addr-line><country>Germany</country></aff></contrib><contrib contrib-type="author"><name><surname>Jeong</surname><given-names>Hyun-Woo</given-names></name><role specific-use="author">Author</role><aff><institution>Max Planck Institute for Molecular Biomedicine</institution><addr-line><named-content content-type="city">Münster</named-content></addr-line><country>Germany</country></aff></contrib><contrib contrib-type="author"><name><surname>Kindler</surname><given-names>Urs</given-names></name><role specific-use="author">Author</role><aff><institution>Ruhr University Bochum</institution><addr-line><named-content content-type="city">Bochum</named-content></addr-line><country>Germany</country></aff></contrib><contrib contrib-type="author"><name><surname>Gomez-Giro</surname><given-names>Gemma</given-names></name><role specific-use="author">Author</role><aff><institution>University of Luxembourg</institution><addr-line><named-content content-type="city">Belvaux</named-content></addr-line><country>Luxembourg</country></aff></contrib><contrib contrib-type="author"><name><surname>Kienitz</surname><given-names>Marie-Cecile</given-names></name><role specific-use="author">Author</role><aff><institution>Ruhr University Bochum</institution><addr-line><named-content content-type="city">Bochum</named-content></addr-line><country>Germany</country></aff></contrib><contrib contrib-type="author"><name><surname>Stehling</surname><given-names>Martin</given-names></name><role specific-use="author">Author</role><aff><institution>Max Planck Institute for Molecular Biomedicine</institution><addr-line><named-content content-type="city">Münster</named-content></addr-line><country>Germany</country></aff></contrib><contrib contrib-type="author"><name><surname>Psathaki</surname><given-names>Olympia E</given-names></name><role specific-use="author">Author</role><aff><institution>CellNanOs Center of Cellular Nanoanalytics Osnabruck</institution><addr-line><named-content content-type="city">Osnabruck</named-content></addr-line><country>Germany</country></aff></contrib><contrib contrib-type="author"><name><surname>Zeuschner</surname><given-names>Dagmar</given-names></name><role specific-use="author">Author</role><aff><institution>Max Planck Institute for Molecular Biomedicine</institution><addr-line><named-content content-type="city">Muenster</named-content></addr-line><country>Germany</country></aff></contrib><contrib contrib-type="author"><name><surname>Bixel</surname><given-names>Gabriele</given-names></name><role specific-use="author">Author</role><aff><institution>Max Planck Institute for Molecular Biomedicine</institution><addr-line><named-content content-type="city">Münster</named-content></addr-line><country>Germany</country></aff></contrib><contrib contrib-type="author"><name><surname>Han</surname><given-names>Dong</given-names></name><role specific-use="author">Author</role><aff><institution>Max Planck Institute for Molecular Biomedicine</institution><addr-line><named-content content-type="city">Münster</named-content></addr-line><country>Germany</country></aff></contrib><contrib contrib-type="author"><name><surname>Morosan-Puopolo</surname><given-names>Gabriela</given-names></name><role specific-use="author">Author</role><aff><institution>Ruhr University Bochum</institution><addr-line><named-content content-type="city">Bochum</named-content></addr-line><country>Germany</country></aff></contrib><contrib contrib-type="author"><name><surname>Gerovska D</surname><given-names>Daniela</given-names></name><role specific-use="author">Author</role><aff><institution>Biodonostia Health Research Institute</institution><addr-line><named-content content-type="city">San Sebastián</named-content></addr-line><country>Spain</country></aff></contrib><contrib contrib-type="author"><name><surname>Yang</surname><given-names>Ji Hun</given-names></name><role specific-use="author">Author</role><aff><institution>Next&amp;Bio Inc.</institution><addr-line><named-content content-type="city">Seoul</named-content></addr-line><country>Republic of Korea</country></aff></contrib><contrib contrib-type="author"><name><surname>Kim</surname><given-names>Jeong Beom</given-names></name><role specific-use="author">Author</role><aff><institution>UNIST</institution><addr-line><named-content content-type="city">Ulsan</named-content></addr-line><country>Republic of Korea</country></aff></contrib><contrib contrib-type="author"><name><surname>Arauzo-Bravo</surname><given-names>Marcos J</given-names></name><role specific-use="author">Author</role><aff><institution>Biodonostia Health Research Institute</institution><addr-line><named-content content-type="city">San Sebastian</named-content></addr-line><country>Spain</country></aff></contrib><contrib contrib-type="author"><name><surname>Schwamborn</surname><given-names>Jens Christian</given-names></name><role specific-use="author">Author</role><aff><institution>University of Luxembourg</institution><addr-line><named-content content-type="city">Esch-sur-Alzette</named-content></addr-line><country>Luxembourg</country></aff></contrib><contrib contrib-type="author"><name><surname>Hahn</surname><given-names>Stephan</given-names></name><role specific-use="author">Author</role><aff><institution>Ruhr University Bochum</institution><addr-line><named-content content-type="city">Bochum</named-content></addr-line><country>Germany</country></aff></contrib><contrib contrib-type="author"><name><surname>Adams</surname><given-names>Ralf H</given-names></name><role specific-use="author">Author</role><aff><institution>Max Planck Institute for Molecular Biomedicine</institution><addr-line><named-content content-type="city">Münster</named-content></addr-line><country>Germany</country></aff></contrib><contrib contrib-type="author"><name><surname>Schöler</surname><given-names>Hans R</given-names></name><role specific-use="author">Author</role><aff><institution>Max Planck Institute for Molecular Biomedicine</institution><addr-line><named-content content-type="city">Münster</named-content></addr-line><country>Germany</country></aff></contrib><contrib contrib-type="author"><name><surname>Vorgerd</surname><given-names>Matthias</given-names></name><role specific-use="author">Author</role><aff><institution>University Hospital Bergmannsheil</institution><addr-line><named-content content-type="city">Bochum</named-content></addr-line><country>Germany</country></aff></contrib><contrib contrib-type="author"><name><surname>Brand-Saberi</surname><given-names>Beate</given-names></name><role specific-use="author">Author</role><aff><institution>Ruhr University Bochum</institution><addr-line><named-content content-type="city">Bochum</named-content></addr-line><country>Germany</country></aff></contrib><contrib contrib-type="author"><name><surname>Zaehres</surname><given-names>Holm</given-names></name><role specific-use="author">Author</role><aff><institution>Ruhr University Bochum</institution><addr-line><named-content content-type="city">Bochum</named-content></addr-line><country>Germany</country></aff></contrib></contrib-group></front-stub><body><p>The following is the authors’ response to the original reviews.</p><p>We want to thank you for organizing the review process a of our manuscript ‘Human skeletal muscle organoids model fetal myogenesis and sustain uncommitted PAX7+ myogenic progenitor’ for eLife and the reviewers for providing their criticisms.</p><p>We have changed some Figures within the manuscript and added two new Supplementary Figures as outlined below</p><disp-quote content-type="editor-comment"><p><bold>Reviewer #1 (Public Review):</bold></p><p>The authors aimed to establish a cell culture system to investigate muscle tissue development and homeostasis. They successfully developed a complex 3D cell model and conducted a comprehensive molecular and functional characterization. This approach represents a critical initial step towards using human cells, rather than animals, to study muscular disorders in vitro. Although the current protocol is time-consuming and the fetal cell model may not be mature enough to study adult-onset diseases, it nonetheless provides a valuable foundation for future disease modelling studies using isogenic iPSC lines or patient-derived cells with specific mutations. The manuscript does not explore whether or how this stem cell model can advance our understanding of muscular diseases, which would be an exciting avenue for future research. Overall, the detailed protocol presented in this paper will be useful for informing future studies and provides an important resource to the stem cells community. The inclusion of data on disease modelling using isogenic iPSC lines or patient-derived cells would further enhance the manuscript's impact.</p></disp-quote><p>We agree, that data on disease modelling using patient-derived cells would further enhance the manuscript's impact. The manuscript in its current form should present our skeletal muscle organoid differentiation protocol to the community with a focus of the developmental processes which are mimiced by this model. We are not aiming to disease model e.g. LGMD or Duchenne within the context of this study. Our protocol is just the starting point of us and others to use this organoid protocol for skeletal muscle disease modelling in further studies. We already have a study of Duchenne musculular dystrophy modelling using our organoid system under way.</p><disp-quote content-type="editor-comment"><p><bold>Reviewer #2 (Public Review):</bold></p><p>This paper illustrates that PSCs can model myogenesis in vitro by mimicking the in vivo development of the somite and dermomyotome. The advantages of this 3D system include (1) better structural distinctions, (2) the persistence of progenitors, and (3) the spatial distribution (e.g. migration, confinement) of progenitors. The finding is important with the implication in disease modeling. Indeed the authors tried DMD model although it suffered the lack of deeper characterization.</p><p>The differentiation protocol is based on a current understanding of myogenesis and compelling. They characterized the organoids in depth (e.g. many time points and immunofluorescence). The evidence is solid, and can be improved more by rigorous analyses and descriptions as described below.</p><p>Major comments:</p><p>1. Consistency between different cell lines.</p><p>I see the authors used a few different PSC lines. Since organoid efficiency differ between lines, it is important to note the consistency between lines.</p><p>1. Heterogeneity among each organoid</p><p>Let's say authors get 10 organoids in one well. Are they similar to each other? Does each organoid possess similar composition of cells? To determine the heterogeneity, the authors could try either FACS or multiple sectioning of each organoid.</p></disp-quote><p>Concerning the raised issue of consistency between different PSC lines we stated under Material and Methods that skeletal muscle organoids were generated from six hiPSC lines: CB-CD34 iPSC, DMD iPSC, DMD_iPS1, BMD_iPS1, LGMD2A iPSC, LGMD2A-isogenic iPSC. We have evaluated the organoid approach with six hiPSC lines with independent genetic backgrounds with more than 5 independent derivations per line, for the control line (CB CD34+) with more than 20 derivations. At the time of creating the first preprint in 2020 our reported protocol was based on about 45 independent differentiation inductions.</p><p>The heterogeneity among each organoid is a valid point, however very cumbersome to address with FACS or multiple sectioning.</p><p>We have now addressed the heterogeneity of organoids within a line and the consistency of organoids between different lines by diffusion map analysis for early organoid stages and further single cell RNA seq analyses for mature stages and include this data as Figure 4 – figure supplement 6.</p><disp-quote content-type="editor-comment"><p>1. Consistency of Ach current between organoids.</p><p>Related to comment 2, are the currents consistent between each organoid? How many organoids were recorded in the figures? Also, please comment if the current differ between young and aged organoids.</p></disp-quote><p>The acetylcholine (ACh)-induced changes in holding currents in Figure 3K are representative recordings with n = 6. The further recordings in Figure 3 – Figure Supplemental 3 for organoids derived from three additional lines, were also recorded with n = 6. Cells were taken for electrophysiological characterization in all analyses from 8 weeks organoids.</p><disp-quote content-type="editor-comment"><p>1. Communication between neural cells and muscle?</p><p>The authors did scRNAseq, but have not gone deep analysis. I would recommend doing Receptorligand mapping and address if neural cells and muscle are interacting.</p></disp-quote><p>We are now providing a characterization of the cell-cell communication network for all clusters at week 12 of human skeletal muscle organoid development as the new Figure 4 – figure supplement 5.</p><disp-quote content-type="editor-comment"><p>1. More characterization of DMD organoids.</p><p>One of the key applications of muscle organoids is disease model. They have generated DMD muscle organoids, but rarely characterized except for currents. I recommend conducting immunofluorescence of DMA organoids to confirm structure change. Very intriguing to see scRNAseq of DMD organoids and align with disease etiology.</p></disp-quote><p>We agree, that data on disease modelling using DMD patient-derived cells would further enhance the manuscript's impact. The manuscript in its current form should present our skeletal muscle organoid differentiation protocol to the community with a focus of the developmental processes which are mimiced by this model. We already have a study of Duchenne muscular dystrophy modelling using our organoid system under way.</p><disp-quote content-type="editor-comment"><p>1. More characterization of engraft.</p><p>Authors could measure the size of myotube between mice and human.</p></disp-quote><p>We have quantitatively evaluated the myotubes in the transplantation experiment illustrated in Figure 4I,J. The mean diameter is 41+/-6 µm for the human and 63+/-7 µm for the mice fibers (n = 15 each). See Author response image 1.</p><fig id="sa3fig1" position="float"><label>Author response image 1.</label><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-87081-sa3-fig1-v1.tif"/></fig><disp-quote content-type="editor-comment"><p>Does PAX7+ satellite cell exist in engraft? To exclude cell fusion events make up the observation, I recommend to engraft in GFP+ immunodeficient mice. Could the authors comment how long engraft survive.</p></disp-quote><p>We would claim satellite cells within our engrafts with the DAPI-blue nuclei surrounded by green human lamin A/C as in Author response image 2. We have analysed all our mice six weeks post transplantation for engrafting similar to other groups in the field.</p><fig id="sa3fig2" position="float"><label>Author response image 2.</label><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-87081-sa3-fig2-v1.tif"/></fig><disp-quote content-type="editor-comment"><p><bold>Reviewer #1 (Recommendations For The Authors):</bold></p><p>The manuscript ends abruptly with the mouse transplantation experiment that appears a bit preliminary. It basically shows that cells survive but functional (or ultrastructural) integration is not shown. Suggest clarifying motivation and interpretation of the in vivo data.</p></disp-quote><p>Back in 2020 our manuscript had already passed detailed review processes whereby we struggled by not providing any in vivo data concerning repopulation of our progenitor cells. Coming from the human pluripotent stem cell biology field we have never completely understood the value of this hybrid experiments to test human cells in mouse again.</p><p>For the current version, we have then taken additional efforts to transplant our progenitor cells into injured skeletal muscle cells similarly to other groups in the field (Alexander et al., 2016, Marg et al., 2019, Tanoury et al., 2020) (Figure 4I,J). A proof that 3D-derived progenitor cells have a clear repopulation advantage over progenitor cells derived in a 2D protocol would go beyond what can be done within the scope of our study. We are still mainly basing our claims on the extended bulk and single RNA seq comparison to progenitor cells obtained by others. However, to address the demand of several experts to test our cells also in vivo, we can also provide in vivo data in the current manuscript version.</p><p>Within the Discussion we are suggesting further evaluations using these transplantations: It would be of interest for future studies to investigate whether increased engraftment can be achieved in 3D protocols (Faustino Martins et al., 2020; Shahriyari et al., 2022; ours) versus 2D patterned progenitor cells.</p><disp-quote content-type="editor-comment"><p><bold>Reviewer #2 (Recommendations For The Authors):</bold></p><p>Minor comments:</p><p>1. Plot CD82 gene on UMAP of Figure 4</p></disp-quote><p>We had provided a CD82 scRNAseq analysis within the t-SNE plots of Figure 3 – figure supplement 1, which is demonstrating, that CD82-positive cells almost exclusively overlap with Pax7-positive cells, being a subcluster of them. We agree, that the reader will benefit from this further analysis and we are now providing in Author response image 3 additional CD82 and Pax7 UMAP plots on the myogenic progenitor / satellite cell clustering analysis of Figure 4F within the new Figure 4 – figure supplement 4E.</p><fig id="sa3fig3" position="float"><label>Author response image 3.</label><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-87081-sa3-fig3-v1.tif"/></fig><disp-quote content-type="editor-comment"><p>1. Immunofluorescence of CD82 in organoids</p></disp-quote><p>We have tried CD82 immunofluorescence analysis on our organoids but are not very satisfied with the technical outcome. The available CD82 antibody seems to be primarily suited for FACS analysis and not for immunohistochemistry on slices.</p><disp-quote content-type="editor-comment"><p>1. Change red-green color of the heatmap. Color-blind person cannot see it well</p></disp-quote><p>We have changed all heatmaps to yellow-purple in the main Figure 2G and the Supplemental Figures S2.1 and S3.1..</p></body></sub-article></article>